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The Nobel Prize in Medicine 1968 for interpretation of the genetic code and its function 
in protein synthesis and in Chemistry 2009 for studies of the structure and function of 
the ribosome highlighted the ground-breaking experiment performed on May 15, 1961 
by Nirenberg and Matthaei and their principal breakthrough on the creation of “cell-free 
protein synthesis (CFPS) system”. Since then the continuous technical advances have 
revitalized CFPS system as a simple and powerful technology platform for industrial and 
high-throughput protein production. CFPS yields exceed grams protein per liter reaction 
volume and offer several advantages including the ability to easily manipulate the 
reaction components and conditions to favor protein synthesis, decreased sensitivity to 
product toxicity, batch reactions last for multiple hours, costs have been reduced orders 
of magnitude, and suitability for miniaturization and high-throughput applications. 
With these advantages, there is continuous increasing interest in CFPS system among 
biotechnologists, molecular biologists and medical or pharmacologists.
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Preface 
A half century ago, Nierenberg and Matthaei discovered the first codon UUU for 
phenyl alanine using a cell-free translation system from DNase treated E.coli extract.
From that time on, the cell-free protein synthesis has been used for the analysis in
molecular biology, protein production and protein design, taking advantage of
compartment-free experiment. Post-genome proteomics and functional genomics
require a high throughput systematic production of proteins. Evolutionary protein 
engineering requires the translation of a large diversity library. Studies on the
translation itself (its molecular mechanism, its origin etc.) require a simplified model
system. Cell-free protein synthesis systems are useful for all these themes. This book 
reviews briefly the history of the translation and the history of its study. 
One of the most astonishing molecular events which molecular biology has discovered 
is the translation process, that is, a Natural digital-to-digital decoding process.
Structural biology found the ribozymatic peptidyl transferase action of ribosome and 
finally gave us the concept of RNA-makes-Protein. And it suggested the RNA+Protein
world was emerged from the RNA world. In the RNA world, the molecular coding
process was established probably due to three folds complementarities of RNA
molecules as follows: (i) complementary base pairing for amplification, (ii) 
complementary base pairing for folding and (iii) the complementarity between the
surface of the folded RNA and a ligand molecule. The first is related to genotype and
the second plus the third are related to phenotype. The phenotype as the molecular
function (e.g. specific binding to the ligand) could be digitally encoded in the genotype
as the base sequence of the RNA molecule, through the Darwinian selection process
just as that of exploiting an RNA aptamer. On the other hand, the decoding process is 
very simple, i.e., folding and binding. This is the digital-to-real-world decoding. The
above mentioned encoding process is also not so complicated, due to the RNA-type 
genotype-phenotype linking strategy, that is, both on the same molecule. Evolvability 
of RNA is based on this molecular coding ability. Using this evolvability, evolutionary 
RNA engineering in these two decades have been creating many kinds of functional 
artificial RNAs (including new drugs!) and thus indicated the potentiality of RNA
molecules and the physico-chemical possibility of the RNA world.
Linking with nucleic acids, polypeptide finally got evolvability and was able to
become proteins. The genotype-phenotype linking strategy for Darwinian selection of
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protein is not so simple. There are three types of the strategy in evolutionary protein 
engineering as follows: the virus-type, the cell-type and the external intelligence-type. 
In the virus–type, mRNA and its protein are bound together just as in the simplest 
virus particle. In the cell-type, mRNA and its protein are in a same compartment, e.g. a 
bacterial cell or a micro plate well. In the origin of the translation, what strategy was 
adopted is not clear. The most complicated aspect of the translation, however, may be 
the digital-to-digital decoding process. Note: there is no problem in the digital-to-digital 
encoding because there is no reverse-translation. The encoding process is accomplished 
via the Darwinian selection using this digital-to-digital decoding and the above 
mentioned genotype- phenotype linking. 
The central issue in the origin of the translation is the establishment of the genetic code 
table for the digital-to-digital decoding. Present-day standard genetic code table seems 
to be evolutionally optimized if we admit our twenty amino acids. But whether twenty 
and these twenty were optimal or not is open question. In fact, protein engineers have 
been introducing many kinds of non-natural amino acids, tricking the code table for 
their purposes. What is the primitive ribosome is also open question. But there is a 
primitive tRNA model as the first gene. Anyway there should have been a co-
evolution process of RNA replication and the primitive translation. There are 
evidences to suggest common unit processes in both RNA replication and the 
translation. Present-day standard genetic code table is almost universal on the Earth. 
And the translational apparatuses are the most conservative molecular machines. 
These indicate the bottleneck of the biological evolution on the Earth was the 
establishment of the translation. The enhancement of evolvability of an organism by 
introducing evolving proteins must overbalance the difficulties of passing the 
bottleneck. Thus, protein biosynthesis had two important aspects from the beginning 
as a matter of course: innovative molecular design and regulated production. These 
two aspects are also important for modern protein engineers. 
The editor of this monograph, Dr. Manish Biyani, is an innovative researcher in the 
field of cell-free protein synthesis, evolutionary protein engineering and experimental 
genome analysis. I hope readers enjoy the scope of Dr. Biyani and splendid 
informative chapters by expert scientists contributed in this book. 
Preface written by: 
Yuzuru Husimi  
Prof, Saitama University,  
Japan 
Preface confirmed by:  
Manish Biyani 
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1. Introduction 
Trypanosomatids are a monophyletic group of protozoa that diverged early from the 
eukaryotic lineage, constituting valuable model organisms for studying variability in 
different highly conserved processes including protein synthesis. Moreover, several species 
of trypanosomatids are causing agents of endemic diseases in the third world. There are 
many evidences suggesting that translation in these organisms shows important differences 
with that of model organisms such as yeast and mammals. These unique features, which 
have a great potential relevance for both basic and applied research, will be discussed in this 
chapter. 
2. Structural analysis 
2.1. Cryo-electron microscopy map of Trypanosoma cruzi ribosome:  
Unique features of the rRNA 
Using the cryo-electron microscopy (cryo-EM) technique, a 12Å resolution density map of 
the T. cruzi 80S ribosome has been constructed [1]. The overall structure of the T. cruzi 80S 
ribosome exhibits well defined small (40S) and large (60S) subunits (Figure 1). Some of the 
landmark characteristics of the ribosome structure can be identified in the density map. 
Compared with the 80S ribosome from yeast, both the small and large ribosomal subunits 
from T. cruzi are larger, mainly due to the size of the ribosomal RNA molecules. T. cruzi 
rRNA (18S rRNA: 2,315 nt and 28S rRNA: 4,151 nt) is one-fifth larger than yeast rRNA (18S 
rRNA: 1,798 nt; 25S rRNA: 3,392 nt) in total number of nucleotides. 
Although the T. cruzi 80S ribosome possesses conserved ribosomal structures, it exhibits 
many distinctive structural features in both the small and large subunits. Compared with 
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other eukaryotic ribosomes, the T. cruzi ribosomal 40S subunit appears expanded, due to the 
addition of a large piece of density adjacent to the platform region (Figure 1). As can be seen 
in the secondary structure of the T. cruzi 18S rRNA (Figure 2), this extra density must be 
attributed to two large expansion segments (ES) in domain II of the 18S rRNA, ES6 and ES7, 
designated as insertions of helices 21 and 26. These are the two largest ES in the T. cruzi 18S 
rRNA, involving 504 and 147 nucleotides, respectively. 
 
Figure 1. Cryo-electron microscopy map of T. cruzi 80S ribosome. Blue: large subunit. Yellow: small 
subunit. Landmark characteristics are indicated: SB, stalk base; SRL, sarcin-ricin loop; L1, L1 protein; 
CP, central protuberance; pr, prong. 
Part of ES6/ES7 makes up a large helical structure (named the ‘‘turret’’), located at the most 
lateral side of the 40S subunit (Figures 1 and 2). The turret measures 205 Å in length and 
forms the longest helical structure ever observed in a ribosome. The upper end of the turret 
appears as a sharp, freestanding spiral of 50 Å in length, named ‘‘spire,’’ located next to the 
exit of the mRNA channel. The distance between the spire and the mRNA exit is ~130 Å. The 
lower portion of the turret extends all of the way to the bottom of the 40S subunit. At its 
lower end, it bends by almost 90° and forms a bridge with the 60S subunit. This is a unique 
type of connection between the small and large subunits, as compared with all other ribosomal 
structures investigated to date [2]. Apart from the turret, the extra density in the 40S subunit 
also includes several small helical structures as part of ES6 and ES7. These helical structures 
observed in the density map are in accordance with the comparative analysis result based on 
ES6 sequences from >3,000 eukaryotes, in which several helices were identified only in 
kinetoplastida [3]. The ES3, ES9, and ES10 are located near helices 9, 39, and 41, respectively, 
and are associated with three small masses in the density map of the 40S ribosomal subunit, 
one at the bottom of the 40S ribosomal subunit, the other two in the head region. 
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Figure 2. Secondary structure of T. cruzi 18S rRNA with the characteristic ES. The 40S subunit was 
superposed with the crystallized S. cerevisiae 18S rRNA (PDB: 3U5E). The volume occupied by ES6 and 
ES7 is indicated. 
In contrast to the other rRNA regions, ES12, located in the long penultimate helix from 18S 
rRNA, is shorter in T. cruzi compared to other eukaryotes. This results in the helix 44 in T. cruzi 
(113 nt) being longer than in E. coli (103 nt), but shorter than in yeast (129 nt). Consistently with 
these variations in length, the span of the density attributable to helix 44 in the T. cruzi ribosome 
also has an intermediate position between E. coli and yeast. Interestingly, this region forms the 
decoding center, and is also the action site of aminoglycoside antibiotics. Moreover, differences 
in this region have shown to be responsible for the higher susceptibility of trypanosomatid 
ribosomes to the aminoglycoside paromomycin [4], as will be discussed below. 
The T. cruzi 60S subunit contains several large extra densities located at its periphery, in 
contrast with the large ribosomal subunit in yeast. The most common structures can be 
identified, such as the central protuberance (CP), L1 stalk, and stalk base of P proteins, as 
well as the conserved rRNA core structure (Figure 1). Although the secondary structure of 
the T. cruzi rRNAs in the 60S subunit is not available, the locations of most of the observed 
extra densities are consistent with the general locations of the rRNA expansion segments, 
which are, as a rule, at the surface of eukaryotic ribosomes. Among the extra densities, there 
is a large helical structure (‘‘prong’’) located between the CP and helix 38, in the back of the 
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60S subunit (Figure 1, pr). Interestingly, a similar feature was reported only in the structure 
of the human ribosome, but not in yeast neither bacterial ribosomes [5]. Morphological 
comparison of the 60S ribosomal subunit from T. cruzi with those from yeast and higher 
eukaryotes reveals that the T. cruzi 60S ribosomal subunit does not possess the universal 
eukaryotic feature of a planar surface near the exit site of polypeptide [2]. Instead, the 60S 
ribosomal subunit from T. cruzi presents a shape that is similar to those from bacteria. In 
contrast to the conserved eukaryotic rRNA core structure, the location of the L1 stalk in T. 
cruzi, which is on one side of the CP, does not match either of the two reported positions in 
yeast, known as the ‘‘in position’’ and ‘‘out position,’’ in relation to the ratchet-like subunit 
rearrangement. Instead, the L1 stalk in T. cruzi takes an in-between position, possibly due to 
its high mobility. On the other side of the CP, the P protein stalk is not visible in the density 
map of the T. cruzi 60S ribosomal subunit, whereas Western blots of the ribosome 
preparation using monoclonal antibodies against P proteins (P0/P1/P2) showed that these 
proteins were present in the ribosome preparation. As homologs of the bacterial moiety 
L10/(L7/L12)4, P proteins are known to be very flexible, and the absence of a stalk in the 
cryo-EM density map is likely due to the lack of stabilization. A complete description of T. 
cruzi stalk region, components, interactions and complex formation will be discussed below. 
2.2. Sequence and proteomic analysis: Differences on the ribosomal proteins 
The Cryo EM map of T. cruzi ribosomes exposed important differences in comparison with 
the corresponding organelles of model organisms such as S. cerevisiae and mammals [1]. 
Some of them were attributed to large expansions in the primary sequence of the ribosomal 
RNA molecules. However, the presence of specific features due to ribosomal proteins is 
difficult to demonstrate by this technique. Therefore, using the S. cerevisiae ribosomal 
protein sequences as probes, it was possible to identify in the T. cruzi genome database all 
homologue genes [6]. The average amino acid identity between the S. cerevisiae and T. cruzi 
ribosomal proteins was remarkably low (~50%), taking into account the high degree of 
conservation of the ribosome through evolution.  
The ribosomal proteins inferred by data mining were compared to the MS analysis results 
from whole parasites [7] and purified ribosomes [6]. Results are summarized in Tables 1 and 
2 for proteins from the large and small subunits, respectively.  
 
S. cerevisiae T. cruzi 
Prot 3U5E Length (aa) Length (aa) % ID Prot MS Ribo MS 
L1 - 217 214 51 + - 
L2 + 254 260 62 + + 
L3 + 387 428 57 + + 
L4 + 362 374 49 + + 
L5 + 297 309 49 + + 
L6 + 176 193 43 + + 
L7 + 244 242 41 + + 
L8 + 256 315 47 + + 
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S. cerevisiae T. cruzi 
Prot 3U5E Length (aa) Length (aa) % ID Prot MS Ribo MS 
L9 + 191 189 46 + + 
L10 + 221 213 61 + + 
L11 + 174 192 69 + + 
L12 - 165 164 56 + + 
L13 + 199 218 39 + + 
L14 + 138 180 30 + + 
L15 + 204 204 57 + + 
L16 + 199 222 44 + + 
L17 + 184 166 54 + + 
L18 + 186 193 43 + + 
L19 + 189 357 50 + + 
L20 + 174 179 37 + + 
L21 + 160 159 41 + + 
L22 + 121 130 33 - + 
L23 + 137 139 69 + + 
L24 + 155 125 32 + + 
L25 + 142 226 45 + + 
L26 + 127 143 57 + + 
L27 + 136 133 43 + + 
L28 + 149 145 59 + + 
L29 + 59 71 82 + + 
L30 + 105 105 55 + + 
L31 + 113 188 42 + + 
L32 + 130 133 42 + + 
L33 + 107 149 42 + + 
L34 + 121 170 38 + + 
L35 + 120 127 44 + - 
L36 + 100 114 41 + + 
L37 + 88 84 57 + + 
L38 + 78 82 43 - + 
L39 + 51 51 60 - - 
L40 + 52 52 65.4 + - 
L41 + 25 Not Found
L42 + 106 106 65 - + 
L43 + 92 90 61 + + 
Table 1. Proteins from the large subunit. Left, S. cerevisiae: protein name, presence in the crystal 
structure (PDB: 3U5E) and number of residues. Right, T. cruzi homologues: amino acid length, 
percentage of identity and positive (+) or negative (-) detection by MS on whole parasites (Prot MS) or 
purified ribosomes (Ribo MS). 
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comparison of the 60S ribosomal subunit from T. cruzi with those from yeast and higher 
eukaryotes reveals that the T. cruzi 60S ribosomal subunit does not possess the universal 
eukaryotic feature of a planar surface near the exit site of polypeptide [2]. Instead, the 60S 
ribosomal subunit from T. cruzi presents a shape that is similar to those from bacteria. In 
contrast to the conserved eukaryotic rRNA core structure, the location of the L1 stalk in T. 
cruzi, which is on one side of the CP, does not match either of the two reported positions in 
yeast, known as the ‘‘in position’’ and ‘‘out position,’’ in relation to the ratchet-like subunit 
rearrangement. Instead, the L1 stalk in T. cruzi takes an in-between position, possibly due to 
its high mobility. On the other side of the CP, the P protein stalk is not visible in the density 
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proteins were present in the ribosome preparation. As homologs of the bacterial moiety 
L10/(L7/L12)4, P proteins are known to be very flexible, and the absence of a stalk in the 
cryo-EM density map is likely due to the lack of stabilization. A complete description of T. 
cruzi stalk region, components, interactions and complex formation will be discussed below. 
2.2. Sequence and proteomic analysis: Differences on the ribosomal proteins 
The Cryo EM map of T. cruzi ribosomes exposed important differences in comparison with 
the corresponding organelles of model organisms such as S. cerevisiae and mammals [1]. 
Some of them were attributed to large expansions in the primary sequence of the ribosomal 
RNA molecules. However, the presence of specific features due to ribosomal proteins is 
difficult to demonstrate by this technique. Therefore, using the S. cerevisiae ribosomal 
protein sequences as probes, it was possible to identify in the T. cruzi genome database all 
homologue genes [6]. The average amino acid identity between the S. cerevisiae and T. cruzi 
ribosomal proteins was remarkably low (~50%), taking into account the high degree of 
conservation of the ribosome through evolution.  
The ribosomal proteins inferred by data mining were compared to the MS analysis results 
from whole parasites [7] and purified ribosomes [6]. Results are summarized in Tables 1 and 
2 for proteins from the large and small subunits, respectively.  
 
S. cerevisiae T. cruzi 
Prot 3U5E Length (aa) Length (aa) % ID Prot MS Ribo MS 
L1 - 217 214 51 + - 
L2 + 254 260 62 + + 
L3 + 387 428 57 + + 
L4 + 362 374 49 + + 
L5 + 297 309 49 + + 
L6 + 176 193 43 + + 
L7 + 244 242 41 + + 
L8 + 256 315 47 + + 
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S. cerevisiae T. cruzi 
Prot 3U5E Length (aa) Length (aa) % ID Prot MS Ribo MS 
L9 + 191 189 46 + + 
L10 + 221 213 61 + + 
L11 + 174 192 69 + + 
L12 - 165 164 56 + + 
L13 + 199 218 39 + + 
L14 + 138 180 30 + + 
L15 + 204 204 57 + + 
L16 + 199 222 44 + + 
L17 + 184 166 54 + + 
L18 + 186 193 43 + + 
L19 + 189 357 50 + + 
L20 + 174 179 37 + + 
L21 + 160 159 41 + + 
L22 + 121 130 33 - + 
L23 + 137 139 69 + + 
L24 + 155 125 32 + + 
L25 + 142 226 45 + + 
L26 + 127 143 57 + + 
L27 + 136 133 43 + + 
L28 + 149 145 59 + + 
L29 + 59 71 82 + + 
L30 + 105 105 55 + + 
L31 + 113 188 42 + + 
L32 + 130 133 42 + + 
L33 + 107 149 42 + + 
L34 + 121 170 38 + + 
L35 + 120 127 44 + - 
L36 + 100 114 41 + + 
L37 + 88 84 57 + + 
L38 + 78 82 43 - + 
L39 + 51 51 60 - - 
L40 + 52 52 65.4 + - 
L41 + 25 Not Found
L42 + 106 106 65 - + 
L43 + 92 90 61 + + 
Table 1. Proteins from the large subunit. Left, S. cerevisiae: protein name, presence in the crystal 
structure (PDB: 3U5E) and number of residues. Right, T. cruzi homologues: amino acid length, 
percentage of identity and positive (+) or negative (-) detection by MS on whole parasites (Prot MS) or 
purified ribosomes (Ribo MS). 
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S. cerevisiae T. cruzi 
Prot 3U5C Length (aa) Length (aa) % ID Prot MS Ribo MS 
S0 + 252 245 52 + + 
S1 + 255 261 40 + + 
S2 + 254 263 58 + + 
S3 + 240 214 58 + + 
S4 + 261 273 50 + + 
S5 + 225 190 64 + + 
S6 + 236 250 49 + + 
S7 + 190 211 34 + + 
S8 + 200 221 47 + + 
S9 + 197 190 59 + + 
S10 + 105 161 34 + + 
S11 + 156 173 54 + + 
S12 + 143 
142 30.8 + + 
141 34.5 + - 
S13 + 151 151 62 - + 
S14 + 137 144 74 + + 
S15 + 142 152 53 + + 
S16 + 143 149 56 + + 
S17 + 136 141 57 + + 
S18 + 146 153 58 + + 
S19 + 144 167 35 + + 
S20 + 121 117 41 + + 
S21 + 87 251 43 + + 
S22 + 130 130 72 + - 
S23 + 145 143 68 + + 
S24 + 135 137 47 + + 
S25 + 108 110 39 + - 
S26 + 119 112 42 + + 
S27 + 82 86 61 + + 
S28 + 67 91 68 - + 
S29 + 56 57 54 + + 
S30 + 63 65 65 - - 
S31 + 152 150 60 + + 
RACK1 + 319 317 43 + + 
Table 2. Proteins from the small subunit. Left, S. cerevisiae: protein name, presence in the crystal 
structure (PDB: 3U5C) and number of residues. Right, T. cruzi homologues: amino acid length, 
percentage of identity and positive (+) or negative (-) detection by MS on whole parasites (Prot MS) or 
purified ribosomes (Ribo MS). 
 
Ribosomes from Trypanosomatids: Unique Structural and Functional Properties 9 
This analysis showed that T. cruzi ribosomal proteins are, in average, longer than the 
corresponding S. cerevisiae proteins. The extra regions in T. cruzi ribosomal proteins are 
generally at the N- or C-terminal ends. The most intriguing examples of these terminal 
extensions, when comparing to yeast, are TcL19 and TcS21 (blue rows on Tables 1 and 2, 
respectively), showing C-terminal extensions of 168 and 164 amino acids, respectively. 
These extensions are only present in kinetoplastids, although their length varies among 
species. MS analyses of T. cruzi ribosomes confirmed the presence of peptides matching to 
TcL19 and TcS21, strongly suggesting that these genes correspond to the functional 
ribosomal components [6]. The possible functional roles of these extensions, as well as the 
molecular mechanisms that generated them over time, constitute interesting fields for future 
studies. 
It is interesting to note that S. cerevisiae L19 protein has been described as forming part of the 
polypeptide chain exit channel [8]. In addition to L19, the polypeptide chain exit channel is 
formed by L17, L25, L26, L31 and L35. All of these proteins show important extensions in T. 
cruzi, ranging from 41 amino acids (L35) up to 57 amino acids (L26). This fact can be related 
to the absence of a flat surface on this region in T. cruzi 80S ribosome, in contrast to the 
corresponding region in the yeast ribosome [1]. 
Two putative homologue genes for the S12 protein sharing 65% of amino acids identity are 
present in the T. cruzi genome (named TcS12A and TcS12B). TcS12A is slightly closer to 
yeast S12 (34.5% of amino acids identity) than TcS12B (30.8% of amino acids identity). Both 
genes were expressed at the protein level [7] but only TcS12B was detected in the proteomic 
analysis of purified ribosomes (Table 2). Interestingly, there are also two genes in T. brucei 
(S12A and S12B) but only one in L. major, suggesting a gene duplication event after the 
divergence of Leishmania spp into the trypanosomatid lineage. 
In other eukaryotes, such as mammals and yeast, ribosomal proteins S31 and L40 are 
synthesized as a C-terminal fusion with ubiquitin. Data mining revealed similar fusion 
genes in the T. cruzi genome. From these ubiquitin fusion proteins, only TcS31 (also named 
S27A) was detected by mass spectrometry on pure ribosomes. 
Out of the 32 proteins found by sequence identity to S. cerevisiae 40S proteins, 29 were 
detected by MS of T. cruzi ribosomes, including S13 and S28, which had not been detected in 
the proteome of T. cruzi [7]. Nevertheless, peptides matching to S22, S25 and S30 were not 
detected in the MS analysis of pure ribosomes. Interestingly, S30 was also not detected in 
MS studies on total extracts of T. cruzi (red row Table 2) [7]. 
For the large subunit (60S), out of the 48 yeast proteins screened, 47 were found to have a 
homologous gene in T. cruzi. The exception was L41, a short peptide of 25 amino acids long. 
The ribosome MS analysis detected all predicted proteins, excepting L1, L35, L39 and L40. 
From these, L1 and L35 were previously detected in epimastigote crude extracts [7]. 
Moreover, ribosome MS analysis detected two large subunit proteins that were not 
previously detected in the T. cruzi total proteome; L22 and L42 (Table 1). 
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Table 2. Proteins from the small subunit. Left, S. cerevisiae: protein name, presence in the crystal 
structure (PDB: 3U5C) and number of residues. Right, T. cruzi homologues: amino acid length, 
percentage of identity and positive (+) or negative (-) detection by MS on whole parasites (Prot MS) or 
purified ribosomes (Ribo MS). 
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It is interesting to note that S. cerevisiae L19 protein has been described as forming part of the 
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genes in the T. cruzi genome. From these ubiquitin fusion proteins, only TcS31 (also named 
S27A) was detected by mass spectrometry on pure ribosomes. 
Out of the 32 proteins found by sequence identity to S. cerevisiae 40S proteins, 29 were 
detected by MS of T. cruzi ribosomes, including S13 and S28, which had not been detected in 
the proteome of T. cruzi [7]. Nevertheless, peptides matching to S22, S25 and S30 were not 
detected in the MS analysis of pure ribosomes. Interestingly, S30 was also not detected in 
MS studies on total extracts of T. cruzi (red row Table 2) [7]. 
For the large subunit (60S), out of the 48 yeast proteins screened, 47 were found to have a 
homologous gene in T. cruzi. The exception was L41, a short peptide of 25 amino acids long. 
The ribosome MS analysis detected all predicted proteins, excepting L1, L35, L39 and L40. 
From these, L1 and L35 were previously detected in epimastigote crude extracts [7]. 
Moreover, ribosome MS analysis detected two large subunit proteins that were not 
previously detected in the T. cruzi total proteome; L22 and L42 (Table 1). 
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In addition to the previously discussed large and small subunit proteins (S and L), MS 
analyses detected other well-known ribosome components. Here we discuss some examples: 
i. RACK1, a protein tightly associated to the small ribosomal subunit in eukaryotes, and 
apparently involved in the regulation of translation initiation [9, 10]. This protein, 
present on the cryo-EM map of yeast ribosome was not detected on the cryo-EM map of 
T. cruzi (Figure 3). This difference can be explained by a weaker interaction between 
RACK1 and the ribosome in T. cruzi, compared to other species. This could result in too 
low amounts of RACK1 in purified ribosomes for cryo-EM visualization, but sufficient 
for MS detection. 
ii. The ribosomal P proteins, a pentameric complex that form a long and protruding stalk 
on the large subunit involved in the translocation of the ribosome during the elongation 
step of protein synthesis. This complex is generally absent in cryo-EM and has not yet 
completely elucidated by crystallography due to its high flexibility (Figure 3). All 
proteins that form the P complex in T. cruzi were detected in purified ribosome 
particles, indicating the presence of a functional pentameric complex. A complete 
description of T. cruzi stalk region, components, interactions and complex formation 
will be discussed below. 
 
Figure 3. Left, Cryo-EM of the T. cruzi 80S ribosome. Center, superposition of T. cruzi and S. cerevisiae 
80S particles. Right, Cryo-EM of the S. cereviseae 80S ribosome. Rack1 and the stalk region, which are 
only present in S.cerevisiae ribosome are indicated. 
2.3. The ribosomal stalk: variable components and assembly 
The large subunit of the eukaryotic ribosome possesses a long and protruding stalk formed 
by the ribosomal P proteins. This structure is involved in the translocation of the ribosome 
during the elongation step of protein synthesis through interaction with the elongation 
factor 2 (EF-2) [11]. Although the elongation step is a highly conserved process, the stalk is 
one of the most variable regions of the ribosome. The proteins forming this structure in 
prokaryotes and eukaryotes show very low sequence similarity. Moreover, among 
eukaryotes, the composition of the stalk is also variable, due to gene duplications and 
sequence divergence of genes encoding P proteins. In general terms the eukaryote complex 
is formed by the ribosomal P proteins, including P0 (a 34 kDa polypeptide) as a central 
component of the stalk and two distinct but closely related proteins of about 11 kDa, P1 and 
P2. The number of ribosomal P1/P2 proteins varies among species and these variations have 
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consequences in the stalk composition. In mammals, the P1 and P2 families have only one 
member and the stalk is formed by two identical copies of each P1 and P2 proteins, linked to 
P0 [12]. The binding of P2 protein to P0 can only be detected in the presence of P1, 
suggesting a pivotal role of the latter in the conformation of the stalk [13]. In S. cerevisiae 
there are two P1 (α and β) and two P2 (α and β) proteins [14] and the stalk seems to be 
organized in preferential pairs; P1α/P2β and P1β/P2α. Again, both P1 proteins seem to be 
necessary for the binding of the corresponding P2 partners to P0 [15]. In T. cruzi, five 
components of the stalk have been identified: P0, of approximately 34 kDa, containing a C-
terminal end that deviates from the eukaryotic P consensus and bears similarity with 
Archaea L10 protein; and four proteins of about 11 kDa (P1α, P1β, P2α and P2β) with the 
typical eukaryotic P consensus sequence at their C-terminal end [16, 17]. It should be noted 
that independent gene duplication events have originated the P1 and P2 subtypes in yeast 
and trypanosomatids.  
Combining yeast two-hybrid technique and surface plasmon resonance (SPR) it was possible 
to make a complete interaction map of T. cruzi ribosomal P proteins [17-19]. These two 
techniques were both necessary to fully characterize the complex and to map the interaction 
regions in P0 (Figure 5). This analysis exposed some trypanosomatid-specific features 
among P proteins interactions. TcP0 protein (the central component of the stalk) was able to 
interact with all P1/P2 proteins. Both P1 proteins were unable to interact with each other nor 
to homo-oligomerize. Interestingly, both P2 proteins showed a highly redundant interaction 
profile but P2α was not able to interact with P1α. Therefore, if we focus in a T. cruzi stalk 
composed of five different ribosomal P proteins the only possible arrangement for the low 
molecular weight protein association will be: P1α-P2β/P1β-P2α. Any other possible 
combination will exclude one of the four components. This association pattern resembles 
that observed in yeast; although not completely, because of the presence of highly 
interacting components like P2β. Consequently, it is possible to postulate heterogeneity on 
the stalk composition in T. cruzi, due to redundancy of some of its components. 
 
Figure 4. Surface image of yeast 80S ribosome crystallography in complex with the EF- 2 (red). The 
postulated location of the ribosomal P proteins on the stalk region of the large subunit is illustrated. 
Since all four small P proteins can bind to P0 the question was whether TcP0 can 
simultaneously bind two or four proteins. Despite the accumulated data about stalk 
organization in several model organisms, the interaction among P0 and P1/P2 proteins is not 
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consequences in the stalk composition. In mammals, the P1 and P2 families have only one 
member and the stalk is formed by two identical copies of each P1 and P2 proteins, linked to 
P0 [12]. The binding of P2 protein to P0 can only be detected in the presence of P1, 
suggesting a pivotal role of the latter in the conformation of the stalk [13]. In S. cerevisiae 
there are two P1 (α and β) and two P2 (α and β) proteins [14] and the stalk seems to be 
organized in preferential pairs; P1α/P2β and P1β/P2α. Again, both P1 proteins seem to be 
necessary for the binding of the corresponding P2 partners to P0 [15]. In T. cruzi, five 
components of the stalk have been identified: P0, of approximately 34 kDa, containing a C-
terminal end that deviates from the eukaryotic P consensus and bears similarity with 
Archaea L10 protein; and four proteins of about 11 kDa (P1α, P1β, P2α and P2β) with the 
typical eukaryotic P consensus sequence at their C-terminal end [16, 17]. It should be noted 
that independent gene duplication events have originated the P1 and P2 subtypes in yeast 
and trypanosomatids.  
Combining yeast two-hybrid technique and surface plasmon resonance (SPR) it was possible 
to make a complete interaction map of T. cruzi ribosomal P proteins [17-19]. These two 
techniques were both necessary to fully characterize the complex and to map the interaction 
regions in P0 (Figure 5). This analysis exposed some trypanosomatid-specific features 
among P proteins interactions. TcP0 protein (the central component of the stalk) was able to 
interact with all P1/P2 proteins. Both P1 proteins were unable to interact with each other nor 
to homo-oligomerize. Interestingly, both P2 proteins showed a highly redundant interaction 
profile but P2α was not able to interact with P1α. Therefore, if we focus in a T. cruzi stalk 
composed of five different ribosomal P proteins the only possible arrangement for the low 
molecular weight protein association will be: P1α-P2β/P1β-P2α. Any other possible 
combination will exclude one of the four components. This association pattern resembles 
that observed in yeast; although not completely, because of the presence of highly 
interacting components like P2β. Consequently, it is possible to postulate heterogeneity on 
the stalk composition in T. cruzi, due to redundancy of some of its components. 
 
Figure 4. Surface image of yeast 80S ribosome crystallography in complex with the EF- 2 (red). The 
postulated location of the ribosomal P proteins on the stalk region of the large subunit is illustrated. 
Since all four small P proteins can bind to P0 the question was whether TcP0 can 
simultaneously bind two or four proteins. Despite the accumulated data about stalk 
organization in several model organisms, the interaction among P0 and P1/P2 proteins is not 
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completely understood at the molecular level. Tsurugi and Mitsui [20], based on sequence 
analysis of S. cerevisiae and H. sapiens P0, proposed the presence of eight putative hydrophobic 
zippers involved in the interaction with P1 and P2 proteins. Functional complementation 
assays in yeast using C-terminal truncated P0 variants showed that deletion of 87 amino acids 
(the entire putative hydrophobic zipper) abolishes the binding of P1/P2 proteins to the 
ribosome [21]. Using yeast two-hybrid technique (Y2H), it has been shown that the 100 amino 
acid long C-terminal domain of P0 strongly interacts with P1 and P2 proteins [22]. However, 
the last 50 amino acids of P0 (including only two of the eight hydrophobic residues) were not 
able to interact with P1/P2. More recently, using Y2H and deletion mutant strains, the P0 
region between positions 213 and 260 has been involved in the interaction with the P1/P2 
proteins in S. cerevisiae. In contrast, mutation of the putative interacting leucine residues in this 
region did not impair the binding of P1 and P2 proteins [23]. Based on the crystal structure of 
the archaeon Pyrococcus horikoshii stalk complex recently reported [24], it was possible to 
identify two putative P1/P2 interaction sites in TcP0. The first site is situated between 
aminoacids 222 and 232 and the second between aminoacids 248 and 258. Although the 
general mechanism mediating the interaction between P0 and P1/P2 proteins seems to be 
similar among all species, it should be noted that some of the residues on TcP0 involved in this 
interaction are not strictly conserved. This result is in agreement with other studies showing 
that ribosome from yeast strains carrying heterologous P0 proteins are not able to bind S. 
cerevisiae P1/P2 proteins efficiently [25, 26]. Altogether our data indicate that TcP0 possesses 
two P1/P2 interaction sites and that P1/P2 proteins can associate in pairs (P1α-P2β/P1β-P2α) 
but it was not known whether a hierarchy for P1/P2 association to TcP0 exists. To answer this 
question we performed a sequential SPR analysis in which we randomly injected one protein 
after the other (P1/P2) without regeneration steps on a sensor chip containing TcP0 [19]. This 
study showed that it is possible to form stable pentameric complexes when any of both P1 
proteins were first injected. There were a few other combinations that raised stable complexes 
but in general terms it is possible to conclude that the injection of multi-interacting proteins 
(like P2β and to a lesser extent P2α) at the beginning blocks the binding of the other 
components of the complex. This also means that other complexes containing not all P1/P2 
proteins are possible. Unfortunately, there are no functional data available. 
 
Figure 5. Summary of P protein interactions assessed by SPR and yeast two hybrid technique (Y2H). 
NA: Not analyzed. 
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Finally, the complete picture of the system can be illustrated in Figure 6, where the T. cruzi 
stalk resembles that of yeast due to the ability of all P1/P2 proteins to interact with P0. 
 
Figure 6. Assembly of the P complex in mammals, yeast and the proposed model for T.cruzi complex. 
As it was mentioned before, the C-terminal end of ribosomal P proteins interacts with EF-2 
and this interaction is essential during the elongation step of protein synthesis. Notably, 
antibodies against the C-terminal end of T. cruzi ribosomal P proteins are present in the sera 
of a high percentage of chronic chagasic patients. These antibodies are specific for the T. 
cruzi C-terminal peptide of ribosomal P proteins, being unable to recognize the mammalian 
epitope. This specificity is due to only one amino acid change (Ser by Glu) [27-30]. In a 
previous work, we have obtained a recombinant single chain antibody (scFvC5), derived 
from a monoclonal antibody against the C-terminal region of T. cruzi P2β protein [31, 32]. 
This recombinant antibody, similarly to human antibodies from chagasic patients, shows 
very high selectivity toward the parasite epitope. In Western blot assays, scFvC5 specifically 
recognized P proteins on extracts of trypanosomatids T. cruzi. T. brucei and Crithidia 
fascilculata, but it did not detect their rat counterparts. Based on earlier reports showing that 
antibodies (and their recombinant single chain versions) directed against the mammalian C-
terminal end of P proteins inhibit protein synthesis in cell-free systems [33], we reasoned 
that scFvC5 would selectively block translation process by trypanosomatid ribosomes. As 
expected, scFvC5 strongly inhibited the incorporation of radioactive amino acids when 
trypanosomatid ribosomes (from T. cruzi, T. brucei and C. fasciculata), but not mammalian 
(Rattus norvegicus) ribosomes were used under identical experimental conditions [30]. 
Moreover, the translation inhibition on trypanosomatid ribosomes could be reverted by pre-
incubation of the scFvC5 with the peptide corresponding to the T. cruzi epitope, but not with 
the mammalian equivalent. Therefore, we evaluated the ability of this recombinant antibody 
to inhibit protein synthesis in vivo, by using a tightly regulated inducible expression vector 
in T. brucei. The growth of parasites was significantly delayed when the scFvC5 expression 
was induced; clearly showing that blocking of the C-terminal end can be used as a strategy 
to inhibit trypanosomatid protein synthesis in vivo. In addition, and taking into account that 
the crystal structure of the monoclonal antibody originating scFvC5 has been reported [34] 
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Figure 5. Summary of P protein interactions assessed by SPR and yeast two hybrid technique (Y2H). 
NA: Not analyzed. 
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Finally, the complete picture of the system can be illustrated in Figure 6, where the T. cruzi 
stalk resembles that of yeast due to the ability of all P1/P2 proteins to interact with P0. 
 
Figure 6. Assembly of the P complex in mammals, yeast and the proposed model for T.cruzi complex. 
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(PDB 3SGE), the antibody combining site would be an interesting starting point for 
designing peptide mimetics as specific inhibitors of trypanosomatid translation. 
3. Functional analysis 
3.1. Translation activity: Initiation and elongation factors 
3.1.1. Trans-splicing of trypanosomatid mRNAs 
In several organisms, a variable proportion of mRNAs are processed by a mechanism 
named spliced-leader (SL) trans-splicing, which transfers a short RNA sequence (the SL) 
from the 5´ end of a specialized non-mRNA molecule, the SL RNA, to unpaired splice-
acceptor sites on pre-mRNA molecules. As a result, depending on the organism, a variable 
proportion of the mRNAs acquires a common 5´ sequence. The SL trans-splicing mechanism 
is widely and patchily distributed across phylogenetically distant organisms. The 
evolutionary origin of this process is still an enigma, and two different hypotheses have 
been postulated [35]: 
i. SL trans-splicing was present in an ancestral eukaryotic organism and has been lost in 
many different lineages, or 
ii. SL trans-splicing appeared independently several times during evolution of eukaryotes. 
Although this point has not been solved yet, recent evidences from analysis of large ESTs 
and genomic databases, seem to better support the second hypothesis [36, 37]. 
Several different functions for the SL sequences have been reported [35], among them: 
i. providing a 5´ cap structure for protein coding RNAs transcribed by RNA polymerase I 
ii. Converting polycistronic transcripts into capped, monocistronic mRNAs 
iii. enhancing mRNA translational efficiency 
In trypanosomatids, 100 % of their mRNA is processed by SL trans-splicing, adding a 39 nt 
sequence. Besides the universally conserved 7-methyl guanosine cap, which is linked to the 
first nucleotide via a 5´-5´ triphosphate bridge, the first four nucleotides of the SL are all 
methylated at the ribose ring. In addition, the first (m26A) and fourth (m3U) nucleotides are 
methylated at the base [38] (Figure 7). This unusually modified structure, known as the cap-
4, is the most highly modified cap structure of all eukaryotic cells. Due to the important role 
of the mRNA 5´ end during eukaryotic translation initiation, a role for the SL structure has 
been proposed in the process. By using cell lines of Leishmania tarentolae expressing modified 
SL sequences, it has been shown that these modifications do not affect transcription nor 
trans-splicing efficiency. In contrast, mutations of the SL region spanning nucleotides 10-29 
decreased the methylation extent and polysome association of mRNAs, demonstrating a 
direct role for the cap4 methylations and/or the primary sequence of the SL in the translation 
process [39]. More recently, Zamudio et al used Trypanosoma brucei strains lacking one or 
more of the three 2´-O-ribose methyl transferases involved in the cap4 biogenesis, to 
specifically evaluate the role of SL methylation in the absence of sequence changes [40]. In 
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this study, attempts to derive cells with complete loss of mRNA cap ribose methylation 
were unsuccessful, indicating an essential role in kinetoplastid biology. Moreover, even 
when cells lacking the kinetoplastid-specific ribose methylation at positions 3 and 4 were 
viable, they showed a decreased rate of protein synthesis, clearly showing a role for these 
modification (in the absence of SL sequence changes) in the translation process. The above 
mentioned evidences, demonstrating a direct role of hypermethylated SL in trypanosomatid 
protein synthesis, reinforce the hypothesis that translation initiation would show unique 
features in these organisms. 
 
Figure 7. The T. cruzi spliced leader sequence 
3.1.2. Initiation factors 
Cap-dependent initiation in eukaryotes is a very complex, highly regulated limiting step of 
translation. In this process, the 5´ cap interacts with a multi-protein complex named eIF4F, 
formed by at least three proteins: eIF4A, an ATP-dependent RNA helicase; eIF4E, the cap-
binding protein; and eIF4G, a scaffold protein that interacts with the poly(A) binding protein, 
IF4A and IF4E. Data mining on the Leishmania major genome database has revealed four 
eIF4Es (LmEIF4E1-4), two eIF4As (LmEIF4A1-2) and five eIF4Gs (LmEIF4G1-5) putative 
proteins [41]. 
The presence of multiple homologues for the different IF4F subunits in trypanosomatids, and 
in some cases in other eukaryotes, makes it difficult to identify these proteins that are actually 
involved in translation. In addition, knowledge of the protein synthesis in trypanosomatids is 
inferred by indirect evidences such as sequence similarities. Moreover, proteins with high 
homology to translation initiation factors are involved in other processes such as mRNA 
processing. Since orthologous proteins have, in general, conserved functional roles, 
phylogeny analysis could have some clues for identifying those proteins involved in protein 
synthesis. Below we discuss the biochemical, molecular and phylogenetic evidences available 
on the IF4F components. 
3.1.3. Trypanosomatid eIF4E 
A recent phylogenetic analysis of IF4E-family members has revealed that many organisms 
contain multiple genes encoding proteins with sequence similarity to prototypical IF4E 
proteins [42]. Unfortunately, no trypanosomatid IF4E-family members were included in this 
analysis. 
The highly modified cap of trypanosomatids suggests that eIF4E orthologous in these 
organisms would show atypical features. The L. major genome revealed four putative eIF4E 
encoding genes (named LeishIF4E-1 to -4) with limited homology. All of them have easily 
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identifiable orthologues in T. brucei and T. cruzi, suggesting that their functional roles are 
conserved among trypanosomatids, as can be inferred from phylogenetic analysis (Figure 8). 
In contrast, the phylogenetic relationships between putative trypanosomadid IF4E proteins 
and the homologous translation factors characterized in other species seem to be much more 
complex. This complex evolutionary scenario strongly suggests that multiple gene 
duplications have taken place during evolution of IF4E homologous genes, some of them 
before, and others after the evolutionary divergence between organisms, yielding both 
paralogous and orthologous genes. In spite of this complexity, it is clear that trypanosomatid 
IF4E-2 and IF4E-3 are paralogous genes originated by duplications into the trypanosomatid 
lineage. 
The L. major genes have been cloned and their respective protein products have been 
biochemically characterized [43]. The corresponding recombinant proteins showed variable 
relative affinities for chemically synthesized mammalian and trypanosomatid cap structures. 
Despite a detailed study of these proteins, including pull-down assays with a mammalian 
interacting partner of eIF4E, analysis of co-sedimentation with polysome fractions and 
detection at different stages of the parasite, no clear conclusions could be obtained leading to 
an eIF4E candidate. Moreover, none of these proteins was able to rescue the phenotype of a S. 
cerevisiae null strain, indicating a significant functional divergence of these proteins in the 
trypanosomatid lineage. This conclusion is reinforced by the observation that several eIF4E 
homologues from phylogenetically distant organisms (mammals, Drosophila melanogaster, 
zebrafish and Arabidopsis) are functional in yeast (red letters in Figure 8) [44-47]. Interestingly, 
other IF4E homologous from these species are not functional in yeast, suggesting that they 
are involved in roles other than translation initiation (i.e. translation repression, binding to 
nuclear mRNAs). 
More recently, the orthologue genes from T. brucei (TbEIF4E-1 through 4) have been 
functionally analyzed in vivo [50]. By using RNAi knock down of different TbIF4E genes, 
combined with metabolic labeling with radioactive amino acids, this study strongly 
suggested that TbIF4E-3 (and also probably TbIF4E-4) are directly involved in protein 
synthesis. This is supported by their cytosolic localization, in contrast to the TbIF4E-1 and 2 
proteins, which are both nuclear and cytosolic. Unfortunately, no yeast complementation 
assays were performed with T. brucei proteins which could be correlated with the data of 
their L. major orthologues. 
A similar situation seems to take place in the ancient eukaryotic, non-kinetoplastid, Giardia 
lamblia. Two IF4E homologous proteins have been identified and characterized; Gl_IF4E-1 
and Gl_IF4E-2. Notably, Gl_IF4E-1 seems to be the orthologous gene of LmIF4E-4, whereas 
Gl_IF4E-2 is more closely related to LmIF4E-1. This suggests that duplications of genes 
encoding IF4E-family proteins have taken place very early during eukaryotic evolution. 
Functional analyses suggest that Gl_IF4E-2 is involved in protein synthesis. However, 
similarly to the Leishmania proteins, none of these IF4E homologues is able to rescue a null 
phenotype in yeast [51]. These observations suggest that early eukaryotes, such as Giardia 
and trypanosomatids, have major functional differences with model organisms in protein 
synthesis initiation, particularly in the case of IF4E. Moreover, it seems that after divergence  
 
Ribosomes from Trypanosomatids: Unique Structural and Functional Properties 17 
 
Figure 8. Inferred phylogenetic relationships among putative trypanosomatid IF4E proteins and 
homologous proteins from other eukaryotes. Sequences are derived from H. sapiens (Hs), Mus musculus 
(Mm), S. cerevisiae (Sc), Drosophila melanogaster (Dm), Giardia lamblia, (Gl), Arabidopsis thaliana (At), Danio 
rerio (zebra fish) (Dr), L. major (Lm), T. brucei (Tb) and T. cruzi (Tc). Accession codes for GenBank or L. 
major database (http://www.genedb.org/Homepage/Lmajor) are shown in parenthesis. Sequences 
covering the IF4E domain (PFAM 01652) were aligned using T-COFEE under default parameters 
(http://tcoffee.vital-it.ch). LG+G was chosen as the best evolutionary model using ProtTest [48]. PhyML 
was run using the algorithm Subtree Pruning and Regrafting (SPR) [49] with 5 initial starting trees. To 
estimate the robustness of the phylogenetic inference, 500 bootstrap replicates were run. Color letters 
indicate whether these proteins are able (red) or unable (green) to complement a S. cerevisiae deficient 
strain. Arrows indicate the proteins that have proved functional roles in protein synthesis in ancient 
eukaryotes (trypanosomatid and Giardia). 
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of Giardia and trypanosomatid lineages, different paralogous genes acquired a major 
functional role in protein synthesis initiation, giving an additional level of complexity to the 
evolution of IF4E-family genes. Data from studies in L. major and T. brucei suggest that 
functional roles can be inferred by orthology into the trypanosomatid lineage, but these 
conclusions cannot be further extrapolated to other eukaryotic organisms. 
3.1.4. Trypanosomatid IF4A 
The sequence analysis of IF4A gives a more simple interpretation than IF4E, because of a 
lower number of homologous genes in each species, and the fact that these proteins show a 
higher degree of sequence conservation. IF4A belongs to a DEAD-box helicase family, which 
includes translation factors, as well as proteins involved in splicing. The inferred 
phylogenetic relationships amongst these proteins yield two clearly separate clades (Figure 
9). In each of these clades, the phylogeny of the proteins is coincident with that of their 
organisms, strongly suggesting that a unique duplication event of an ancestor IF4A gene 
took place before the divergence of early eukaryotes. As can be seen, S. cerevisiae IF4AI 
(P10081.3) and Homo sapiens IF4A2 (Q14240.2), both having demonstrated roles in protein 
synthesis initiation are in the same clade. Consistently, the paralogous proteins IF4A-like 
FAL1 (Q12099.1) and IF4AIII (P38919.4), from S. cerevisiae and H. sapiens, respectively, have 
been shown to be involved in splicing, and consistently they belong to a separate clade. This 
analysis suggests that trypanosomatid IF4A homologous proteins of the first clade, would 
be expected to be involved in protein synthesis initiation. 
The first functional analysis of a trypanosomatid IF4A homologue was performed with a 
Leishmania infantum protein (LeIF; XP_001462692.1), initially identified as an antigen 
inducing IL12 mediated immune response in infected patients [52]. This protein shows 
RNA-dependent ATPase and ATP-dependent RNA helicase activities and interaction with 
yeast eIF4G in vitro. However, LiIF4A does not complement a yeast eIF4A deficient strain, 
leading the authors to suggest that LiIF4A is indeed the orthologue of human eIF4AIII, 
involved in splicing. The phylogenetic analysis (Figure 9) allows us to propose an 
alternative hypothesis, since LiIF4A is located in the translation factor clade. We propose 
that this protein is indeed an initiation translation factor and that its inability to complement 
yeast cells reflects the evolutionary functional divergence of trypanosomatid protein 
synthesis. This hypothesis is supported by the finding of another gene in the genome of L. 
infantum; LiIF4A-like (XP_001470194.1), which groups with the clade of splicing factors. 
Additional evidences supporting this hypothesis have been provided by knock-down of the 
two T. brucei paralogous genes, combined with metabolic labeling with radioactive amino 
acids in silenced strains. These studies showed that knock-down of TbIF4AI, but not of 
TbIF4AIII, specifically decreases the rate of protein synthesis [53]. Figure 9 shows a 
phylogenetic tree of IF4A homologous proteins from different organisms, highlighting those 
with demonstrated roles in translation (blue letters) or other functions than translation (pink 
letters). 
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Figure 9. Inferred phylogenetic relationships among putative trypanosomatid IF4A proteins and 
homologous proteins from other eukaryotes. The complete open reading frames were aligned using T-
COFEE under default parameters. LG+G was chosen as the best evolutionary model. All those proteins 
with demonstrated role in protein synthesis are located in one of these clades, whereas the second clade 
seems to group the proteins involved in splicing. ScIF4AI (P10081.3) [54] and HsIF4A2 (Q14240.2) [55] 
(blue letters), have demonstrated roles in protein synthesis, whereas ScIF4A-like FAL1 (Q12099.1) [56] 
and HsIF4AIII (P38919.4) [57] (pink letters), have been implicated in other processes. L. infantum LiIF4A 
(XP_001462692.1) (bold and underlined) has been cloned and characterized as unable to complement an 
IF4A yeast null strain [52]. 
3.1.5. Trypanosomatid IF4G 
As mentioned before, IF4G is a scaffold protein that coordinates the assembly of the 
translation initiation factors and the 40S ribosomal subunit. The middle domain of IF4G 
(MIF4G) is the hallmark of these proteins. In addition, this domain is also present in several 
other proteins not involved in translation, such as the nuclear cap-binding protein CBP80. 
This fact reflects the common origin shared by IF4G with other cap-binding proteins, being 
difficult to deduce, based only on homology, which proteins harboring this domain have 
indeed initiation factor activity. 
Five different proteins harboring MIF4G domain are present in the genome of L. major, 
named LmIF4G-1 to LmIF4G-5 [41]. All of them have clearly predictable orthologues in T. 
brucei and T. cruzi. From these, and based on different functional assays including pull-
down, yeast-two hybrid and polysome profiles, LmIF4G-3 seems to be the most probable 
orthologous with a major role in translation initiation [41, 58]. Interestingly, phylogeny 
inference shows that trypanosomatid IF4G proteins form a separate clade, implying several 
gene duplication events into the trypanosomatid lineage (Figure 10). It has been postulated 
that MIF4G domain appeared during the early stages of eukaryotic evolution [59]. 
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Interestingly, TBLASTN searches on Giardia genome database using many different MIF4G 
domains as probe, give no significant hits. This strongly suggests that this domain appeared 
during the evolution of eukaryotes, after the divergence of the Giardia lineage. This implies 
that trypanosomatids would be amongst the earliest diverging organisms harboring IF4G 
proteins. 
 
Figure 10. Inferred phylogenetic relationships among putative trypanosomatid IF4G and homologous 
proteins from other eukaryotes. Sequences are derived from Homo sapiens (Hs), Saccharomyces cerevisiae 
(Sc), L. major (Lm), T. brucei (Tb) and T. cruzi (Tc). Accession codes for GenBank or L. major database 
(http://www.genedb.org/Homepage/Lmajor) are shown in parenthesis. Sequences covering the MIF4G 
domain (PFAM cd11559) were aligned using T-COFEE under default parameters (http://tcoffee.vital-
it.ch). LG + G was chosen as the best evolutionary model using ProtTest [48]. PhyML was run using the 
algorithm Subtree Pruning and Regrafting (SPR) [49] with 5 initial starting trees. To estimate the 
robustness of the phylogenetic inference, 500 bootstrap replicates were run. LmIF4G-3, the only 
trypanosomatid IF4G-like protein that has been experimentally associated to the formation of the IF4F 
complex is indicated by an arrow. 
3.1.6. Elongation factors 
The elongation step of protein synthesis has been highly conserved trough evolution, in 
comparison with initiation. According to this, the sequences encoding for elongation factors 
can be easily inferred by homology. However, elongation factors from bacteria and eukaryotes 
are not functionally interchangeable. Moreover, the specificity of ribosomes for their 
homologous elongation factors can be changed by interchanging their stalk components [60]. 
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The eukaryotic EF-2 is a GTPase involved in translocation of the peptidyl-tRNA from the A site 
to the P site on the ribosome. Two major mechanisms involving EF-2 regulate protein 
elongation. One of them is EF-2 reversible phosphorylation [61]. The second is EF-2 inactivation 
by ADP-ribosylation of a diphthamide residue (a post-translational modification of a conserved 
histidine residue) [62, 63]. In addition, EF-2 interacts with the ribosomal P proteins that form the 
stalk region [64]. A direct interaction between the stalk base and the EF-2 has been visualized 
by cryoelectron microscopy in yeast [65]. Real time measurements, using surface plasmon 
resonance (SPR), demonstrated the binding of rat EF-2 to rat P1 and P2 proteins, with a higher 
affinity for P1 (KD 3.810-8 M) than for P2 (KD 2.210-6 M) [66]. Moreover, antibodies against the 
conserved C-terminal region of ribosomal P proteins inhibited the elongation step of protein 
synthesis, blocking the binding of EF-2 to the ribosome as well as its ribosome dependent 
GTPase activity [67]. Below, we will summarize evidence of structural and functional 
divergences amongst eukaryotes at the ribosomal stalk level, and its partner EF-2.  
It has been largely demonstrated that the antifungal sordarin, which selectively inhibits some 
eukaryotic ribosomes, acts at the elongation step. Detailed studies about its action mechanisms 
have revealed that specificity of this compound for a group of fungi is due to specific 
molecular features of their stalk components (mainly the P0 protein) and EF-2 [68, 69]. 
On the other hand, trypanosomatid ribosomes have been shown to be highly resistant, in 
comparison to mammalian particles, to two ribosome inactivating proteins; ricin and 
trichosanthin [70, 71]. These toxins bind initially to the ribosomal stalk and depurinate a 
conserved base on the 28S rRNA, blocking the binding of EF-2 to ribosomes, supporting the 
idea that the trypanosomatid stalk has specific features. 
 
Figure 11. Model of T. cruzi EF-2. 
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The amino acid sequence of TcEF-2 was identified by probing the T. cruzi Gene Data Base 
(http://www.genedb.org) with the amino acid sequence of S. cerevisiae EF-2. Two identical 
copies of the TcEF-2 gene were found. The TcEF-2 protein was 60% identical to ScEF-2, and 
both EF-2 shared over 76% homology. In contrast to ScEF-2 that is regulated by 
phosphorylation of Threonine 57, TcEF-2 presented a Methionine in this position, 
suggesting a lack of regulation through phosphorylation (Figure 11). The histidine involved 
in ADP-ribosylation in ScEF-2 (H699) is conserved in trypanosomatids (H703 in T. cruzi), 
and consequently, diphtheria toxin inactivates protein synthesis in T. brucei [70]. Secondary 
structure comparative analysis showed an overall conserved architecture. The four 
canonical helices of domain I (GTPase) were conserved as well as the motif involved in 
nucleotide binding [72]. Using PHYRE protein fold recognition server [73], we generated a 
3D model of TcEF-2 that contains the six structural domains described for ScEF-2 [74]. 
Therefore, taking into account the high structural similarity between ScEF-2 and TcEF-2, it 
may be assumed that the different domains have conserved similar functions. The 
interaction of TcEF-2 with the ribosomal P proteins showed that all P1/P2 proteins interacted 
with TcEF-2 with similar affinities. Interestingly, TcP0 showed a decreased affinity in 
concordance with its modified C-terminal region. Our results are in agreement with those 
reported by Bargis-Surgey et al. [67] for the rat homologues. However, in T. cruzi no 
differential interaction between the EF-2 and the different P1/P2 proteins was observed. 
Unfortunately, data from functional comparison between trypanosomatid EF-2 and its 
orthologous in model species, such as yeast functional complementation, are not yet available. 
3.2. Selective inhibition of trypanosomatid ribosomes by paromomycin 
Aminoglycosides are a group of antibiotics binding to the decoding center of rRNA. As a 
result, aminoglycosides interfere with protein synthesis, facilitating amino acid 
misincorporation. The target site of aminoglycosides is the helix 44 of the 18S rRNA. As noted 
before, this helix is located in the ES12, the only expansion segment which is shorter in T. 
cruzi than in other eukaryotes, being intermediate between bacterial and higher eukaryotes 
[1]. Paromomycin is an aminoglycoside antibiotic with low toxicity to mammalian cells. This 
antibiotic has shown strong anti-leishmania activity when used alone or in combination with 
other drugs [75]. In a recent work, advances on the molecular basis for the differential effect 
of paromomycin on Leishmania have been reported [4]. In this work it was demonstrated that 
paromomycin selectively inhibits the rate of in vitro protein synthesis by trypanosomatid 
ribosomes, comparing to mammalian extracts. Moreover, the effect of paromomycin was 
even more dramatic when translation misreading was evaluated. Finally, affinity 
measurements using BIACORE demonstrated that paromomycin displays high affinity for 
the RNA oligonucleotide corresponding to the decoding site of trypanosomatids, whereas no 
interaction was detected with the oligonucleotide corresponding to the mammalian site. 
4. Conclusion 
In summary, we have described several direct and indirect evidences justifying future in-
deep studies on the trypanosomatid protein synthesis machinery.  
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The sequence and functional analysis of trypanosomatid homologous to well-characterized 
initiation factors, along with the fact that SL sequence is present in all the trypanosomatid 
mRNAs, strongly suggest that protein synthesis initiation would have remarkable unique 
features in these protozoa. This hypothesis is reinforced by structural features of T. cruzi 
ribosomes, where a large, trypanosomatid-specific rRNA extra density is present adjacent to 
the platform region, involved in translation initiation. 
The sequence analysis of ribosomal proteins also shows peculiarities in T. cruzi, being L19 
and S21 proteins the most notable examples, possessing large trypanosomatid-specific 
domains with unknown functional roles. 
Even when the elongation step of translation is much more conserved through evolution, 
the stalk composition and structure also seem to have special features in trypanosomatids. 
Consistently with this observation, some ribotoxins binding to this site show differential 
selectivity against parasite ribosomes. Unfortunately, no functional data are available on the 
functional similarities between trypanosomatid and mammalian elongation factors. 
Paromomycin is the first example of a compound with a well characterized action 
mechanism, showing higher activity on trypanosomatid translation machinery in 
comparison with its mammalian counterpart. This fact, along with the number of key 
features of trypanosomatid ribosomes and translation factors, should strongly encourage the 
future search for novel, trypanosomatid-specific translation inhibitors. 
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1. Introduction 
Proteins are one of the elementary components of life and account for a large fraction of 
mass in the biosphere. They catalyze the big majority of reactions sustaining life, and play 
structural, transport, and regulatory roles in all living organisms. Hence, “Translation”, i.e. 
the process of decoding a messenger (m)RNA by the ribosome to synthesize a protein, is a 
fundamental process for all forms of life (1, 2). Accordingly, many mechanisms to control 
gene expression at the translational level have evolved. They allow organisms to i) rapidly 
and reversibly respond to different stresses or sudden environmental changes; ii) quickly 
produce proteins in tissues and developmental processes where transcription is absent or 
limited; and iii) elicit asymmetric localization of proteins when is required (1-3). For 
instance, gametogenesis, early embryogenesis, memory and neurogenesis are processes 
where translational control plays a prominent role (4-8). 
The knowledge of the basic processes of translation was established some decades ago, and 
many regulatory mechanisms have been subsequently elucidated in different organisms (9-
11). In recent years, the use of powerful genome-wide sequencing, proteomics and 
bioinformatics-based technologies in both model and non-model organisms, has shown that 
a number of components of the translation apparatus has undergone a large diversification 
across eukaryotes, and that many of them emerged at different times on evolution (11, 12). 
Moreover, universal and lineage-specific mechanisms regulating translation have been 
described, and evidence supports the notion that some of them might have emerged at 
different times during evolution (11, 12). Evidence supports the notion that some of these 
mechanisms might have appeared by tinkering, i.e. co-opting and assembling molecules and 
regulatory mechanisms from other cellular processes (11). Overall, the emerging view 
suggests two general principles. On one hand, that while the fundaments of translation are 
well conserved across all forms of life, in eukaryotes the initiation step has undergone 
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substantial increase in complexity as compared to prokaryotes (11, 13-18); on the other hand, 
that after eukaryotes emerged the translation apparatus continued evolving to certain 
degree during eukaryotic diversification (12). The continue divergence of eukaryotes led to 
the diversification of metabolic requirements, to the appearance of different levels of body 
plans and organismal complexity, and to the arousal of novel developmental programs and 
behavioural patterns. Altogether, these changes led to the invasion of novel ecological 
niches. These events most probably were both the causes and effects of a parallel 
diversification and specialization, to different levels in different taxa, of components and 
mechanisms of the translation apparatus. Here I will review current knowledge on how this 
apparatus might have originated and further evolved in eukaryotes, making emphasis on 
the initiation step of translation. 
2. An overview of the translation process in eukaryotes 
Eukaryotic translation is a sophisticated and tightly regulated process, the basic steps of 
which are conserved in all eukaryotes. It is performed by the ribosome together with 
multiple ‘translation’ factors and aminoacyl-tRNA synthetases (aaRSs). It is divided into 
four major groups of steps: initiation, elongation, termination and recycling (Fig. 1).  
 
Figure 1. The general process of translation in eukaryotes. A typical eukaryotic mRNA is represented. 
The cap structure (m7G), the open reading frame (light blue box) and the poly(A) tail are depicted. 
During Initiation, most eukaryotic mRNAs are translated by the cap-dependent mechanism, which 
requires recognition by eIF4E (light purple) complexed with eIF4G (red) and eIF4A (light green) –the 
so-called eIF4F complex– of the cap structure at the 5’ end. A 43S pre-initiation complex (consisting in a 
40S ribosomal subunit (dark gray) loaded with eIF3 (pink), eIF1 and eIF1A (light grey), initiator Met-
tRNAiMet (blue clover), eIF2 (dark green) and GTP binds the eIF4F-mRNA complex and scans along the 
5’-UTR of the mRNA to reach the start codon (usually an AUG triplet). During the scanning eIF4A, 
stimulated by eIF4B (dark blue), unwinds secondary RNA structure in an ATP-dependent manner. The 
poly A-binding protein (PABP, dark brown) binds both the poly(A) tail and eIF4G promoting mRNA 
circularization. Free 60S ribosomal subunit is stabilized by eIF6 and eIF3. Elongation is assisted by 
elongation factors eEF1A and eEF2 (light brown). During this step, aminoacyl-tRNA synthetases (aaRSs, 
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blue) catalyze the binding of amino acids (aa) to cognate tRNAs. Termination is mediated by the release 
factors eRF1 (gray) and eRF3 (light blue), and happens when a termination codon (STOP) of the mRNA 
is exposed in the A-site of the ribosome. In this step, the completed polypeptide (blue line) is released. 
During Recycling, which is required to allow further rounds of translation, both ribosomal subunits 
dissociate from the mRNA. Recycling is assisted by ABCE1 (light blue). eRF1 remains associated with 
the post-termination complexes after polypeptide release. 
2.1. Initiation 
Translation initiation is mediated by eukaryotic initiation factors (eIF). For the big majority 
of mRNAs, translation initiation happens by the so-called cap-dependent mechanism (19-
23). It begins with the dissociation of the ribosome into its 60S and 40S subunits by eIF6. Free 
40S subunit, which is stabilized by eIF3, eIF1 and eIF1A, binds to a ternary complex 
(consisting of eIF2 bound to an initiator Met-tRNAiMet and GTP) to form a 43S pre-initiation 
complex. In separate events, the cap structure (m7GpppN, where N is any nucleotide) 
present in the 5’ end of the mRNA is recognized by eIF4E in complex with eIF4G (forming 
the so-called eIF4F complex). Then the 43S pre-initiation complex is recruited to the 5’ end of 
the mRNA, a process that is coordinated by eIF4G through its interactions with eIF4E and 
the 40S ribosomal subunit-associated eIF3. eIF4G also interacts with the poly A-binding 
protein (PABP) which interacts with the mRNA 3’-poly(A) tail, thereby promoting 
circularization of the mRNA and increasing its stability. The closed-loop model proposes 
that during translation, cross-talk occurs between both mRNA ends due to this circularity. 
The ribosomal complex then scans in a 5’ ⎯> 3’ direction along the 5’-untranslated region 
(UTR) of the mRNA to reach the start codon, usually an AUG. During scanning, eIF4B 
stimulates the activity of eIF4A, which unwinds secondary RNA structures in the mRNA. 
eIF1, eIF1A, and eIF5 assist in the positioning of the 40S ribosomal subunit at the correct 
start codon so that eIF2 can deliver the anti-codon of the initiator Met-tRNAiMet as the 
cognate partner for the start codon, directly to the peptidyl (P)-site of the 40S ribosomal 
subunit. Once the ribosomal subunit is placed on the start codon, a 48S pre-initiation 
complex is formed. Then eIF5 promotes GTP hydrolysis by eIF2 to release the eIFs. Finally, 
the 60S ribosomal subunit joins the 40S subunit in a eIF5B-dependent manner to form an 80S 
initiation complex. The outcome of the initiation process is a 80S ribosomal complex 
assembled at the start codon of the mRNA containing a Met-tRNAiMet in the P-site (19-22). 
In some mRNAs, 5’-UTR recognition by the 40S ribosomal subunit is driven by RNA 
structures located in cis within the mRNA itself. Such structures are defined as Internal 
Ribosome Entry Site (IRES) and are located nearby the start codon. This mechanism takes 
place without involvement of the cap structure and eIF4E and is called an IRES-dependent 
initiation of translation (13, 24, 25). 
2.2. Elongation 
Translation elongation is assisted by elongation factors (eEF). During this step, mRNA 
codons are decoded and peptide bonds are formed sequentially to add amino acid residues 
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to the carboxy-terminal end of the nascent, mRNA-encoded, peptide (21, 26-28). Elongation 
involves four major steps: i) formation of the ternary complex eEF1A⋅GTP⋅aminoacyl-tRNA 
and delivery of the first elongator aminoacyl-tRNAs to an empty ribosomal tRNA-binding 
site called the A (acceptor)-site. It is in the A-site where codon/anticodon decoding takes 
place; ii) Interaction of the ribosome with the mRNA-tRNA. This duplex activates 
eEF1A⋅GTP hydrolysis and guanine nucleotide exchange on eEF1A; iii) Peptide bond 
formation then occurs between the P-site peptidyl-tRNA and the incoming aminoacyl 
moiety of an A-site aminoacyl-tRNA. This reaction is catalyzed by the peptidyl transferase 
center of the 60S ribosomal subunit, and the products comprise of a new peptidyl-tRNA that 
is one amino acid residue longer and a deacylated (discharged) tRNA. iv) Binding of 
eEF2⋅GTP and GTP hydrolysis promote the translocation of the mRNA such that the 
deacylated tRNA moves to the E (exit)-site, the peptidyl-tRNA is in the P-site, and the 
mRNA moves by three nucleotides to place the next mRNA codon into the A-site. The 
deacylated tRNA in E-site is then ejected from the ribosome. The whole process is repeated 
along the mRNA sequence. When a stop codon is reached the process of termination is 
initiated (21, 26-28). 
2.3. Termination 
Translation termination is mediated by two polypeptide chain-release factors, eRF1 and 
eRF3. When any of the termination codons is exposed in the A-site, eRF1 recognizes the 
codon, binds the A-site, and triggers the release of the nascent polypeptide from the 
ribosome by hydrolysing the ester bond linking the polypeptide chain to the P-site tRNA. 
This reaction leaves the P-site tRNA in a deacylated state, leaving it to be catalyzed by the 
peptidyl transferase center of the ribosome. eRF1 recognizes stop signals and functionally 
acts as a tRNA-mimic, whereas eRF3 is a ribosome- and eRF1-dependent GTPase that, by 
forming a stable complex with eRF1, stimulates the termination process (21, 29, 30). 
2.4. Recycling 
In the recycling step, both ribosomal subunits are dissociated releasing the mRNA and 
deacetylated tRNA, so that both ribosomal subunits can be used for another round of 
initiation (21, 29, 30) (Fig.1). Evidence suggests that the ABC-type ATPase ABCE1 is 
probably the general ribosome recycling factor which coordinates termination with 
recycling (31). ABCE1 establishes multiple contacts with both ribosomal subunits as well as 
with the release factors and stimulates ribosome dissociation. ABCE1 also influences eRF1 
function during stop-codon recognition and peptidyl-tRNA hydrolysis. During ribosome 
recycling, eRF3 dissociates from ribosomal complexes after GTP hydrolysis, whereas eRF1 
remains associated with posttermination ribosomal complexes after peptide release (31-33).  
According to the closed-loop model, termination and recycling may not release the 40S 
ribosomal subunit back into the cytoplasm. Instead, this subunit may be passed from the 
poly(A) tail back to the 5’-end of the mRNA, so that a new round of initiation can be started 
on the same mRNA (21, 29, 34) 
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3. The emergence of eukaryotic translation  
The emergence of eukaryotes from prokaryotic ancestors led toward novel, higher levels of 
cell organization. A plethora of new features emerged at the cellular level, including the 
acquisition of a nucleus, an endoplasmic reticulocyte and endosymbiotic bacteria, the 
formation of split genes sorted out in chromosomes, an actin-based cytoskeleton and, in 
many phyla, the emergence of multicellularity, behavioural patterns and developmental 
programs. In this new type of cell, novel features appeared in the translation process, 
including the spatio-temporal separation between transcription and translation, and the 
increase of the number of events occurring during the initiation step that led to the 
establishment of the cap-dependent mechanism. 
During the emergence of eukaryotes, the translation apparatus itself also underwent 
profound changes, including the evolution of the 40S and 60S ribosomal subunits from the 
prokaryotic 30S and 50S, respectively. This was due to the addition of several rRNA 
expansion segments, peptide additions to most ribosomal proteins, and the addition of extra 
eukaryotic-specific components, including novel ribosomal proteins and the 5.8S rRNA (26, 
35-38). Moreover, the number of initiation factors increased. While in prokaryotes 
translation initiation is assisted by three factors, in eukaryotes initiation needs the interplay 
of at least fourteen factors. Thus, novel, eukaryotic-specific translation factors evolved 
(including eIF3, eIF4B, eIF4E, eIF4G, eIF4H and eIF5). The mRNA also underwent profound 
changes which can be summarized as follows: i) it acquired a novel molecular structure, 
from polycistronic to monocistronic, capped, and polyadenylated transcripts; ii) it acquired 
a novel life cycle, from simultaneous transcription/translation, to be transcribed, spliced and 
exported from the nucleus, to be stored, translated and degraded in the cytoplasm; and iii) it 
acquired a novel functional conformation when engaged in translation, displaying a 
functional cross-talk between the 5’- and 3’-ends. Finally, with the emergence of eukaryotes 
the number of different mechanisms that regulate translation was expanded (11-15, 17, 39). 
How the transition from prokaryotic to eukaryotic translation occurred remains still 
unresolved. I will discuss some ideas that have been set forward to try to address this 
question. 
4. The transition from prokaryotic to eukaryotic translation initiation  
4.1. Translation initiation in the prokaryotic world 
It was established in the 1970s that in eubacteria the recruitment of the small ribosomal 
subunit to the mRNA occurs by a direct interaction. This happens via the complementary 
base pairing between the Shine-Dalgarno (SD) sequence of the mRNA, which is a purine-rich 
region located at around 10 nucleotides upstream the start codon, and a sequence at the 3’ 
end of the 16S rRNA on the ribosome (referred to as anti-Shine-Dalgarno sequence, ASD) (40, 
41). The importance of the SD sequence to initiate translation was later experimentally 
corroborated in different eubacteria and archaea (42-44), and has been retained in some cell 
organelles that evolved from eubacteria over a billion years ago (45). This, together with the 
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4.1. Translation initiation in the prokaryotic world 
It was established in the 1970s that in eubacteria the recruitment of the small ribosomal 
subunit to the mRNA occurs by a direct interaction. This happens via the complementary 
base pairing between the Shine-Dalgarno (SD) sequence of the mRNA, which is a purine-rich 
region located at around 10 nucleotides upstream the start codon, and a sequence at the 3’ 
end of the 16S rRNA on the ribosome (referred to as anti-Shine-Dalgarno sequence, ASD) (40, 
41). The importance of the SD sequence to initiate translation was later experimentally 
corroborated in different eubacteria and archaea (42-44), and has been retained in some cell 
organelles that evolved from eubacteria over a billion years ago (45). This, together with the 
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large proportion of genes having the SD sequence in the well studied bacteria, led to the 
general idea that for the vast majority of prokaryotic mRNAs the SD sequence was the 
essential (although not necessarily the sole) element to select the correct initiation codon, and 
that the SD/ASD interaction during initiation is conserved in most prokaryotes (16, 46, 47). 
However, in recent years a large number of mRNAs lacking a SD sequence have been 
discovered widespread in a variety of different eubacterial and archaeal lineages. These 
include mRNAs devoid of 5'-UTR (and hence referred to as “leaderless” mRNAs) (15, 16, 39, 
45, 48-54), and mRNAs that possess a 5’-UTR and lack a SD sequence (45, 48-53, 55). For 
leaderless mRNAs the start codon itself was found to serve as the most important signal for 
ribosome recruitment and for translation initiation. Here the initiator tRNA and IF2 are 
critical for complex formation between the start codon and the ribosome. It is noteworthy that 
translation initiation of leaderless mRNAs involves the undissociated ribosome 70S instead of 
the 30S ribosomal subunit (15, 16, 39, 51, 56-59). mRNAs with a 5’-UTR devoid of a SD 
sequence exhibit a pronounced minimum in secondary structure and AUG start codons 
reside in single-stranded regions of the mRNAs. For these mRNAs, ribosome binding to the 
start codon is a sequence-independent event, but is strictly dependent on the local absence of 
RNA secondary (45). Translation initiation of these transcripts is promoted by the ribosomal 
protein S1 (RPS1), which is a component of the 30S ribosomal subunit. RPS1 interacts with 
the 5’-UTR of an mRNA initiating translation efficiently, regardless of the presence of a SD 
sequence. Intriguingly, neither archaeobacteria nor eukaryotes contain a RPS1 gene, raising 
the question of how leadered mRNAs devoid of a SD sequence are translated in Archaea (39, 
46, 49, 51). Finally, evidence suggests that alternative, unknown mechanisms might be used 
to initiate translation in Cyanobacteria (49) and in haloarchaea (60). 
Overall, the emerging view indicates that in the prokaryotic world, both SD-dependent and 
SD-independent translation mechanisms are present in all major groups of prokaryotes. 
Indeed, evidence suggests that the leaderless mechanism might represent the major 
pathway to initiate translation in Archaea (52-54). Thus, it has been suggested that the last 
common ancestor of existing life already possessed an established fundamental translational 
apparatus, but the mechanisms to initiate translation initiation further diversified in the 
bacterial and archaeal lineages (17, 49, 50, 60). 
4.2. What was the mechanism to recruit mRNAs in the last common ancestor of 
existing life? 
Despite the presence of leaderless and leadered, SD-lacking mRNAs across prokaryotes, a 
recent study using the genomes of 277 prokaryote species, both eubacteria and archaea, 
showed that the anti-SD sequence at the 3’ end of the 16S rRNA on the ribosome is highly 
conserved among all species, and that loss of the SD sequence seems to have occurred 
multiple times, independently, in different phyla (49). These observations strongly suggest 
that the SD/ASD interaction plays an important role in translation initiation in essentially all 
prokaryote species that are descended from the last universal common ancestor. Thus, the 
SD-based mechanism of ribosome recruiting might have driven translation initiation in the 
last common ancestor of existing organisms, but was further lost in different phyla (49). For 
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those phyla which lost the SD sequence, RSP1-mediated or leaderless mRNA-used 
mechanisms of translation initiation work to great extent (49). The evolutionary pressures 
that led to the loss of SD sequences, however, are completely unknown. 
4.3. The transition to eukaryotes 
As mentioned above, while the fundaments of translation are well conserved in all forms of 
life, in eukaryotes the initiation step underwent substantial increase in complexity and in 
number of initiation factors as compared to prokaryotes. 
Although it is established that eukaryotes evolved from archaeal ancestors, we still don’t 
know what lineage they evolved from. Thus, we don’t know what type of mRNA (i.e. SD-
containing, leaderless, or SD-lacking transcript) the first eukaryotes possessed. Nevertheless, 
all eukaryotic mRNAs lack SD sequences and ribosomes have no RPS1. I have previously 
suggested that three were the most important evolutionary forces that led to the emergence 
of the cap-dependent initiation mechanism in eukaryotes, namely (i) the need to adjust to 
the emergence of the nuclear membrane and interrupted genes, (ii) the subsequent 
requirement to splice and export intron-less mRNAs to the cytoplasm, and (iii) the absence 
of SD sequence and RSP1 in eukaryotic mRNAs (11, 13, 14). Because eukaryotic mRNAs lack 
both SD sequences and RPS1 protein, they cannot efficiently recruit the small ribosomal 
subunit directly to the initiation codon. This, together with the fact that most initiation 
factors that evolved only within the eukaryotes (including eIF4E, eIF4G, eIF4B, eIF4H and 
eIF3) are involved in the cap-binding and the scanning processes, indicates that the absence 
of both SD sequences and RSP1 protein was one of the crucial selection pressures that led to 
early eukaryotes to develop a novel mechanism to ensure the correct landing of the 
ribosome at the 5’-end of mRNAs, namely the cap-dependent initiation (11, 13, 14). 
I have discussed that during eukaryogenesis and before the time when the cap-dependent 
initiation was developed, it is possible that there would have been a transition period where 
the mRNAs of the early eukaryotes were translated in a cap-independent, IRES-driven 
manner. In this period, 5’-UTRs lacking SD motifs that were able to passively recruit the 40S 
ribosomal subunit would have been positively selected for and could, therefore, have 
become the first examples of IRESs (Fig. 2). In this scenario, the cap structure, a proto-eIF4G, 
the poly(A) tail and an ancestral PABP, might have appeared for functions in RNA 
metabolism that emerged among the primary adaptive responses to the emergence of split 
genes and the need for nucleocytoplasmic RNA export, but initially had no role in 
translation (11, 13, 14). As a consequence of the absence of the SD sequence in eukaryotic 
mRNAs, the scaffold proteins eIF4G, eIF3 and eIF4B, as well as the 5’-end cap structure, 
eIF4E, and RNA helicases were later incorporated into the already established but incipient 
eukaryotic translation machinery because they ensured a more efficient recruitment of the 
40S ribosomal subunit by the mRNA. Altogether, these events led the “scanning” process to 
evolve and to the establishment of the current cap-dependent translation initiation. 
Mutations in PABP, which allowed binding to eIF4G and promoted mRNA circularization 
underwent a strong positive selection because they ensured a more efficient recruitment of 
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the 40S ribosomal subunit by the mRNA, stimulating translation and increasing mRNA 
stability. mRNA circularization provides an effective means for the protein synthesis 
apparatus to selectively translate only intact mRNAs, i.e., those that harbor both a cap and a 
poly(A) tail. Thus, mRNA circularization also (and perhaps primarily) underwent a strong 
positive selection because it represents a checkpoint that determines whether or not to 
initiate translation (11, 13, 14). 
 
Figure 2. A proposed model for the evolution of the cap-dependent. 
initiation of translation. (A) Ancestral archaeal cells had polycistronic (blue boxes) mRNAs. It is not 
known what was the mechanism used by the prokaryotic ancestors of eukaryotes to recruit the mRNA by 
the 30S ribosomal subunit. (B) The evolutionary transition from ancestral archaeal cells to early 
eukaryotes is represented. Due to the appearance of the nucleus and split genes, transcription and 
translation were decoupled, and a need to splice, export and protect the transcripts during nucleus-
cytoplasm export emerged. The cap structure might have first appeared at this evolutionary stage to 
provide a "platform" to assemble the splicing, export and RNA protection mechanisms (see reference 14 
for details). The arousal of PABP might have happened at this stage as part of the mechanisms to protect 
mRNAs (see reference 11 for details). The lack of SD sequences in the mRNAs, probably as a result of 
massive invasion of introns from endosimbionts, as well as the apparition of monocistronic mRNAs and 
both the 40S and the 60S ribosomal subunits, happened at this stage. Initiation of translation occurred 
perhaps in an IRES-dependent manner via the direct recruitment of the 40S ribosomal subunit by the 
mRNA. (C) The evolution in the cytoplasm of a proto-eIF4G (Pr-4G), along with the emergence of eIF3 
and eIF4B, gradually improved the delivery of the 40S ribosomal subunit to the early mRNAs during 
evolution. The scanning process (orange arrow) evolved probably at this stage due to the activity of RNA 
helicases coming from different processes of metabolism that at the same time could participate in the 
unwinding of mRNA secondary structure during translation initiation. Among them, however, only an 
eIF4A-like helicase evolved functional interactions with eIF4G thus becoming later the canonical 
initiation factor eIF4A. (D) It is not know when eIF4E evolved during eukaryogenesis. However, an 
interaction of eIF4G with eIF4E, eIF4A and PABP evolved, which eventually led to the establishment of 
today's widespread cap-dependent mechanism to initiate translation. 
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5. Diversification of eukaryotes and further evolution of the translation 
apparatus 
5.1. Functional divergence of initiation factors 
After eukaryotes emerged, components of the translation machinery further evolved along 
the radiation into different phyla (Fig. 3). The continue appearance of different levels of 
organismal complexity led to the arousal of new phyla, developmental programs, 
behavioral patterns, and the invasion of novel ecological niches by eukaryotes. These events 
most probably were the causes of a further evolution, to different levels, of components and 
mechanisms of the translation apparatus in different taxa (11, 12). In the following, I will 
summarize the most studied examples of this.  
 
Figure 3. Diversity in the components of the translation apparatus across eukaryotes. The different 
components of the translation machinery with well-studied diversity in different phyla are shown in 
colors. Components with some diversity that is not discussed here are depicted in gray. Several cognates 
of eIF4E (purple) and eIF4G (red) have been found in plants, metazoan, protists and some fungi. In some 
cases, eIF4E cognates have evolved towards translational repressors (4E-HP, dark blue, is an example). 
Many 4E-binding proteins (including Maskin, 4E-BPs, Eap1, p20 and Cup, light blue) have been 
discovered in different species. The subunit composition of eIF3 (pink) ranges from 5 to 13 nonidentical 
polypeptides in different phyla. There is, however, a core of five homolog subunits shared by most 
eukaryotes. Some diversity has been found in eIF6. Several RNA helicases (light green) from diverse 
organisms are involved in the Initiation step. A family of five kinases (HRI, PERK, GCN2, PKR and PKZ, 
red) phosphorylate the alpha subunit of eIF2 to inhibit global translation under stress conditions. The 
presence of eIF2alpha kinases varies in different lineages. Different domains, such as WHEP, EMAPII, 
and UNE-S, have been added to different aminoacyl-tRNA synthetases (aaRSs, blue) in distinct phyla of 
multicellular species. For Elongation to happen, a number of protist, algae and fungi lack eEF1A (light 
brown) and instead possess the related factor elongation factor-like (EFL, dark brown). Ribosomes from 
all eukaryotes perform Elongation with eEF1A and eEF2. However, the yeast S. cerevisiae requires an 
additional essential factor, eEF3 (dark pink), for Elongation to proceed. Genes encoding eEF3 have been 
found exclusively in many species of fungi. Evidence supports the notion that eEF3 activity promotes 
ribosome recycling. Several cytoplasmic PABP (dark brown) cognates have been found in many phyla. 
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Most evidence for molecular and functional diversification among the translation 
components has been found in the eIF4 proteins. All major eukaryotic lineages possess 
several paralog genes for members of the eIF4 families. For some of them, differential 
expression patterns, and even variable biochemical properties among paralogs of the same 
organism, have been found (12, 14, 61-66). For eIF4E and eIF4G cognates, physiological 
specialization has been also found and, in some cases, eIF4E cognates have evolved towards 
translational repressors (12, 14, 61-63, 65). These findings support the hypothesis that in 
organisms with several paralogs, a ubiquitous set of eIF4 factors supports global translation 
initiation whereas other paralogs perform their activity in specific cellular processes (61). 
Whereas the need for distinct eIF4 proteins in different tissues may have been the driving 
force behind the evolution of various paralogs in multicellular organisms, in unicellular 
eukaryotes different paralogs may be differentially needed during distinct life stages 
(67).The multisubunit eIF3 is another example of factor that has undergone molecular 
diversification across eukaryotes, whose subunit composition ranges from 5 to 13 
nonidentical polypeptides in different phyla (68). However, the functional relevance of these 
phenomena is not known. 
5.2. Multiple helicases involved in the initiation step  
eIF4A is the factor traditionally thought to perform RNA helicase activity to unwind the 5’-
UTR secondary structure during the scanning. Recently, other RNA helicases from diverse 
organisms have also been found to be involved in different steps of translation initiation. 
Such is the case of the mammalian, Drosophila and yeast helicases DDX3 and Ded1, as well 
as the human helicases RHA and DHX29 (69-71). Evidence supports the idea that in 
Drosophila, the helicase Vasa is a translational activator of specific mRNAs involved in 
germline development (5, 6). In contrast, orthologs of the Xenopus helicase Xp54 in several 
organisms, including Drosophila Me31B, Saccharomyces Dhh1, human rck/p54, and 
Caenorhabditis CGH-1 have been found to repress translation of stored mRNAs and promote 
aggregation into germplasm-containing structures (72). In Arabidopsis, the eIF4F complex 
contains eIF4A in proliferating cells but different RNA helicases in quiescent cells (73). 
These findings show that evolutionary convergence has happened in different lineages to 
fulfill the need of RNA helicase activity during translation initiation.  
5.3. Divergence in molecules involved in the elongation step 
In contrast to the initiation step, the process of elongation is highly conserved among all forms 
of life. Strikingly, a recent genome-wide analysis revealed that a number of eukaryotic lineages 
lack eEF1A, a canonical factor that delivers aa-tRNAs to the A-site of ribosomes during the 
elongation step. Instead, they possess a related factor called elongation factor-like (EFL) 
protein that retains the residues critical for eEF1A (74). It was later found that EFL-encoding 
species are scattered widely across eukaryotes and that eEF1A and EFL genes display mutually 
exclusive phylogenetic distributions. Thus, it is assumed that eEF1A and EFL are functionally 
equivalent (74-82). It is thought that eEF1A is ancestral to all extant eukaryotes and that a 
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single duplication event in a specific lineage gave rise to EFL. EFL genes were then spread to 
other lineages via multiple independent lateral gene transfer events, where EFL took over the 
original eEF1A function resulting in secondary loss of the endogenous eEF1A. It is thought that 
both genes co-existed for some time before one or the other was lost. Indeed, the diatom 
Thalassiosira bears both EFL and eEF1A genes (79) and might be an example of this situation. It 
is also possible that there was a single gain of EFL early in evolution followed by differential 
loss of it (74, 78, 79, 81, 82). So far, EFL genes have been identified in widespread taxa, 
including diatoms, green and red algae, fungi, euglenozoans, foraminiferans, cryptophytes, 
goniomonads, katablepharid, chlorarachniophytes, oomycetes, dinoflagellates, choanozoans, 
centrohelids and haptophytes. Most of them are unicellular organisms. In contrast, most 
eukaryotes contain only eEF1A (74-82). 
Key molecules for elongation are aaRSs, which catalyze the aminoacylation reaction 
whereby an amino acid is attached to the cognate tRNA (21, 26, 27). aaRS represent an 
intriguing and perhaps unique case of evolution among the components of the translation 
apparatus. Throughout evolution of multicellularity, different domains such as the 
tripeptide ELR (Glu-Leu-Arg), the oligonucleotide binding fold-containing EMAPII domain, 
the WHEP domain, the glutathione S-transferase (GST) domain and a specialized amino-
terminal helix (N-helix), have been progressively added to different aaRSs in distinct phyla. 
The tripeptide ELR and the EMAPII domain were incorporated simultaneously to TyrRSs in 
metazoans starting from insects; the WHEP domain is present in TrpRS only in chordates; 
and a unique sequence motif, UNE-S, became fused to the C-terminal of SerRS of all 
vertebrates. In bilaterian the glutamylRS and prolylRS were linked via WHEP domains 
giving rise to a bifunctional glutamyl-prolylRS (83, 84). 
It has been found that the function of the aaRSs was either increased or impaired by the 
addition of the new domains. Whereas the WHEP domain regulates interaction of TrpRS 
with its cognate receptor, with MetRS this domain plays a tRNA-sequestering function. The 
Leu-zipper motif in ArgRS is important for the formation of multi aaRSs complex (MSC), 
which enhances channeling of tRNA to the ribosome. Moreover, different aaRSs play 
diverse roles in cellular activities beyond translation, such as stress response, plant and 
animal embryogenesis, cell death, immune responses, transcriptional regulation, and RNA 
splicing (83-85). It has been found that the incorporation of domains to aaRSs correlates 
positively with the increase in organism’s complexity. For example, the number of aaRSs 
carrying the GST domain increases from two in fungi to four in insects, to five in fish and six 
in humans (83). Thus, it has been proposed that the newly fused aaRSs domains triggered 
the appearance of new biological functions for these proteins in different lineages, and that 
the fusion of domains to aaRSs could have played an important part in expanding the 
complexity of newly emerging metazoan phyla (83). 
5.4. Divergence in termination and recycling factors 
Termination is governed by eRF1, which is a monophyletic protein that was inherited by 
eukaryotes from archaeal ancestors. eRF1 is universally present in eukaryotes and, with the 
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several paralog genes for members of the eIF4 families. For some of them, differential 
expression patterns, and even variable biochemical properties among paralogs of the same 
organism, have been found (12, 14, 61-66). For eIF4E and eIF4G cognates, physiological 
specialization has been also found and, in some cases, eIF4E cognates have evolved towards 
translational repressors (12, 14, 61-63, 65). These findings support the hypothesis that in 
organisms with several paralogs, a ubiquitous set of eIF4 factors supports global translation 
initiation whereas other paralogs perform their activity in specific cellular processes (61). 
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force behind the evolution of various paralogs in multicellular organisms, in unicellular 
eukaryotes different paralogs may be differentially needed during distinct life stages 
(67).The multisubunit eIF3 is another example of factor that has undergone molecular 
diversification across eukaryotes, whose subunit composition ranges from 5 to 13 
nonidentical polypeptides in different phyla (68). However, the functional relevance of these 
phenomena is not known. 
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UTR secondary structure during the scanning. Recently, other RNA helicases from diverse 
organisms have also been found to be involved in different steps of translation initiation. 
Such is the case of the mammalian, Drosophila and yeast helicases DDX3 and Ded1, as well 
as the human helicases RHA and DHX29 (69-71). Evidence supports the idea that in 
Drosophila, the helicase Vasa is a translational activator of specific mRNAs involved in 
germline development (5, 6). In contrast, orthologs of the Xenopus helicase Xp54 in several 
organisms, including Drosophila Me31B, Saccharomyces Dhh1, human rck/p54, and 
Caenorhabditis CGH-1 have been found to repress translation of stored mRNAs and promote 
aggregation into germplasm-containing structures (72). In Arabidopsis, the eIF4F complex 
contains eIF4A in proliferating cells but different RNA helicases in quiescent cells (73). 
These findings show that evolutionary convergence has happened in different lineages to 
fulfill the need of RNA helicase activity during translation initiation.  
5.3. Divergence in molecules involved in the elongation step 
In contrast to the initiation step, the process of elongation is highly conserved among all forms 
of life. Strikingly, a recent genome-wide analysis revealed that a number of eukaryotic lineages 
lack eEF1A, a canonical factor that delivers aa-tRNAs to the A-site of ribosomes during the 
elongation step. Instead, they possess a related factor called elongation factor-like (EFL) 
protein that retains the residues critical for eEF1A (74). It was later found that EFL-encoding 
species are scattered widely across eukaryotes and that eEF1A and EFL genes display mutually 
exclusive phylogenetic distributions. Thus, it is assumed that eEF1A and EFL are functionally 
equivalent (74-82). It is thought that eEF1A is ancestral to all extant eukaryotes and that a 
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single duplication event in a specific lineage gave rise to EFL. EFL genes were then spread to 
other lineages via multiple independent lateral gene transfer events, where EFL took over the 
original eEF1A function resulting in secondary loss of the endogenous eEF1A. It is thought that 
both genes co-existed for some time before one or the other was lost. Indeed, the diatom 
Thalassiosira bears both EFL and eEF1A genes (79) and might be an example of this situation. It 
is also possible that there was a single gain of EFL early in evolution followed by differential 
loss of it (74, 78, 79, 81, 82). So far, EFL genes have been identified in widespread taxa, 
including diatoms, green and red algae, fungi, euglenozoans, foraminiferans, cryptophytes, 
goniomonads, katablepharid, chlorarachniophytes, oomycetes, dinoflagellates, choanozoans, 
centrohelids and haptophytes. Most of them are unicellular organisms. In contrast, most 
eukaryotes contain only eEF1A (74-82). 
Key molecules for elongation are aaRSs, which catalyze the aminoacylation reaction 
whereby an amino acid is attached to the cognate tRNA (21, 26, 27). aaRS represent an 
intriguing and perhaps unique case of evolution among the components of the translation 
apparatus. Throughout evolution of multicellularity, different domains such as the 
tripeptide ELR (Glu-Leu-Arg), the oligonucleotide binding fold-containing EMAPII domain, 
the WHEP domain, the glutathione S-transferase (GST) domain and a specialized amino-
terminal helix (N-helix), have been progressively added to different aaRSs in distinct phyla. 
The tripeptide ELR and the EMAPII domain were incorporated simultaneously to TyrRSs in 
metazoans starting from insects; the WHEP domain is present in TrpRS only in chordates; 
and a unique sequence motif, UNE-S, became fused to the C-terminal of SerRS of all 
vertebrates. In bilaterian the glutamylRS and prolylRS were linked via WHEP domains 
giving rise to a bifunctional glutamyl-prolylRS (83, 84). 
It has been found that the function of the aaRSs was either increased or impaired by the 
addition of the new domains. Whereas the WHEP domain regulates interaction of TrpRS 
with its cognate receptor, with MetRS this domain plays a tRNA-sequestering function. The 
Leu-zipper motif in ArgRS is important for the formation of multi aaRSs complex (MSC), 
which enhances channeling of tRNA to the ribosome. Moreover, different aaRSs play 
diverse roles in cellular activities beyond translation, such as stress response, plant and 
animal embryogenesis, cell death, immune responses, transcriptional regulation, and RNA 
splicing (83-85). It has been found that the incorporation of domains to aaRSs correlates 
positively with the increase in organism’s complexity. For example, the number of aaRSs 
carrying the GST domain increases from two in fungi to four in insects, to five in fish and six 
in humans (83). Thus, it has been proposed that the newly fused aaRSs domains triggered 
the appearance of new biological functions for these proteins in different lineages, and that 
the fusion of domains to aaRSs could have played an important part in expanding the 
complexity of newly emerging metazoan phyla (83). 
5.4. Divergence in termination and recycling factors 
Termination is governed by eRF1, which is a monophyletic protein that was inherited by 
eukaryotes from archaeal ancestors. eRF1 is universally present in eukaryotes and, with the 
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exception of some vascular plants and some ciliates, eukaryotes contain only one eRF1 gene 
(86-89). Interestingly, unusually high rates of eRF1 evolution have been found in organisms 
with variant genetic codes (mostly protists and unicellular fungi), especially in the N-
terminal domain, which is responsible for stop-codon recognition (86, 87, 89-92). eRF1 
displays structural similarity to tRNA molecules and mimics its activity during binding of 
ribosomal A-site during recognition of a stop codon (91-94). Since mutations in eRF1 N-
terminal domain switch from omnipotent to bipotent mode for stop-codon specificity (94-
98), most likely the accelerated evolution of eRF1 in organisms with variations to the nuclear 
genetic code has been driven mainly to accommodate these variations (89-99). 
Another striking case of evolutionary divergence was found in the fungi. Ribosomes from 
all eukaryotes perform elongation with eEF1A and eEF2. Surprisingly, it was found that the 
yeast Saccharomyces cerevisiae requires an additional essential factor, eEF3, for the elongation 
cycle to proceed (100). Genes encoding eEF3 were subsequently identified exclusively in 
other fungi, including Candida, Pneumocystis, Neurospora, Aspergillus and Mucor (101-104). 
eEF3 is an ATPase that interacts with both ribosomal subunits and that is required for the 
binding of aminoacyl-tRNA-eEF1A-GTP ternary complex to the ribosomal A-site by 
enhancing the rate of deacylated tRNA dissociation from the E-site (105). Recently, it was 
shown that post-termination complex, consisting of a ribosome, mRNA, and tRNA, is 
disassembled into single components by ATP and eEF3. Because the release of mRNA and 
deacylated tRNA and ribosome dissociation takes place simultaneously and no 40S⎯mRNA 
complexes remain, it is proposed that eEF3 activity promotes ribosome recycling (106). It 
remains unsolved what were the evolutionary forces that led to the emergence of eEF3 
exclusively in fungi.  
6. Concluding remarks 
One of the enigmas in current Biology is how eukaryotic protein synthesis emerged. I have 
discussed that, in the absence of SD sequence in mRNAs and RPS1 in ribosomes, the 
evolution of translation machinery followed a gradual addition of scaffold proteins, namely 
eIF4G, eIF3 and eIF4B, which highly improved the efficiency and regulation of mRNA 
binding to the 40S ribosomal subunit (14). This, together with the incorporation of several 
RNA helicases, eIF4E and PABP, gradually improved the global efficiency, accuracy and 
possibilities of gene expression regulation at the level of translation initiation (14). Most 
likely the molecular diversification of the translation apparatus is among the basis that 
provided to early eukaryotes the scope to invade new ecological niches and overcome the 
different environmental and biological challenges this represented. Indeed, the evolution of 
the translation apparatus might have been both, cause and consequence of eukaryotic 
radiation. 
Translation in eukaryotes is tightly coupled to other features and components of cellular 
metabolism. For example, translation control is coupled to RNA transport to ensure 
different developmental programs to occur (107, 108). The RNA transport machineries have 
also diverged in different phyla, and together with them some components of the translation 
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apparatus also diverged (108). Another fundamental aspect of RNA metabolism is the 
storage and degradation of mRNAs in different cytoplasmic bodies, such as P-bodies and P-
granules, which contain translation factors (109). The diversity and conservation of these 
foci across phyla are a reflection of the general evolution that the translation machinery and 
its regulation have undergone during eukaryotes evolution. 
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1. Introduction 
With the completion of human genome project in 2003, the 50th anniversary year of the 
discovery of the structure of DNA, we entered in the post-genomic era that concentrates on 
harvesting the fruits hidden in the genomic text. Since then we have witnessed the 
generation of a tremendous volume of DNA information (genetic information). As of 
September 2011, the Genomes OnLine Database (GOLD, http://www.genomesonline.org) 
has documented 1914 complete genome projects which comprise 1644 bacterial, 117 archaeal 
and 153 eukaryal genomes [1]. However, only a fraction of these DNA data are associated 
with their encoded proteins, i.e., their phenotypes (functional information) [2]. Even when a 
phenotype is associated with the encoding gene, the function of a particular gene cannot be 
fully understood until it is possible to describe all of the phenotypes that result from the 
wild-type and mutant forms of that gene. Moreover, unlike a genome that contains a fixed 
number of genes, the levels of proteins within cells are likely an order of magnitude greater 
than the number of genes. Therefore, the focus of the scientific community has recently been 
shifted from gene sequencing to annotation of gene function and regulation through 
elucidation of protein abundance, expression, post-translational modifications, and protein-
protein interactions. While the pre-genomic era which lasted less than 15 years, the post-
genomic era can be expected to last much longer, probably extending over several 
generations, and thus there is an increasing need for high throughput expression of the 
genome encoded proteins to profile the entire proteome and get a deeper understanding of 
protein abundance and reveal novel protein functions. Protein synthesis is therefore a 
powerful tool for large-scale analysis of proteins for a large-variety of low- and high-
throughput applications (see Fig.1) and an essential tool for bridging the gap between 
genomics and proteomics in the post-genomic era. Noteworthy, the ribosome that catalyses 
and provide the platform for protein synthesis was in the spotlight recently, as the Nobel 
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Prize in Chemistry 2009 was awarded to the work that unlocked the structure and function 
of the ribosomes. 
2. Significance of protein synthesis enhancer sequences (5’UTR) 
Cell-based (in vivo) and cell-free (in vitro) methods have been developed for production of 
protein synthesis [3]. Cell-based host systems such as bacteria, yeast, worms, mammalians 
used for protein synthesis and protein expression analysis, however, have been unable to 
meet the requirement of producing large amounts of purified and functional proteins which 
is a prerequisite to facilitate structure-based functional analysis. For example, purified 
proteins are necessary to grow protein crystals whose X-ray diffraction patterns provide the 
most precise structural information. Other limitations in host organisms includes such as 
bacteria don’t have the intracellular organelles found in eukaryotes; yeast lack a dimension 
of complexity in intracellular communication observed in metazoans; and even other 
mammalian system are different from human in important aspects of both normal 
physiology and disease pathogenesis [4]. In addition, many biochemical pathways are 
simply difficult to study in the larger context of other events happening at the same time 
within the cell. In contrast to the cell-based systems, cell-free protein expression systems are 
now becoming the favored alternative with far greater fidelity as it offers a simple and 
flexible system for the rapid synthesis of functional proteins. There is currently a wide range 
of cell-free translation systems due to the ready availability of cell extracts prepared from 
various cell sources, including Escherichia coli, yeast, wheat germ, rabbit reticulocytes, 
Drosophila embryos, hybridomas, and insect, mammalian, and human cells [5-11]. Although 
encouraging, there would be some major issues in the use of cell-free systems. First, a major  
 
Figure 1. Application of Protein synthesis 
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drawback of synthesizing proteins in the lysate is that the lysate contains a large portion of 
the cellular proteins and nucleic acids that are not necessarily involved in the targeted 
protein synthesis and can lead to low protein yields through interfering with the subsequent 
purification reactions. In addition, the presence of proteases and nucleases in the lysates 
could be inhibitory to protein synthesis. In order to addressing this issue, cell-free protein 
synthesis system was reconstituted in vitro from purified components of the E. coli 
translation machinery. This system, termed the “protein synthesis using recombinant 
elements” (PURE) system, contains all necessary translation factors, purified with high 
specific activity, and allows efficient protein production [12]. Remarkably, this reconstituted 
system has been shown to catalyze efficient in vitro protein synthesis by providing a much 
cleaner background than a lysate-based system [13].  
The second issue is that existing cell-free systems differ substantially from each other with 
respect to their efficiency and scalability to produce proteins and therefore these systems 
has to be programmed for given exogenous mRNA templates. Although different lysates 
may contain specific cellular factors that promote protein synthesis, a key factor in 
ensuring high protein production is the use of strong translational enhancer sequences 
(untranslated regions, UTRs) in the mRNA templates, which has long been known to 
enhance protein production up to several hundred-folds [14]. UTRs are known to play 
crucial role in the post-transcriptional regulation of gene expression, including 
modulation of the transport of mRNAs out of the nucleus and of translation efficiency 
[15]. The average length of UTRs motifs located at the 5’end of the exon, called 5’-UTR, 
ranges between 100 and 200 nucleotides and strikingly varies a lot within a species, e.g., 
in humans, the longest known 5’UTR is 2,803 while the smallest is just 18 nucleotides 
[16,17] (Fig.2).  
 
Figure 2. The average length of untranslated region sequences in the different taxonomic classes. Grey 
bar representing 5’-UTR and black bar is 3’-UTR. 
The structural features of the 5’UTR have a major role in the control of protein synthesis. 
Those proteins which are involved in developmental processes, including growth factors, 
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untranslated regions of mRNAs have crucial roles in protein regulation through protein 
synthesis. Structural elements of the eukaryotic mRNA, including the 5’cap and 3’poly(A) 
tail, and a series of protein-mRNA and protein-protein interactions, including several eIF 
(eukaryotic initiation factors), are important determinants of translation initiation (Fig.3). In 
eukaryotes, a multifactor complex of eukaryotic initiation factors are involved in the 
initiation phase of protein synthesis. But, in particular, 5’UTR plays a major role in the 
translation initiation, a critical step in protein synthesis which is determining qualitatively 
and quantitatively which proteins are made, when and where. 5’UTR is composed of several 
regulatory elements, including the Shine-Dalgarno (SD) and the AU-rich sequences which 
facilitates 16s rRNA-specific ribosome binding to initiate the protein synthesis [18,19]. In 
cell-based or in vivo systems, the translation of natural mRNAs is finely regulated by 
several mechanisms using 5’-capped and 3’-poly(A) containing long-untranslated regions 
(UTRs).     
 
Figure 3. A schematic drawing of a eukaryotic mRNA, illustrating some post-transcriptional regulatory 
elements that affect initiation of protein synthesis. 
Therefore, the efficiency of a cell-free translation system which is reconstituted using crude 
cell extract is restricted due to the problematic of maintaining long-natural UTRs in the in 
vitro construct. Even if so, the obvious question here is that “are the natural UTRs can meet 
the requirements of various translation factors in a cell-free system to carry similar 
mechanisms as in in vivo system?” Looking at this ‘black box’ may open a new window into 
the post-transcriptional regulation of gene expression using cell-free translation systems. 
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Therefore, it is prerequisite to find an alternate for natural UTRs dependency and 
optimization of translation initiation in cell-free system for next-generation in vitro high 
throughput protein synthesis systems. In a recent study using cell-free systems, the 
translation-enhancing activity of some commonly used natural enhancer sequences, such as 
omega from tobacco mosaic virus and the 5’UTR of β-globin mRNA from Xenopus laevis, 
was reported to vary from 1- to 10-fold, depending on the source of the cell-free extract used 
(e.g., wheat germ, rabbit reticulocyte lysate, insect) [20]. Therefore, optimization of enhancer 
sequences of an exogenous mRNA template with a given crude cell extract is desirable 
before using a cell-free protein synthesis system. A recent new development has been the 
remarkable generation of a universal cell-free translation system that mediates efficient 
translation in multiple prokaryotic and eukaryotic systems by bypassing the need for early 
translation initiation steps [21]. 
3. Co-evolutionary relationship between translational initiation and 
protein synthesis 
In the course of evolution on the Earth, how the early life evolved beginning with a 
hypothetical RNA world-to-the world we know today (DNA world) is the persistent issue 
of debate for evolutionary biologist. In 1968, Francis Crick argued about the existence of the 
RNA world in the initial stage of evolution in which RNA molecules assembled from a 
nucleotide soup and supposed to carry both the genetic and catalytic information (Fig.4). In 
later stage, some special types of RNA molecules (now termed as Ribozymes) was 
considered to catalyzes its own self-replication and therefore to develop an entire range of 
enzymatic activities to form DNA world through an intermediate RNP (RNA/Protein) 
world. However, there are certain questions that cannot be answered with proposed RNP 
world. These include: 1. How did ‘RNA-world (Ribozyme-type)’ evolved to ‘DNA-world 
(cell-type)’ since there is no record exists of the intermediates between the RNA-world and 
organized complexity of cell? 2. What was the first Protein evolved out of an RNA world? 3. 
How could it have evolved and how the process of translation emerged? 4. If ribosome 
make protein then how the first ribosomal protein appeared? 5. Why is ribosome made half 
of protein and half of RNA ?  
The recent advances in evolutionary molecular engineering have revealed the bonding 
strategy of the genotype to its phenotype as a unique and essential nature of a ‘virus’ and 
thus the role of virus-type strategy in the course of evolution on the Earth. In 1995, Nemoto 
and Husimi proposed a ‘virus-early and cell-late model’ that a virus-like molecule consist of 
genotype (mRNA) and phenotype (its coded protein) molecules emerged in the latter period 
of RNA world was the key molecule which enforced the transition from RNA-to-RNP world 
by co-evolving the translation system and a virus-like molecule coded a primitive protein of 
replicase [22]. In this theory, they also showed that such virus-like molecule could introduce 
Darwinian evolution into the Eigen’s hypercycle members (RNA replicase of RNA, RNA 
translation members, RNA replicase of protein) resulting in carrying out co-evolution 
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between translation system and protein replicase. This was later reinforced by inventing and 
demonstrating a genotype-phenotype linked method (IVV, in vitro virus) for evolutionary 
molecular engineering [26] and this strongly suggest the potential of IVV method to 
understand the relation between ribosome-mRNA interaction.  
 
Figure 4. A schematic drawing to represent co-evolution of the translation initiation and protein 
synthesis system, prior to ‘birth of first cellular life’. 
4. Directed molecular evolution and screening of protein synthesis 
enhancer sequences 
Directed molecular evolution mimics the natural Darwinian evolution process to evolve 
new functional molecules in the laboratory rather than in the jungle and in days rather than 
in millenniums and thus has emerged as a dominant approach for exploiting the sequence 
space to generate biomolecules with novel functions. Directed molecular evolution rely on 
the application of selection pressure to identify a bio-molecule with desirable properties 
from a diverse pools (or ‘libraries’) of bio-molecules with hundreds of millions of mutations 
and consist of four essential and repeating cycles: the creation of mutation and diversity at 
the DNA molecular level; the coupling of genetic information (DNA/mRNA) to functional 
information (Protein); the application of selection pressure; and the amplification of selected 
molecules (Fig.5).  
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Figure 5. A schematic drawing of Directed Molecular Evolution 
A number of well-established strategies, called display technologies, have been developed 
which use natural cell-based environment, such as yeast surface display, bacterial surface 
display, phage display or use a cell-free environment, such as ribosome display, mRNA 
display (in vitro virus), cDNA display, CIS display, IVC (in vitro compartmentalization) 
(Fig.6). 
 











Cell-Free Protein Synthesis 56 
between translation system and protein replicase. This was later reinforced by inventing and 
demonstrating a genotype-phenotype linked method (IVV, in vitro virus) for evolutionary 
molecular engineering [26] and this strongly suggest the potential of IVV method to 
understand the relation between ribosome-mRNA interaction.  
 
Figure 4. A schematic drawing to represent co-evolution of the translation initiation and protein 
synthesis system, prior to ‘birth of first cellular life’. 
4. Directed molecular evolution and screening of protein synthesis 
enhancer sequences 
Directed molecular evolution mimics the natural Darwinian evolution process to evolve 
new functional molecules in the laboratory rather than in the jungle and in days rather than 
in millenniums and thus has emerged as a dominant approach for exploiting the sequence 
space to generate biomolecules with novel functions. Directed molecular evolution rely on 
the application of selection pressure to identify a bio-molecule with desirable properties 
from a diverse pools (or ‘libraries’) of bio-molecules with hundreds of millions of mutations 
and consist of four essential and repeating cycles: the creation of mutation and diversity at 
the DNA molecular level; the coupling of genetic information (DNA/mRNA) to functional 
information (Protein); the application of selection pressure; and the amplification of selected 
molecules (Fig.5).  
 
Evolutionary Molecular Engineering to Efficiently Direct in vitro Protein Synthesis 57 
 
Figure 5. A schematic drawing of Directed Molecular Evolution 
A number of well-established strategies, called display technologies, have been developed 
which use natural cell-based environment, such as yeast surface display, bacterial surface 
display, phage display or use a cell-free environment, such as ribosome display, mRNA 
display (in vitro virus), cDNA display, CIS display, IVC (in vitro compartmentalization) 
(Fig.6). 
 











Cell-Free Protein Synthesis 58 
Interestingly, a few groups have reported the application of directed molecular evolution to 
the screening of enhancer sequences with high translation efficiency in a cell-free translation 
system using ribosome display or polysome-mediated selection methods [23-25]. Recently, a 
novel strategy is also described for the in vitro selection of strong translation enhancer 
sequences for use in a cell-free translation system using an mRNA display method. The 
mRNA display method (originally called an “in vitro virus’’) [26,27], which covalently links 
the mRNA molecule (genotype) to its encoded protein (phenotype), is a powerful evolutionary 
method for searching for functional protein molecules in a large-scale library. In this strategy, a 
simplified new gel shift assay system was developed to demonstrate that short but efficient 
translation enhancer sequences can be created for use in a given cell-free translation system 
(Fig.7). This method is based on an mRNA display method in which a covalent linkage is 
formed between the mRNA and the encoded protein through the antibiotic molecule 
puromycin. The steps involved in the synthesis of the covalently linked mRNA–protein fusion, 
and in the selection of 5’UTR sequences, are summarized below. First, a model gene construct 
is designed (Fig.7A) as a positive control (wt), which consists of a T7 promoter and a natural 
5’UTR sequence (X. laevis b-globin) upstream of the PDO coding sequence. The stop codon is 
deleted to facilitate RNA–protein fusion, and a short DNA fragment complementary to a Puro-
linker DNA sequence is ligated downstream of the coding sequence. Second, a random 
variable 5’UTR library is constructed by replacing the cognate secondary structure part of the 
X. laevis b-globin UTR sequence (36 nt) with a randomized 20-nt-long sequence with all possible 
combinations of the four nucleotides (N20) (Fig.7B), resulting in an initial library size of 
approximately 1012 (420) molecules. Third, the cDNA library is then transcribed into an mRNA 
library using T7 RNA polymerase with/without the cap analogue (m7GpppG). Fourth, the 3’-
terminal end of the mRNA library is ligated to a synthetic Puro-linker DNA. Fifth, the 
resulting mRNA–Puro-linker conjugate library is then used as a template in a given cell-free 
translation system and is converted into an mRNA–protein fusion library. Sixth, to select 
efficient 5’UTR candidates from inefficient ones, the resulting mRNA–protein fusion is 
analyzed using SDS–PAGE. As shown in Fig.7F, fusion products (translated products) of 
efficiently translated 5’UTRs will migrate with a decreased mobility compared with 
untranslated products from 5’UTR regions with no and/or slow translation efficiency. Thus, 
translated and nontranslated candidates can be distinguished, and translated candidates can 
be clearly identified, by a shift in the gel band pattern. Seventh, the fusion product of 
translated candidates is then carefully excised from the gel, and the associated mRNAs that 
represent selected 5’UTR candidates for efficient translation are directly reverse-transcribed 
and amplified using a single-step RT–PCR. This PCR step completes one round of selection. 
Finally, the selected 5’UTR candidates are then used as templates for a subsequent selection 
round for further enrichment of efficient 5’UTR sequences. Using this gel-shift assay, the 
translation of an mRNA template using a population of randomized 20-nt-long sequences 
upstream of a Pou-specific DNA-binding domain of Oct-1 (PDO) was screened with a rabbit 
reticulocyte extract and the time for translation was successively shortened. A total of five 
selection rounds were performed, starting with a translation time of 45 min and reducing the 
time by 10 min for each subsequent round. The final round used a translation time of only 5 
min. The total yield of RNA–protein fusion constructs following translation after each round 
was evaluated using SDS–PAGE analysis and reported to gradually increased with each 
successive round of selection [28]. 
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Figure 7. Schematic representation and flow diagram of a novel gel-shift selection method for searching 
a strong translation enhancer sequence against a given cell-free translation system using mRNA display. 
DNA template constructs used in the screening experiments including known 5’-untranslated region of 
Xenopus-Globin (wt-UTR) (a) and random-UTR library (b). The mRNA library which is lacking a stop 
codon (c) is ligated at the 3’-terminus end to the complementary portion of 5’-terminus end of the 
puromycin-linker DNA (d) and translated in a cell-free translation system (e). The ribosome stalls at the 
mRNA and linker-DNA junction during translation.  This permits puromycin to enter the ribosomal A-
site and to bind to the nascent polypeptide chain.  Translated products are analyzed by SDS-PAGE 
analysis and carefully excised from gel to separate them from non-translated products (f). The associated 
mRNAs which represent the selected 5’UTR candidates were then directly revere-transcribed and 
amplified using single-step RT-PCR (g) and used as template for next selection-round (h). 
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This increase confirmed that the selected library is successively enriched for strong 
translation enhancer sequences after each round of selection and thus the gel shift selection 
method using mRNA display is indeed a simple and effective method of screening for 
strong translation enhancer sequences. The analysis of selected sequences showed the 
richness of T and G bases with an average of 53% and 35%, respectively, indicating a 
significant role of U and G bases in the translation enhancer sequences. In addition, these 
selected sequences was confirmed to show higher translation efficiency in comparison with 
the natural and longer enhancer sequences. These results encouraged that the described gel-
shift method could be applied to a rapid screening of novel 5’UTR which can facilitate cap-
independent (IRES-mediated) protein synthesis in cell-free translation systems without the 
assistance of the full set of initiation factors. Very recently, a few interesting 5’UTRs have 
been proposed to accelerate the translation initiation reaction [29,30]. These findings of 
simple and effective 5’UTR suggest the possibility of improvement of 5’UTR under the 
conditions in various cell-free translation systems. Our approach can be applied to the 
further searching for 5’UTR by combining with these researches. In conclusion, gel-shift 
method demonstrated that shorter but strong translation enhancer sequences which should 
be easier to handle than long natural sequences can be selected rapidly by simple and robust 
mRNA display method. Searching for novel 5’UTR will contribute much toward the 
development of proteomics and evolutionary protein engineering research by 
improvements of cell-free translation methodologies. 
5. Conclusion and future perspective 
This chapter represents a simple, rapid, easy, and novel strategy, called ‘Gel-shift selection’, 
to obtain strong translation enhancer sequence variants for tunable protein synthesis using 
cell-free system. This method can further explore for (i) discovering of nuclease-resistant 
stable hairpin secondary structure to stabilize the 5’-terminus end of mRNA template with 
improved half-life instead of using synthetic 5’-cap analog; (ii) optimization of strong 
translational enhancer motifs which is free of 5’-cap dependency of translation initiation to 
improve the translational efficiency on given mRNAs under given translational conditions 
in cell-free system; (iii) optimization of enhancer motifs which is free of 3’-poly(A) 
dependency to eliminate the poly(A) leader effect which provide the abolition of the 
inhibition of translation at excess mRNA concentration. 
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1. Introduction 
When researchers wish to obtain recombinant proteins, a primary choice of the method is in 
most cases the expression in E. coli. If this system does not work for the protein of interest, 
they may turn to insect or mammalian cells. Protein expression in vitro may be chosen if 
these in vivo expression systems do not give the protein satisfactorily. There are several 
reasons why expression of some recombinant proteins in living cells is poor. If the protein to 
be expressed is toxic to host cells or inhibitory for growth, it should be difficult to express 
the protein to a high level. The cell-free system is derived from the extract from broken cells, 
and therefore the above-mentioned problems that occur in the living cells, if not all, are 
avoidable. 
The value of the cell-free protein system seems unlimited. Radioactive amino acids or 
unnatural amino acids are relatively easily incorporated into proteins, rendering the 
system very useful for structural analysis of the synthesized proteins (1). The cell-free 
translation systems have also been used in the high-throughput production of thousands of 
gene products derived from cDNA libraries to facilitate screening in the identification of 
kinase or proteinase targets. While E. coli- (2), wheat germ- (3) and rabbit reticulocyte- (4) 
derived systems have been widely employed for the above-mentioned purposes for 
decades, human cells-derived in vitro-protein expression systems are now beginning to 
gain attention. 
What is the merit of a human or mammalian cells-derived system compared with other cell-
free systems? Firstly, many different cell lines that are derived from various organs or 
tissues such as neurons, endocrine glands and immunocytes are available from cell banks 
(eg., ATCC and RIKEN BRC). Since each cell line maintains some properties specific to the 
originated organs or tissues, one can establish a variety of cell-free systems from different 
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cell lines. A successful example is a cell-free glycoprotein-synthesis system derived from a 
monoclonal antibody-producing hybridoma (5). Another merit of the mammalian system is 
that mammalian cell-derived extracts seem to have greater capacity to synthesize large 
proteins (6) than other systems. Lastly, mammalian cell-free systems can directly lead to 
application for medical and pharmaceutical purposes. A remarkable example is the 
synthesis of RNA virus in a test tube (7), which is impossible by other cell-free systems. The 
RNA virus is a super-high molecular weight complex consisting of its RNA genome and 
capsid proteins, and the viral particles are assembled through a complex process. The 
assembly process of the RNA virus such as picornaviruses can be recapitulated in a human 
cell-derived in vitro protein synthesis system. This system can be used for screening anti-
virus chemicals. In the following sections, we discuss these three advantages of the human 
cell-based in vitro protein synthesis systems. 
2. Cell-free synthesis of glycoproteins 
Glycosylation is one of the major post-translation modifications of proteins. The 
polypeptides destined to be localized to the plasma membrane or to be secreted outside 
of the cell enter the endoplasmic reticulum (ER) while being translated. Immediately 
after the polypeptide enters the ER, N-linked glycosylation starts (8). Whereas glycans 
linked to proteins are implicated in many biological aspects such as development, 
differentiation and physiology (9), N-glycosylation itself is thought to be necessary for 
the proper folding of proteins through disulfide bond formation in the ER (8). More than 
half of eukaryotic proteins are predicted to be glycoproteins(10), and thus, it is an urgent 
task to establish an efficient system to produce glycoproteins in vitro. However, neither 
the E. coli nor wheat germ system can glycosylate proteins. rabbit reticulocyte lysates 
(RRL) combined with microsomes from dog pancreas have been a popular system for in 
vitro N-glycosylation (11), but commercially available RRL and canine microsomes are 
expensive, and the activities of the preparations vary depending on the source. 
Furthermore, preparation of these extracts by a researcher is not an easy task, since these 
systems entail sacrifice of animals.  
These problems can be solved by using a specific cell line. HeLa cells represent one of the 
most popular cell lines as a source of mammalian cell-derived in vitro translation systems. 
However, HeLa cell extracts (12) fail to produce a recombinant glycoprotein (5). The major 
envelope glycoprotein (gp120) of human immunodeficiency virus type-1 (HIV-1) consists 
of a core polypeptide of ~60 kDa and ~20 N-linked glycans which increase the total mass of 
the molecule to ~120 kDa (13). When mRNA encoding the HIV-1-gp120 region is translated 
in the HeLa cell extract, a ~60 kDa protein is synthesized as the major product. This 
indicates that N-glycosylation of gp120 is inefficient in the HeLa cell-derived cell-free 
system. The endoplasmic reticulum (ER), where N-glycosylation occurs, may not be well-
developed in HeLa cells, because HeLa is not a secretory cell line. A monoclonal antibody-
producing hybridoma cell line is now chosen, because the hybridoma cell should possess a 
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highly developed ER system to secrete large amounts of immunoglobulins, and, from the 
practical point of view, they can be easily propagated in a suspension culture (5). When 
programmed with the mRNA encoding HIV-1-gp120, the hybridoma extract prominently 
synthesizes one product with a molecular mass of ~100 kDa (Figure 1). This 100 kDa 
product is a glycosylated form of gp120, since treatment with PNGase F changed it into a 
~60 kDa product (Figure 1). Other than HIV-1-gp120, biologically active human 
choriogonadotropin (hCG), a glycoprotein hormone consisting of α  and β subunits was 
successfully synthesized (5).  
  
Figure 1. Glycosylation of HIV gp120 in the hybridoma-derived cell-free translation system.  
The hybridoma extract was incubated with mRNA encoding gp120-HA. After incubation, samples were 
treated with or without PNGase F, resolved by SDS-PAGE, and analyzed by western blotting with anti-
HA antibody.  
3. Cell-free synthesis of large proteins 
Many human proteins are very large (>150 kDa), and these large proteins consist of several 
functional domains. Each domain may be expressed by conventional protein expression 
systems such as in E. coli for the functional and structural analysis. However, it is obviously 
necessary to examine the structure and function of the whole molecule to gain insight into 
the real function of the protein, yet many large proteins remain uncovered for the structure 
and function due to the difficulty in preparation of the full-length form. Since the 
mammalian cells have many large proteins, it is expected that the mammalian translation 
machinery basically possesses a high capacity to elongate a long chain of the peptide. 
Translation initiation is the limiting step in the eukaryotic protein synthesis, and therefore 
the capacity to elongate a peptide chain of thousands amino acids can be recapitulated in 
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Among the factors involved in translation initiation, eukaryotic translation initiation factor 
(eIF) 2 plays a pivotal role in translational regulation (14). eIF2 comprises three subunits: 
α, β and γ. A ternary complex consisting of eIF2-GTP-methionyl initiator tRNA (Met-
tRNAiMet) transfers Met-tRNAiMet to the 40S ribosomal subunit. When the anticodon of 
Met-tRNAiMet base-pairs with the AUG initiation codon, the eIF2-bound GTP is hydrolyzed 
to GDP, and eIF2-GDP is subsequently released from the ribosomal complex. For the next 
round of translation initiation, eIF2-GDP must be converted to eIF2-GTP to regenerate the 
ternary complex, a reaction catalyzed by eIF2B, a multi-protein complex with 5 subunits. 
When the α subunit of eIF2 is phosphorylated, the affinity of eIF2 for eIF2B dramatically 
increases, and eIF2B is thereby sequestered by eIF2. Since eIF2B is then unable to 
regenerate the ternary complex, translation is consequently attenuated (14). 
Phosphorylation of the α subunit of eIF2 occurs in response to stress conditions such as 
viral infection, oxidation, deprivation of amino acids, and accumulation of misfolded 
proteins (15).  
The mammalian cell extract-derived in vitro translation system has an intrinsic problem, 
namely, phosphorylation of the α subunit of eIF2 due to a high concentration of ATP 
(5). During preparation of the cell extract, eIF2α-kinases seem to aggregate or dimerize, 
and addition of ATP causes auto--phosphorylation and activation of the kinases. The 
ATP-induced phosphorylation of eIF2α in the cell-free system is a serious problem, 
because phosphorylation of eIF2α attenuates translation initiation (14), yet, ATP is 
indispensable to maintain protein synthesis. This problem is now solved by addition of 
K3L and GADD (growth arrest and DNA damage gene) 34. K3L is a vaccinia virus-
encoded protein, which acts as a pseudosubstrate for eIF2α-kinases because of its 
structural resemblance to an N-terminal part of eIF2α (16, 17). K3L prevents 
phosphorylation of eIF2α during the virus infection, thereby counteracting the 
otherwise repressed translation (18). GADD34 recruits a phosphatase PP1c to eIF2 to 
dephosphorylate eIF2α (19). As expected, addition of recombinant K3L and / or 
GADD34 relieves phosphorylation of eIF2α and effectively stimulates protein synthesis 
in the cell-free system (5, 20).  
The cell-free protein expression system supplemented with K3K/GADD34 is further 
improved by introduction of coupled transcription/translation system and internal 
ribosome entry site (IRES). In cell-free translation systems, mRNA is added or it is 
synthesized with the addition of a DNA (a plasmid or a PCR product) and the 
bacteriophage RNA polymerase (T7, SP6, or T3 RNA polymerase). The latter method, 
called a coupled transcription/translation system (6), is more convenient than the mRNA-
dependent system, because researchers do not need to synthesize and purify RNA. 
Furthermore, mRNA is continuously supplied to compensate for degradation of the mRNA 
in the system. 
A drawback of the coupled transcription/translation system is that RNA produced by a 
bacteriophage RNA polymerase is not 5’-capped unless a high concentration of the cap-
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analogue is supplied. Uncapped RNAs are less efficient for translation than the capped 
counterpart in the HeLa cell-derived cell-free system, and the cap-analogue is very 
expensive. This problem is solved by placing the encephalomyocarditis virus (EMCV) 
internal ribosome entry site (IRES) or the hepatitis C virus (HCV) IRES between the T7 
promoter and the coding region of the plasmid. The ribosome binds to IRES and initiates 
translation without aid of the cap structure.  
Collectively, the HeLa cell-based in vitro coupled transcription/translation system 
supplemented with K3L/GADD34 is able to synthesize large proteins such as GCN2 (170 
kDa), Dicer (200 kD), eIF4G (220 kDa) and mTOR (260 kD) from the IRES-harboring 
plasmids that encode for these proteins (Figure 2). 
  
Figure 2. The HeLa cell-based in vitro coupled transcription/translation system.  
(A) Cartoon depicting the HeLa cell-based in vitro coupled transcription/translation system that  
utilizes IRES and is supplemented with K3L and GADD34. (B) Large proteins were synthesized  
using the system depicted in (A). Samples were separated by SDS-PAGE and stained with CBB.  
Arrows indicate synthesized proteins. 
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4. Cell-free synthesis of RNA virus  
Cell-free synthesis of an infectious virus is an ideal tool for elucidating the mechanism of 
viral replication and for screening anti-viral drugs. Encephalomyocarditis virus (EMCV) is a 
Cardiovirus in the family Picornaviridae. The genome of EMCV is a single-stranded positive-
sense RNA of 7.9 kb. Upon infection by EMCV, the genomic RNA is translated into a single 
polyprotein, which is subsequently processed via a series of proteolytic events into 
structural (capsid) and nonstructural proteins (21). The RNA-dependent RNA polymerase 
(RdRp), one of the viral nonstructural proteins, replicates the genomic RNA, which is 
incorporated into a viral capsid intermediate structure to constitute an infectious virion 
(22) (23). EMCV can be synthesized from its RNA in the HeLa extract-derived cell-free 
protein synthesis systems (24, 25) (Figure 3). Since the synthesized virus is proved to be 
infectious (24) (Figure 4), the in vitro system is a choice of the method to obtain virus 
particles. 
The cell-free synthesis of EMCV is enhanced by employing a dialysis system (Figure 3). A 
batch system (a closed test tube system) does not allow for sustained synthesis of proteins 
over a period of several hours due to amino acid and ATP deficiencies, and to the 
accumulation of waste products. In contrast, a dialysis system, which continuously supplies 
the substrates and energy source for protein synthesis and removes waste products through 
a dialysis membrane, has enabled HeLa cell extracts to maintain protein synthesis for up to 
one day. To investigate the means by which the dialysis system enhances virus synthesis, 
the efficiencies of translation and processing steps were monitored by labeling with radio-
labeled leucine during a 10-h incubation. Neither the processing pattern of the viral proteins 
nor the intensity of each product varied substantially when HeLa cell extracts were 
incubated with the viral RNA by the batch or dialysis system (24). In contrast, the capacity 
of the HeLa cell extract to synthesize EMCV RNA was increased seven-fold by employing 
the dialysis system compared with the batch system (24). Thus, replication of the RNA, 
rather than translation or processing of the viral proteins, is enhanced by the dialysis system 
(Figure 5). 
A ribozyme technology provides opportunities for mutational analyses of EMCV in vitro 
and for production of EMCV particles (24, 26) (Figure 3). Efficient RNA synthesis by the 
virus-encoded RdRp requires a precise sequence at the 5’-end of the template RNA. 
Synthetic RNAs produced by T7, SP6, and T3 RNA polymerases have a guanine nucleotide 
at the 5’-end, which hampers the plus stranded RNA synthesis of EMCV. No detectable 
virus was generated from a synthetic EMCV RNA that possessed extra nucleotides (GG) at 
the 5’-end (24). If genomic RNA purified from EMCV particles were the only available 
template, the usefulness of the cell-free system would be limited, because mutational studies 
could not be done. Thus, a hammerhead ribozyme sequence was introduced at the 5’-end of 
the RNA to catalyze removal of the extra nucleotides; introduction of an appropriately 
designed hammerhead ribozyme sequence at the 5’-end of the RNA yields an RNA with the 
same nucleotide sequence at the 5’-end as the viral genomic RNA (24). Synthetic EMCV 
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RNAs were translated with comparable efficiencies in HeLa cell extracts by the dialysis 
method irrespective of the presence of the ribozyme at the 5’ end. However, while 
replication of synthetic EMCV RNA without the ribozyme was not appreciable, the EMCV 
RNA with the ribozyme replicated at 25% the efficiency of the genomic EMCV RNA (24) 







Figure 3. RNA-dependent and DNA-dependent cell-free systems for EMCV synthesis 
(A) mRNA dependent system. EMCV RNA is synthesized in vitro and purified. The purified EMCV 
RNA is incubated with the HeLa cell-derived cell-free protein synthesis system.  (B) DNA-dependent 
system. The plasmid encoding the EMCV RNA is directly incubated with the HeLa cell-derived cell-free 
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Cardiovirus in the family Picornaviridae. The genome of EMCV is a single-stranded positive-
sense RNA of 7.9 kb. Upon infection by EMCV, the genomic RNA is translated into a single 
polyprotein, which is subsequently processed via a series of proteolytic events into 
structural (capsid) and nonstructural proteins (21). The RNA-dependent RNA polymerase 
(RdRp), one of the viral nonstructural proteins, replicates the genomic RNA, which is 
incorporated into a viral capsid intermediate structure to constitute an infectious virion 
(22) (23). EMCV can be synthesized from its RNA in the HeLa extract-derived cell-free 
protein synthesis systems (24, 25) (Figure 3). Since the synthesized virus is proved to be 
infectious (24) (Figure 4), the in vitro system is a choice of the method to obtain virus 
particles. 
The cell-free synthesis of EMCV is enhanced by employing a dialysis system (Figure 3). A 
batch system (a closed test tube system) does not allow for sustained synthesis of proteins 
over a period of several hours due to amino acid and ATP deficiencies, and to the 
accumulation of waste products. In contrast, a dialysis system, which continuously supplies 
the substrates and energy source for protein synthesis and removes waste products through 
a dialysis membrane, has enabled HeLa cell extracts to maintain protein synthesis for up to 
one day. To investigate the means by which the dialysis system enhances virus synthesis, 
the efficiencies of translation and processing steps were monitored by labeling with radio-
labeled leucine during a 10-h incubation. Neither the processing pattern of the viral proteins 
nor the intensity of each product varied substantially when HeLa cell extracts were 
incubated with the viral RNA by the batch or dialysis system (24). In contrast, the capacity 
of the HeLa cell extract to synthesize EMCV RNA was increased seven-fold by employing 
the dialysis system compared with the batch system (24). Thus, replication of the RNA, 
rather than translation or processing of the viral proteins, is enhanced by the dialysis system 
(Figure 5). 
A ribozyme technology provides opportunities for mutational analyses of EMCV in vitro 
and for production of EMCV particles (24, 26) (Figure 3). Efficient RNA synthesis by the 
virus-encoded RdRp requires a precise sequence at the 5’-end of the template RNA. 
Synthetic RNAs produced by T7, SP6, and T3 RNA polymerases have a guanine nucleotide 
at the 5’-end, which hampers the plus stranded RNA synthesis of EMCV. No detectable 
virus was generated from a synthetic EMCV RNA that possessed extra nucleotides (GG) at 
the 5’-end (24). If genomic RNA purified from EMCV particles were the only available 
template, the usefulness of the cell-free system would be limited, because mutational studies 
could not be done. Thus, a hammerhead ribozyme sequence was introduced at the 5’-end of 
the RNA to catalyze removal of the extra nucleotides; introduction of an appropriately 
designed hammerhead ribozyme sequence at the 5’-end of the RNA yields an RNA with the 
same nucleotide sequence at the 5’-end as the viral genomic RNA (24). Synthetic EMCV 
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RNAs were translated with comparable efficiencies in HeLa cell extracts by the dialysis 
method irrespective of the presence of the ribozyme at the 5’ end. However, while 
replication of synthetic EMCV RNA without the ribozyme was not appreciable, the EMCV 
RNA with the ribozyme replicated at 25% the efficiency of the genomic EMCV RNA (24) 







Figure 3. RNA-dependent and DNA-dependent cell-free systems for EMCV synthesis 
(A) mRNA dependent system. EMCV RNA is synthesized in vitro and purified. The purified EMCV 
RNA is incubated with the HeLa cell-derived cell-free protein synthesis system.  (B) DNA-dependent 
system. The plasmid encoding the EMCV RNA is directly incubated with the HeLa cell-derived cell-free 
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Figure 4. Infection of BHK-21 cells with EMCV synthesized by the cell-free system. 
BHK-21 cells were incubated with RNase-treated HeLa cell extract programmed with (left panel) or 
without (right panel) EMCV RNA. Twenty hours later, cells were observed by microscopy.  
 
 
Figure 5. Dialysis enhances replication of EMCV RNA.  
EMCV RNA was incubated in the HeLa cell extract with 32P CTP by the batch system (lane 3) or the 
dialysis system (lane 4). 
Lane2: no RNA was Incubated in the batch system. After incubation, RNA was purified, resolved by 
gel, and detected by autoradiography. Lane 1: in vitro-synthesized EMCV RNA 
Furthermore, synthesis of EMCV from DNA templates in vitro is now possible (Figure 3). 
When a plasmid or a PCR product harboring the full-length cDNA of EMCV in the T7 
promoter /terminator unit is incubated in the HeLa extract-derived cell-free protein 
synthesis system supplemented with T7 RNA polymerase, EMCV is progressively 
produced, thereby circumventing the handling the easily degradable viral RNA (7). This 
coupled system for the EMCV synthesis provides an opportunity to study the selectiveness 
of the RNA into the viral particle. Two forms of EMCV RNA are synthesized in the DNA-
programmed system: the RNA transcribed from the plasmid by T7 RNA polymerase and 
the RNA amplified by the viral RNA-dependent RNA polymerase. It is thus imperative to 
determine which RNA form is incorporated into the EMCV particles. To this end, RNA was 
purified from EMCV particles from the incubated mixture, and sequencing of the RNA 
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revealed that the EMCV RNA transcribed by the virally encoded RNA-dependent RNA 
polymerase was predominantly incorporated into the EMCV particle even in the presence of 
a larger amount of the EMCV RNA transcribed by T7 RNA polymerase from the plasmid 
(7). This work is a good example that shows the usefulness of the cell-free system for the 
study of the RNA virus. 
 
Figure 6. A ribozyme enables replication of synthetic EMCV RNA.  
Genomic EMCV RNA (lane 2), synthetic EMCV RNA without (lane 3) or with (lane 4) a ribozyme 
sequence at the 5’ end was incubated in the HeLa cell extract as in Figure 5 by the dialysis system. Lane 
1: no RNA was Incubated. After incubation, RNA was purified, resolved by gel, and detected by 
autoradiography.  
5. Concluding remarks 
As discussed in this chapter, the human cells-derived in vitro-protein expression systems 
are unique with fascinating values than compared with other cell-free systems. However, 
the extract-dependent system contains unknown substances, and proteases in the extract 
are particularly problematic, since synthesized proteins would be degraded. In this regard, 
the PURE system (27), which comprises purified translation factors and ribosomes from E. 
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1. Introduction 
Proteins are the most abundant molecules in biology which control virtually every 
biological process on which our lives depend. Therefore, understanding how newly 
synthesized proteins folds into the correct native structure and achieve their biologically 
functional states inside the cell is of paramount importance. Most of what is currently 
known about the process of protein folding has been studied by analyzing proteins outside 
the cells in a ‘dilute solution’ under in vitro conditions. The pioneering work on the creation 
of cell-free (in vitro) protein synthesis (CFPS) reported by Nirenberg and Matthaei in 1961 
has been a powerful and ever expanding tool for large-scale analysis of proteins [1]. In 
general, these systems are derived from the crude extract of cells engaged in a high rate of 
protein synthesis and are consist of all the macromolecular components required for 
translation of exogenous mRNA which are added separately in the system. The cell-free 
system offer several advantages over traditional cell-based (in vivo) systems which are 
specially not good at making exogenous proteins and those which are toxic to the host cell, 
undergoes rapid proteolytic degradation or forms inclusion bodies. Cell-free system 
provides the ability to easily manipulate the reaction components and conditions to favor 
protein synthesis, decreased sensitivity to product toxicity and suitability for 
miniaturization and high-throughput applications. With these advantages, there is 
continuous increasing interest in CFPS system among biotechnologists, molecular biologists 
and medical or pharmacologists. However, CFPS systems rely on the correct folding of the 
expressed polypeptide chain into a fully functional three-dimensional protein. Thus 
‘foldability’ of expressed protein in a cell-free system is one of the most challenging 
conundrums of CFPS science.  
The folding issue (misfolding or aggregation) is believed to be caused by excessive collision 
between growing peptide chain and with other macromolecular components of cell-free 
 The Author(s). L censee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
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system. It is estimated that the total concentration of macromolecules such as proteins, 
nucleic acids, ribosomes and carbohydrates in the crude cell extract is ranged from 300 to 
400 mg/mL that occupy about 30% of total cytoplasmic volume [2]. For easy understanding, 
if 30% of the volume of a cube is filled with macromolecules of a given size, uniformly 
distributed, then there is virtually no volume available for additional molecules of a similar 
size. This leads to ‘macromolecular crowding’ effect which can result in surprisingly large 
qualitative and quantitative effects on both the thermodynamic and kinetic of interactions 
among macromolecules. For example, it can favor the association of macromolecules which 
may lead to a dramatic acceleration in the rate of protein aggregation (a huge variety of 
diseases share the pathological feature of aggregated misfolded protein deposits such as 
formation of amyloid fibrils has a central role in the pathogenesis of Alzheimer disease) [3]. 
Second, crowding also limits the diffusion of molecules that limits the conformational 
flexibility of growing polypeptide chains, adding complexity to folding and multimerization 
reactions. Although CFPS is routinely carried out in relatively dilute solutions but yet the 
commonly used CFPS systems are estimated with a relatively crowding environments 
containing ~5% (w/v) of macromolecules [4]. Very recently, the inhibition of cell-free 
translation of Rluc mRNA was confirmed under macromolecular crowding conditions 
created by adding various biocompatible crowding agents. Interestingly, these crowding 
agents were observed to show an opposite effects on cell-free transcription reactions [4]. 
This study confirms that a macromolecule crowding may lead to terminal misfolding and 
therefore determine the folding rates. Thus protein folding which is crucial to the function of 
proteins requires controlled handling of translation reaction in CFPS system. In this stream, 
consideration of the protein behavior in their intracellular milieu is crucial. This chapter 
presents a novel approach, called solid-phase CFPS, which provides mimetic conditions of 
an intracellular milieu to facilitate efficient cell-free protein translation of more functionally 
active proteins. 
2. Co-translational protein folding: What we can learn? 
Protein synthesis is the universal mechanism for translating the genetic information into 
functional information in all kingdom of life and all synthesized proteins have in common 
to fold and express their biological activity. The machine which carries the protein synthesis 
is the ribosome, a large RNA-protein complex. However, the fundamental understanding of 
how does the ribosome move along an mRNA and how the linear amino acid sequence of a 
growing polypeptide chain folds correctly into its unique three-dimensional structure is still 
not completed. It is widely believed that protein folding generally begins during translation 
on the ribosome, called ‘co-translational folding’ [5-7]. This implies that the N-terminal part 
of a growing polypeptide starts its folding as soon as it has been synthesized, prior to the 
completion of entire polypeptide chain by the ribosome (see Fig.1). The experimental testing 
of this elegant idea was already begun in the early 1960s and today there is substantial 
experimental support for the co-translational folding hypothesis. Very recently, an efficient 
co-translational folding has been demonstrated by using an engineered multidomain fusion 
protein [8]. In one another study, the folding yield of fluorescent protein was compared 
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between ribosome-released GFP and chemically denatured GFP. The yield of native 
fluorescent GFP was dramatically higher with co-translational folding [9]. Although 
encouraging, but yet many details of co-translational folding pathway remain unanswered. 
For example, since the fact that the polypeptide synthesis requires many seconds (50-300 
residues/min) and the folding occurs in much less than one second (or microsecond-level), 
there must be formation of compact structures and/or intermediates in the process of protein 
synthesis. So, what types of structures are these and how they effects on the folding 
efficiency of newly synthesized protein is still remain elusive.  
 
Figure 1. A cartoon representation of ‘co-translational folding’ of a growing polypeptide chain on the 
ribosome. 
The ribosome serves as a platform for co-translational folding. A crucial process is the 
decision whether the folding occurs in the cytosol or across the membranes (eukaryotic 
endoplasmic reticulum (ER) membrane or bacterial plasma membrane). Eukaryotic co-
translational protein translocation involves the interaction of signal recognition particle 
(SRP) with ribosomes. The SRP recognize the hydrophobic signal sequence at the N termini 
of nascent peptide chains as they emerge from the exit tunnel of ribosome and then SRP-
RNC (ribosome–nascent chain) complex interacts with the ER membrane-bound SRP 
receptor to delivers nascent peptide chain to the ER membrane. This process slowing down 
chain elongation and lead to a transient arrest of translation. Once ribosome engages a 
proteinaceous channel located at the ER membrane, only then protein synthesis is resumed 
and nascent protein are co-translationally injected into the ER lumen. So, what we understand 
that slowing down the translation rate (as a result of co-translational process) may improve the 
folding efficiency of newly synthesized proteins. It has been observed that protein synthesis 
speed is faster in bacteria than in eukaryotes. In E. coli, polypeptide synthesis rates vary from 
10 to 20 amino acids per second [10] but it is considerably slower (3 to 8 amino acids per 
second) in the eukaryotes [11]. Presumably, this might be the reason why the eukaryotic 
cytosol appears to be highly capable of folding proteins efficiently (as a result of co-
translational folding) whereas folding of protein is delayed relative to their synthesis in the 
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bacterial cell. It is recently highlighted that a single codon mutation in mRNA that alters the 
translation rate can lead to a dramatic increase in the folding yield [12]. Thus, the speed of 
protein synthesis can affect protein folding pathways. And if this is true, then controlling the 
polypeptide synthesis rate would be promising step to improve the protein foldabiltiy in the 
CFPS systems. Since both the ribosomes and mRNA templates in the CFPS are not in a 
stationary mode (as they are in cell-based system represented by endoplasmic reticulum 
membrane-bound ribosome), providing a similar environment by introducing solid-phase 
chemistry would help to create co-translational protein folding in the CFPS systems. 
3. Solid-phase versus solution-phase chemistry for protein synthesis 
Solution dynamics (representing diversity of molecular conformations and motion) of 
biological macromolecules (e.g., DNAs, mRNAs) has been described by using nanosecond 
molecular dynamics or X-ray scattering approaches [13,14]. These studies suggest 
conformational variation including semi-stable or unstable structures having short life times 
is a general functional feature of these macromolecules and this is profoundly influenced by 
their environment, such as small changes in the concentration of solutes or salts can 
radically alter the properties of DNA/mRNA in the solution. These dynamics, such as spatial 
and temporal dynamic of mRNA movements that undergoes many conformational 
rearrangements and so an integral part of cell-based protein synthesis, however, may not 
require in the cell-free systems and thus should be avoided in the cell-free reactions. 
Secondly, exogenous mRNAs are extremely labile in nature and thus are apt to be degraded 
by contaminating nucleases that are inherently present in the crude cell extracts and thus the 
protein synthesis reaction is inhibited over time. Third, since CFPS carried out in relatively 
dilute concentrations, the ribosome turnover is likely less compared with the cell-based 
system. In order to exploit these issues, here we introduced solid-phase chemistry for the 
CFPS systems where the diffusional migration of key molecules (e.g., mRNAs or ribosomes) 
is restricted in a defined area to improve the positive reactions in a pseudo-first order 
fashion (see Fig.2).  
 
Figure 2. A schematic drawing of diffusional migration in solution-phase and solid-phase reactions. 
Blue circle represent the CFPS reactants. 
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Compared with solution-phase reaction, in which the reactants of CFPS are dispersed in a 
dilute solution, advantages of solid-phase CFPS reaction includes: (i) improved stability: 
the boundaries stabilized and protect biomolecules by capping the free terminal ends 
against nucleases degradation; (ii) higher local concentration: the local concentration of 
the reactants can be greatly increased in solid-phase, a condition that cannot be realized in 
the solution-phase because of the extra volume of the solvent and the fixed solubility of 
template DNAs/mRNAs. For example, ribosome-turnover can be increased to find its next 
substrate in solid-phase reaction; (iii) post-reaction steps: it become easier to perform 
purifications or remove excess reactant or byproducts from the reaction; (iv) co-
translational folding: it mimic the cell-bases system by introducing a diffusion barrier 
which significantly reduces the reaction rate and improve the co-translational folding. A 
schematic drawing of solid-phase CFPS is outlined in Fig.3 and compared with solution-
phase CFPS and cell-based system. Here, we should recall that protein synthesis is 
compartmentalized in the cell-based system and secretory/integral proteins being 
synthesized on endoplasmic reticulum (ER) by trafficking of the ribosome and mRNA 
from the cytoplasm to the ER membrane. Therefore, solid-phase CFPS where mRNAs are 
immobilized on a solid surface provides the similar environment with the cell-based 
system by controlling the reactions in a similar stationary mode using surface-bound 




Figure 3. Schematic representation of protein synthesis in vivo (A) conventional in vitro solution-phase 
(B) and novel in vitro solid-phase (C). 
The solid-phase approach was first invented by Bruce Merrifield in 1963 in an effort to 
overcome difficulties inherent to the liquid-phase synthesis of peptide [15]. Later, the 
immobilization of biomolecule and synthetic solid-phase approaches have been successfully 
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aided research for a widespread applications for both pre-translated biomolecules such as 
RNA/DNA and post-translated biomolecules such as protein/enzymes including SNP 
genotyping [16], DNA amplification [17], differential display [18], in vitro transcription [19], 
immunoassay [20,21], and others while promoted the development of microfabrication 
[22,23], high-throughput screening and automation strategies in many areas including 
proteomics. Very recently, a hydrogel-based system was introduced that improved the 
efficiency of CFPS up to 300 times than solution phase-based system [24]. 
The simplest method for immobilization of biomolecules is physical adsorption between 
the molecule of interest, e.g., protein, and solid surface [25]. However a more stable and 
reliable mean of immobilization is a bonding or linkage between the molecule of interest 
and molecules of the solid support [26]. To date, several methods have been reported to 
bind the functional biomolecules with ligands onto glass, agarose bead gels and magnetic 
particles. Among these, the covalent nature bonding affinity has advantageous over non-
covalent bonding in the ability to orient the immobilized molecule in a defined and 
precise fashion for forthcoming reactions. The affinity of biotin for streptavidin is one of 
the strongest and most stable known in biochemistry [27]. Moreover, a wide range of 
immobilizing materials and binding modes allows a great deal of flexibility in order to 
design a specific bond with specific physical and chemical properties such as charge 
distribution, hydrophobic/hydrophilic, etc. In this chapter, we highlight our new 
approach of solid-phase protein synthesis to improve the stability and foldability of CFPS 
systems. 
4. General concepts for solid-phase CFPS 
In order to exploit the above issues, a novel solid-phase CFPS was described to produce 
proteins in their native folded-state which is schematically outlined in Fig. 4 [28].  The 
requires the template (mRNA) in a stationary phase, which is achieved by immobilizing the 
mRNA molecules to a solid-surface prior to translation. In order to perform solid-phase 
translation, the immobilization of mRNA must satisfy several requirements: (i) mRNAs 
should be attached efficiently to the solid surface via a 3’-UTR end linkage, (ii) the integrity 
of the mRNAs should not be affected by immobilization, (iii) the availability of the free 5’-
end of the mRNA must be sufficient for translation and (iv) the properties of the solid-
surface must be compatible with translation. These are achieved by coupling the mRNA of 
interest to a solid surface via ligation to a synthetic biotinylated DNA oligomer which is 
then immobilized to streptavidin-coated paramagnetic beads. An efficient ligation is an 
essential part of solid-phase translation and for this purpose we have engineered a synthetic 
linker-DNA molecule (see Fig. 4A). To perform an efficient ligation between the mRNA and 
linker-DNA molecules, the 3’-ends of the mRNAs are first hybridized to the linker-DNA 
and then incubated with T4 RNA ligase.  This reaction is efficient even at low concentrations 
of substrates as it is based on quasi-intramolecular ligation. In the next step of solid-phase 
translation, the bead-bounded mRNA molecules are incubated in a cell-free translation 
system (Fig. 4B). 
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Figure 4. Schematic representation of a novel solid-phase cell-free protein synthesis for synthesizing 
native and correctly folded protein.  
5. Yield of natively folded proteins by solid-phase CFPS 
To demonstrate the performance of solid-phase translation system, FP (fluorescent proteins: 
GFP, green fluorescent protein and mCherry) was chosen as the model proteins.  A T7 
promoter driven DNA template encoding mCherry with a stop codon was constructed and 
amplified with biotinylated primer. The PCR products were then immobilized onto 
streptavidin-coated paramagnetic beads. Following cell-free couple transcription/translation 
reaction, the beads were separated and the supernatant was analyzed by native SDS-PAGE.  
To compare the performances of solid-phase and solution-phase systems, an identical 
quantity of free PCR products without immobilization was processed in parallel. The 
original fluorescence of the folded mCherry protein was successfully resolved by SDS-PAGE 
as a major band of ~28 kDa (see Fig. 5A). The RFU (relative fluorescence units) values 
representing the foldability of mCherry bands were monitored by a fluorescence imager. 
The average results obtained by three successive experiments clearly show that synthesis of 
mCherry using novel solid-phase system was at above 2-fold of the solution-phase system 
(Fig. 5B).  
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Figure 5. Comparison of the protein synthesis of correctly folded mCherry by solid-phase and solution-
phase CFPS. A native SDS-PAGE analysis and quantitative measurements (B). 
Indeed, it was surprising to see that by simply converting the free DNA template to surface-
bounded template, the efficiency of protein synthesis using coupled transcription/ 
translation system was much improved. To understand this further, we studied the 
underlying mechanisms by investigating cell-free translation separately. For this purpose, a 
T7 promoter driven mRNA template encoding GFP with a stop codon and short stretch of 
complementary sequence of linker-DNA at the 3’-terminus was constructed (as shown 
partly in Fig.4A). This template was then ligated to linker-DNA and immobilized onto 
streptavidin-coated paramagnetic beads. Following cell-free translation in a wheat germ-
based system, the beads were separated and the supernatant was analyzed quantitatively by 
SDS-PAGE and qualitatively (i.e., correct folding) by a fluorescence microplate reader.  To 
compare the performances of solid-phase and solution-phase systems, an identical quantity 
of free mRNA-template without ligation or immobilization was processed in parallel.  To 
quantitatively compare the production between the solid- and solution-phase methods, GFP 
was expressed using fluorescently labeled lysine residues. Translated products were heated 
at 70°C for 5 min for complete denaturation and removal of the original fluorescence of the 
folded GFP protein, and resolved by SDS-PAGE. Heat-denatured (non-fluorescent) GFP 
migrates as a major band of about 27 kDa (Fig.6A, right two lanes). The intensity of 
FluoroTect labeled GFP bands were monitored by a fluorescence imager. The average 
results obtained by four successive experiments clearly show that production of GFP using 
our solid-phase system was at about 15% of the levels of the liquid-phase system (Fig.6B 
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inset, white columns). However, the quality analysis, i.e., foldability, of the GFP, for these 
two systems obtained by measuring the intensity of original green fluorescence, (Fig.6B 
inset, gray columns) showed similar results. The RFU (relative fluorescence units) values 
representing the foldability of GFP were directly measured using a fluorescence microplate 
reader, and for the solid-phase system was about 80% of the liquid-phase system. This 
suggests that although the production of GFP using the solid-phase approach is 
considerably less compared with the liquid-phase method, the proteins produced in the 
solid phase are up to four-fold more biologically active after normalization (Fig.6B). To 
confirm this finding, the solid-phase products were removed from the beads and then 
analyzed together with solution-phase products by SDS-PAGE.  The results showed a 37 
kDa GFP product from the solid phase reaction, which is shifted upwards from the 
denatured position predicted for its theoretical mass (27 kDa) due to its native folding 
(Fig.6A, left two lanes).  
 
Figure 6. Comparison of the correct folding and productivity of GFP produced by solid-phase and 
solution-phase CFPS systems. (A) SDS-PAGE of non-denatured (folded) GFP (leftmost two lanes) and 
denatured GFP (rightmost two lanes). (b) Quantitative measurements of the relative efficiency of Solid 
versus Solution-phase in terms of ratio values were plotted after recombining the productivity (white 
column) and foldability (grey column) performance (shown in inset) from the solution or solid-phase 
systems.  All plots and error bars represent average and standard coefficient values of more than four 
independent experiments. M, molecular weight markers. 
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6. Conclusion and future perspective 
This chapter described a novel solid-phase cell-free translation system in which template 
molecules (DNAs/mRNAs) were captured onto solid-surfaces to simultaneously induce co-
translational folding and synthesize proteins in a more native-state form. A newly 
constructed biotinylated linker-DNA is ligated to the 3’ ends of the mRNA molecules to 
attach the mRNA-template on a streptavidin-coated surface and further to enable the 
subsequent reactions of cell-free translation on surface. The protein products are therefore 
directly synthesized onto solid-surfaces and furthermore discovered to adopt a more native 
state with proper protein folding and enough biological activity compared with 
conventional solution-phase approaches. The approach described in this chapter may 
enables to embrace the concept of the transformation of ‘DNA-to-Protein microarrays’ using 
solid-phase cell-free protein synthesis system and thus to the development of high-
throughput, CFPS platform to the field of functional proteomics. 
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1. Introduction 
The main problem in the initiation of protein synthesis is the determination of how the 
ribosome recognizes and binds to the initiation site (IS) of the mRNA. There are currently 
three major hypotheses that address this problem, all differently. The Shine-Dalgarno (SD) 
hypothesis for prokaryotes proposed in 1974, postulates that the IS is selected by base 
pairing of a segment of the 3’ end of the 16S rRNA of the small ribosomal subunit and a 
complementary segment in the leader sequence of the IS [1]. The scanning hypothesis for 
eukaryotes proposed in 1978, postulates that the 40S ribosome initiation complex recognizes 
and binds to the 5’ end of the mRNA and scans the IS until it finds the initiator codon [2]. 
The cumulative specificity (CS) hypothesis has its origin in a 1966 proposal that provided an 
essentially unique accessibility of the IS proposal for prokaryotes [3], but with a number of 
recent modifications, it evolved into its current form in 2007 [4]. The CS mechanism 
postulates that the IS of the mRNA is selected by incremental ribosomal binding of the IS, 
the ribosomal binding subsites interacting with their respective IS subsites, one or a few 
subsites at a time.  
An important aspect of any good hypothesis is its ability to stimulate research. The long 
tenure of the SD and the scanning hypotheses as the bases for numerous researches attest to 
the credibility and appeal of the two hypotheses. However, with manifold increase of 
knowledge in the field, evaluation of the current hypotheses is timely, especially the SD and 
the scanning hypotheses, which were proposed so long ago. Repeating, the major 
hypotheses are the SD proposal for prokaryotes, the scanning mechanism for eukaryotes, 
and the CS mechanism, for both prokaryotes and eukaryotes. On another postulated 
mechanism, the internal ribosome entry site (IRES) for eukaryotes [5], there is some question 
whether it and the scanning mechanism are indeed distinct and unconnected [6] so the 
former will not be considered here as a major mechanism.  
 The Auth r(s). Lic nsee InTech. This chapter is distributed under the ms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 







© 2012 Nakamoto and Kezdy, licensee InTech. This is an open access chapter distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits 
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. 
Cumulative Specificity: A Universal Mechanism 
for the Initiation of Protein Synthesis 
Tokumasa Nakamoto and Ferenc J. Kezdy 
Additional information is available at the end of the chapter 
http://dx.doi.org/10.5772/51179 
1. Introduction 
The main problem in the initiation of protein synthesis is the determination of how the 
ribosome recognizes and binds to the initiation site (IS) of the mRNA. There are currently 
three major hypotheses that address this problem, all differently. The Shine-Dalgarno (SD) 
hypothesis for prokaryotes proposed in 1974, postulates that the IS is selected by base 
pairing of a segment of the 3’ end of the 16S rRNA of the small ribosomal subunit and a 
complementary segment in the leader sequence of the IS [1]. The scanning hypothesis for 
eukaryotes proposed in 1978, postulates that the 40S ribosome initiation complex recognizes 
and binds to the 5’ end of the mRNA and scans the IS until it finds the initiator codon [2]. 
The cumulative specificity (CS) hypothesis has its origin in a 1966 proposal that provided an 
essentially unique accessibility of the IS proposal for prokaryotes [3], but with a number of 
recent modifications, it evolved into its current form in 2007 [4]. The CS mechanism 
postulates that the IS of the mRNA is selected by incremental ribosomal binding of the IS, 
the ribosomal binding subsites interacting with their respective IS subsites, one or a few 
subsites at a time.  
An important aspect of any good hypothesis is its ability to stimulate research. The long 
tenure of the SD and the scanning hypotheses as the bases for numerous researches attest to 
the credibility and appeal of the two hypotheses. However, with manifold increase of 
knowledge in the field, evaluation of the current hypotheses is timely, especially the SD and 
the scanning hypotheses, which were proposed so long ago. Repeating, the major 
hypotheses are the SD proposal for prokaryotes, the scanning mechanism for eukaryotes, 
and the CS mechanism, for both prokaryotes and eukaryotes. On another postulated 
mechanism, the internal ribosome entry site (IRES) for eukaryotes [5], there is some question 
whether it and the scanning mechanism are indeed distinct and unconnected [6] so the 
former will not be considered here as a major mechanism.  
 The Auth r(s). Lic nsee InTech. This chapter is distributed under the ms of the Creative Commons 
Attribution License http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited.
 
Cell-Free Protein Synthesis 
 
92 
The model IS of the E. coli mRNA, generated by computer analysis from 68 non-identical IS 
sequences, consists of 46-48 nucleotides with preferred bases (recognition elements) in given 
positions, but without a specific base in any given position except for the initiator codon [7]. 
This means that the IS surface is extensive, nonrigid, complex and the IS is a non-unique 
sequence. The IS of the eukaryotic mRNA has characteristics similar to those obtained for E. 
coli, although not documented as convincingly as in E. coli [8]. The extensiveness, 
nonrigidity, and complexity of the IS of the mRNA would make its binding to the ribosome 
— that is, the perfect meshing together of the large and complex surface of the IS and that of 
the ribosome — unlikely to occur in a single collision. Rather, the binding of the IS of the 
mRNA by the ribosome should occur by one or severable sub-segments at a time as 
proposed by the CS model reaction, which was originally developed to account for the 
specificity of substrate binding to the HIV Type 1 and 2 proteases [9]. The CS reaction was 
then proposed as a paradigm for the initiation of protein synthesis [4]. The main difference 
between the two above binding reactions is that in one case, an enzyme binds its substrate, 
and in the other, a ribosome binds a template mRNA. 
The specificity sites of the protease substrates consist of a sequence of 6-8 amino acids, and the 
recognition signals of these  substrate sites also consist of preferred recognition elements — 
viz. amino acids — in given positions [9]. Thus these active sites are also extended, nonrigid 
and complex and have non-unique sequences of amino acids and are similar in general 
characteristics to those described above for the IS of mRNA. The CS model reaction assumes 
that the protease binds the specificity site of the substrate, by a sub-segment or several sub-
segments at a time. In the initial collision of the enzyme and substrate, the enzyme first binds 
to one or more subsites of the substrate. This process is then followed in the protease and 
protein synthesis reactions by sequential zipper-like juxtapositions and bindings of the 
appropriate, remaining subsites of the enzyme, or the ribosome, and the substrate (or the 
mRNA), until completion of the enzyme-substrate (ribosome-mRNA) binding. 
A very important feature of the CS mechanism is that it is able to recognize as a signal, not a 
rigid, immovable molecular structure, but a structure variable within certain limits, namely 
a sequence of preferred molecular elements in given positions. The consequence of such a 
heterogeneous, multi-pronged binding is that the ensuing chemical transformation, or the 
binding of two large surfaces, does not occur with a single reaction rate, which would reflect 
an all-or-none specificity. Rather, the rate — and hence the specificity — spans over a wide 
range, favorable interactions at each subsite contributing incrementally to the overall 
recognition of the substrate active site or of the IS of the mRNA. 
Further insights on the initiation mechanism of protein synthesis can be obtained by 
considering the implications on the general mechanisms of protein synthesis of the 
evolutionary process and logic [6,10,11]. An important implication of this process and logic 
is that the general mechanisms of protein synthesis, including the initiation mechanism, are 
expected to be universal in all domains of life. The universality of the mechanisms of protein 
synthesis follows from the conservation of the complex protein synthesizing apparatus, 
exhibiting very similar basic components, consisting of ribosome, mRNA, tRNAs (including 
an initiator methionyl-tRNA), aminoacyl-tRNA synthetases, a universal genetic code, and 
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numerous other proteins and factors. This review will examine whether the various current 
hypotheses consider these implications of evolution, along with the characteristics of the IS 
and other logical points. Such an examination will help to evaluate the comprehensiveness 
and reasonableness of the initiation mechanisms advanced by the various hypotheses. 
2. Body 
2.1. Basis for evaluating the hypotheses for the initiation of protein synthesis 
The evolutionary logic, previously presented for evaluating the various hypotheses 
proposed for the mechanism of initiation of protein synthesis [6,10,11 ], should perhaps 
rather be thought of as an ensemble of logical considerations gleaned from general 
knowledge, compiled here to contribute to the evaluation of current hypotheses. We hope 
that these intuitive and axiomatic considerations do provide a firm foundation for the 
assertions and conclusions made in this chapter. 
As mentioned above, evolutionary logic leads one to conclude that with the conservation of 
the numerous constituent elements of the complex protein synthetic apparatus, the 
underlying mechanisms of the synthetic process should also be conserved in all domains of 
life and are universal. As reviewed later, this conservation also extends in the domains of 
prokaryotes and eukaryotes to the similarity of mRNA initiation signals and to the ability of 
the ribosomes to recognize these signals [10,11]. Ribosomes can recognize the mRNA from a 
different domain of life only if the initiation signals are identical or very closely related and 
if ribosomes have also conserved their ability to recognize these signals. Taken together, 
these facts can indicate a conserved initiation mechanism. 
The mechanism of initiation of protein synthesis must have evolved gradually and without 
abrupt changes, from prokaryotes to eukaryotes. Therefore, any hypothesis postulating that 
this evolution is accompanied by profound changes in the mechanistic characteristics of the 
ribosomes is rather improbable. This will have bearing in the evaluation of the scanning 
hypothesis for eukaryotes. 
When a hypothesis postulates an exclusive and primary biological pathway — such as the 
pathway for the initiation of protein synthesis —then the pathway’s unique initiation signals 
and the other essential components of the reaction, must all be obligatory. Moreover, the 
proposed pathway must be in accord with all experimental observations, such as the 
characteristics of the initiation sites. These considerations will be central in the evaluation of 
the SD hypothesis and, to a lesser degree, the other hypotheses. 
Evolution is a very efficient process and is not likely to tolerate the conservation of 
unused information. For instance, the characteristics of the model E. coli initiation site 
suggests the presence of 46-48 nucleotides with signal character. Thus, any comprehensive 
initiation mechanism should have an initiation signal that encompasses the entire 
nucleotide sequence shown to have signal character, which includes essentially the entire 
IS, even the amino acid coding region. The existence and translation of non-SD and 
leaderless mRNAs indicate that any hypothesis that requires the recognition of only the 
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pathway for the initiation of protein synthesis —then the pathway’s unique initiation signals 
and the other essential components of the reaction, must all be obligatory. Moreover, the 
proposed pathway must be in accord with all experimental observations, such as the 
characteristics of the initiation sites. These considerations will be central in the evaluation of 
the SD hypothesis and, to a lesser degree, the other hypotheses. 
Evolution is a very efficient process and is not likely to tolerate the conservation of 
unused information. For instance, the characteristics of the model E. coli initiation site 
suggests the presence of 46-48 nucleotides with signal character. Thus, any comprehensive 
initiation mechanism should have an initiation signal that encompasses the entire 
nucleotide sequence shown to have signal character, which includes essentially the entire 
IS, even the amino acid coding region. The existence and translation of non-SD and 
leaderless mRNAs indicate that any hypothesis that requires the recognition of only the 
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leader sequence cannot be a complete hypothesis. A comprehensive initiation mechanism 
must, therefore, be able to account for the initiation of translation of canonical, as well as, 
of leaderless mRNAs.  
Lastly, as mentioned, the hypotheses will be evaluated on the basis of whether the 
characteristics of the IS and the dictum of a universal initiation mechanism were considered 
in formulating each respective initiation mechanism.  
2.2. Characteristics of the Initiation Site 
The characteristics of the initiation site (IS) were determined by computer analysis of 68 
non-identical E. coli ribosome binding site sequences [7]. The analysis generated a 
model IS containing 46-48 nucleotides that assigns only preferred bases rather than an 
absolute requirement for a specific base in any given position. The only exception to the 
preceding is the absolute requirement of the initiator codon in a given position in every 
IS.  
The model IS reveals important characteristics of the IS. Part of the model sequence is 
complementary to the 3’ of the 16S rRNA, that is, its base frequency profile reflects the SD 
sequence. Nonetheless, there is no unique initiation sequence or even a unique SD 
sequence in the IS, only ensembles of preferred bases. The prokaryotic ISs thus constitute 
a large multiplicity of loosely related nucleotide sequences, and the protein synthesizing 
system, which recognizes all of them, has broad substrate specificity [4]. Nearly half of the 
model site covers the amino acid coding region. In other words, it is the entire IS — about 
one-half of it consisting of the leader region and the other half of the amino 
acid coding region — that serves as the ribosome recognition or initiation signal. The 
authors suggested that the finding that the amino acid coding region has recognition 
features, or signal character, might explain how leaderless mRNAs are recognized by the 
ribosomes.  
The model E. coli IS is a composite of three sequences derived by analysis of the 68 E. coli 
ribosome binding site sequences using the initiator codon, the SD leader sequence and the 
CU at the very 3’ end of the IS as the common reference in aligning the IS sequences for 
analysis. When the initiator codon was the common reference, the model sequence derived 
showed considerable ambiguity in the area where the SD sequence was expected to be 
located. When the SD sequence was used as the common reference and the leader region 
was analyzed, the AUG start codon had a variable locus of 6-9 positions in the 3’ direction 
from the SD sequence. Examination of the sequences showed that CU seemed to be the 3' 
end of the model sequence. As with the SD sequence and its variable distance from the AUG 
codon, analysis found a completely random behavior with the CU as the common reference. 
A realignment of the sequences and subsequent analysis, however, showed a contiguous 
and almost identical model sequence between the AUG codon and the assumed CUCG end 
signal. The best model sequences fragments obtained from the analyses using the three 
common references described above were then combined to form the composite model E. 
coli initiation site. 
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2.3. The conservation of prokaryotic initiation signals and prokaryotic initiation 
mechanism in eukaryotes 
Before discussing specific conservations, it helps to clarify the conclusion that all underlying 
mechanisms of the protein synthetic process should be conserved in all domains of life 
because of the conservation of the numerous constituent elements of the complex protein 
synthetic apparatus. Does this mean that the entire underlying protein synthetic 
mechanisms are universally conserved? We shall review below that, in addition to 
conservation of the physical apparatus and the underlying general mechanisms, other 
aspects of the process, like initiation mechanism features, such as prokaryotic initiation 
signals with the underlying prokaryotic initiation mechanism, are conserved in eukaryotes. 
This could also imply that the mechanisms of peptide bond formation, peptide chain 
elongation and protein chain termination could in all domains of life be identical or very 
similar to each other. 
It may be at present convenient then, when concluding that the initiation mechanism is 
conserved in eukaryotes, to assume tacitly that the rest of the mechanisms of the protein 
synthetic pathway are conserved as well. After all, initiation signals alone do not comprise 
all of the initiation mechanism, and some additional ribosome functions or mechanism are 
needed to complete the process. In any case, this tacit assumption does not invalidate the 
experimental observations from which the conclusion of conservation was deduced, nor 
does it invalidate the deductive process. 
The conservation of prokaryotic initiation signals and the prokaryotic initiation mechanism 
in eukaryotes deduced from experiments using heterologous systems, in which eukaryotic 
mRNAs were translated in E. coli cell-free systems and prokaryotic mRNAs were translated 
in eukaryotic cell-free systems, has been reviewed [6,10,11]. The experiments shed light 
especially on the mechanism of initiation of eukaryotic protein synthesis and provided 
support for a common or a universal initiation mechanism shared by prokaryotes and 
eukaryotes. The studies are reviewed, again, with emphasis on the significance of the 
conservation of initiation signals and the initiation mechanism. 
Polypeptides were synthesized in an E. coli cell-free system with poliovirus as messenger 
whose tryptic digests were found to correspond to tryptic digests of authentic poliovirus 
proteins [12]. The tobacco mosaic virus (TMV) RNA in an E. coli cell-free system directed 
the synthesis of several discrete polypeptides, including one similar to TMV coat protein by 
criteria of polyacrylamide electrophoresis and peptide mapping [13]. Avian myeloblastosis 
viral RNA was translated by E. coli ribosomes to yield a protein that was antigenically 
identical to the group-specific antigen 4 of the virus [14]. The preceding experiments clearly 
show that E. coli, or prokaryotic, ribosomes can recognize eukaryotic viral initiation signals 
and translate the eukaryotic viral mRNAs. This indicates that the eukaryotic viral mRNAs 
contain evolutionarily conserved prokaryotic initiation signals since it is unlikely that the 
two sets of mRNAs would have dissimilar initiation signals and that the same ribosomes 
would recognize both sets of signals. 
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leader sequence cannot be a complete hypothesis. A comprehensive initiation mechanism 
must, therefore, be able to account for the initiation of translation of canonical, as well as, 
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model site covers the amino acid coding region. In other words, it is the entire IS — about 
one-half of it consisting of the leader region and the other half of the amino 
acid coding region — that serves as the ribosome recognition or initiation signal. The 
authors suggested that the finding that the amino acid coding region has recognition 
features, or signal character, might explain how leaderless mRNAs are recognized by the 
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The model E. coli IS is a composite of three sequences derived by analysis of the 68 E. coli 
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CU at the very 3’ end of the IS as the common reference in aligning the IS sequences for 
analysis. When the initiator codon was the common reference, the model sequence derived 
showed considerable ambiguity in the area where the SD sequence was expected to be 
located. When the SD sequence was used as the common reference and the leader region 
was analyzed, the AUG start codon had a variable locus of 6-9 positions in the 3’ direction 
from the SD sequence. Examination of the sequences showed that CU seemed to be the 3' 
end of the model sequence. As with the SD sequence and its variable distance from the AUG 
codon, analysis found a completely random behavior with the CU as the common reference. 
A realignment of the sequences and subsequent analysis, however, showed a contiguous 
and almost identical model sequence between the AUG codon and the assumed CUCG end 
signal. The best model sequences fragments obtained from the analyses using the three 
common references described above were then combined to form the composite model E. 
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2.3. The conservation of prokaryotic initiation signals and prokaryotic initiation 
mechanism in eukaryotes 
Before discussing specific conservations, it helps to clarify the conclusion that all underlying 
mechanisms of the protein synthetic process should be conserved in all domains of life 
because of the conservation of the numerous constituent elements of the complex protein 
synthetic apparatus. Does this mean that the entire underlying protein synthetic 
mechanisms are universally conserved? We shall review below that, in addition to 
conservation of the physical apparatus and the underlying general mechanisms, other 
aspects of the process, like initiation mechanism features, such as prokaryotic initiation 
signals with the underlying prokaryotic initiation mechanism, are conserved in eukaryotes. 
This could also imply that the mechanisms of peptide bond formation, peptide chain 
elongation and protein chain termination could in all domains of life be identical or very 
similar to each other. 
It may be at present convenient then, when concluding that the initiation mechanism is 
conserved in eukaryotes, to assume tacitly that the rest of the mechanisms of the protein 
synthetic pathway are conserved as well. After all, initiation signals alone do not comprise 
all of the initiation mechanism, and some additional ribosome functions or mechanism are 
needed to complete the process. In any case, this tacit assumption does not invalidate the 
experimental observations from which the conclusion of conservation was deduced, nor 
does it invalidate the deductive process. 
The conservation of prokaryotic initiation signals and the prokaryotic initiation mechanism 
in eukaryotes deduced from experiments using heterologous systems, in which eukaryotic 
mRNAs were translated in E. coli cell-free systems and prokaryotic mRNAs were translated 
in eukaryotic cell-free systems, has been reviewed [6,10,11]. The experiments shed light 
especially on the mechanism of initiation of eukaryotic protein synthesis and provided 
support for a common or a universal initiation mechanism shared by prokaryotes and 
eukaryotes. The studies are reviewed, again, with emphasis on the significance of the 
conservation of initiation signals and the initiation mechanism. 
Polypeptides were synthesized in an E. coli cell-free system with poliovirus as messenger 
whose tryptic digests were found to correspond to tryptic digests of authentic poliovirus 
proteins [12]. The tobacco mosaic virus (TMV) RNA in an E. coli cell-free system directed 
the synthesis of several discrete polypeptides, including one similar to TMV coat protein by 
criteria of polyacrylamide electrophoresis and peptide mapping [13]. Avian myeloblastosis 
viral RNA was translated by E. coli ribosomes to yield a protein that was antigenically 
identical to the group-specific antigen 4 of the virus [14]. The preceding experiments clearly 
show that E. coli, or prokaryotic, ribosomes can recognize eukaryotic viral initiation signals 
and translate the eukaryotic viral mRNAs. This indicates that the eukaryotic viral mRNAs 
contain evolutionarily conserved prokaryotic initiation signals since it is unlikely that the 
two sets of mRNAs would have dissimilar initiation signals and that the same ribosomes 
would recognize both sets of signals. 
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Studies were also performed using prokaryotic mRNAs in a eukaryotic cell-free system. 
Bacteriophage Qβ RNA, a polycistronic prokaryotic messenger, was translated in extracts of 
Krebs II mouse ascites cell-free system [15]. Viral coat protein was identified as the primary 
product by co-migration on polyacrylamide gel with authentic coat protein, and by 
mapping of tryptic digests. A specific mRNA for a structural lipoprotein of E. coli was 
translated in a wheat germ cell-free system [16]. Eukaryotic ribosomes can thus faithfully 
translated prokaryotic initiation signals and initiate translation. The translation of 
prokaryotic mRNAs by eukaryotic ribosomes also means that the initiation signals in 
prokaryotes and eukaryotes are identical or very similar, and that the eukaryotic ribosomes 
translate prokaryotic mRNAs by initiating translation with a prokaryotic-like mechanism, or 
with an evolutionarily conserved prokaryotic mechanism.  
Experiments with heterologous systems that were extremely important in establishing the 
universality of the initiation signals involved the translation of capped prokaryotic mRNAs 
by eukaryotic ribosomes. In the experiments, λ phage 8S cro mRNA and other λ transcripts 
that still retained their prokaryotic ISs, when capped in vitro, were found to be  translated in 
a wheat germ cell-free system as efficiently as — or even more efficiently than—naturally 
capped eukaryotic mRNAs [17,18]. The efficient translation of capped prokaryotic mRNAs 
by a eukaryotic cell-free system means that prokaryotic initiation signals are equivalent to, 
or as effective as, the initiation signals of naturally capped eukaryotic mRNAs. Additionally, 
in light of the cross heterologous translations reviewed above, the preceding can be 
construed as evidence that prokaryotic initiation signals with the underlying prokaryotic 
initiation mechanism are conserved in eukaryotes. Thus, the heterologous experiments 
indicate the conservation of a universal initiation mechanism, or at least, the conservation of 
a common initiation mechanism in the domains of the prokaryotes and the eukaryotes.  
2.4. Ribosomal initiation complex 
The ribosome is the predominant constituent of the complex protein synthesizing apparatus. 
In all domains of life it is composed of two subunits, one small and one large. It was 
assumed for some time that the subunits of the ribosome functioned in protein synthesis 
combined as a 70 S ribosome unit. In 1967, however, it was demonstrated that the 
prokaryotic 70S ribosome operates in a cycle when participating in protein synthesis. The 
70S ribosome dissociates into subunits when initiating synthesis, re-associates into the 70S 
ribosome at the completion of initiation and during polypeptide chain elongation, and again 
dissociates into subunits when synthesis is complete [19]. Phage f2 RNA as well as poly 
AUG (1:1:1) in random sequence was shown to stimulate binding of fMet-tRNA to the 30S 
ribosomal subunits, but not to the 70S ribosome. The presence of the 50S subunit inhibited 
the binding of fMet-tRNA to the 30S subunit with phage f2 RNA and the poly AGU. It was 
proposed that the first step in protein synthesis is the formation of a complex consisting of 
the 30S subunit, mRNA, and fMet-tRNA. Later studies established that the binding reaction 
required the participation of GTP and 3 specific initiation protein factors [20]. 
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Although the 70S ribosome does not bind fMet-tRNA with f2RNA or polyAGU, it does bind 
fMet-tRNA with the triplet AUG. This indicates that the mRNA binding site of the 70S 
ribosome can accommodate a small single triplet and not the larger f2 RNA or polyAGU 
containing an AUG codon. These observations support the view that the 30S subunit, being 
only about a third the size of the 70S ribosome, can access the IS more effectively. Another 
obvious possibility for the lower effectiveness of the 70S ribosome to bind mRNA may be 
due in part to the shielding by the 50S subunit in the 70S ribosome of the mRNA biding site. 
A major reason for the difficulty of ribosome binding the IS may be that RNA interacts intra-
molecularly so extensively that a ribosome binding to a nucleotide sequence of about 47 
nucleotides long, which is the length of the model E. coli mRNA initiation site, is no easy 
feat. A synthetic RNA polymer containing 4 bases in equal proportions in random sequence 
has been found to have about 50% of its bases paired [21]. The effectiveness of the small 
ribosomal subunit to access the IS is probably the primary advantage of the ribosome cycle. 
Besides, the 70S ribosome is effective and essential for polypeptide chain elongation.  
Initiation of eukaryotic protein synthesis follows the same pattern as in prokaryotes with the 
small ribosome subunit, the 40S ribosome, forming an initiation complex with eukaryotic 
initiator Met-tRNA that, however, is not formylated. The initiation of the eukaryotic protein 
synthesizing process requires at least 5 initiation factors and is more complex [22].  
2.5. A Cumulative Specificity (CS) reaction model for proteases from human 
immunodeficiency virus (HIV) Types 1 and 2 
The substrate specificities of the aspartyl proteases from HIV Types 1 and 2 were not readily 
discernible. The scissile bond of the substrate chain is surrounded by at least 3-4 amino acids 
on each side without any specific sequence or even a specific amino acid in any given 
position,. To gather some evidence for the basis of the specificity of these enzymes, the 
frequencies of amino acid distribution at each position surrounding the cleavage site of the 
of HIV 1 protease substrate were statistically analyzed in 40 substrates with known amino 
acid sequences [9]. The analysis revealed that certain amino acid residues had quite higher 
than normal frequencies at three subsites in addition to the positions of the amino acids 
directly involved in the cleavage, but there was no absolute requirement for any given 
specific amino acid in any of these positions. Thus, each subsite appeared to have a marked 
specificity toward some residues, and also a marked negative specificity, since some amino 
acid residues did not occur at all at those subsites. Inferring that the characteristics of the 
frequencies of the particular amino acids in given positions are the result of actual molecular 
interactions between the substrate and the active site of the enzyme, a mechanistic model 
was proposed to account for the broad specificity of the HIV proteases. 
The model postulates that the positioning of the cleavage site with respect to the catalytic 
groups of the enzyme is the result of the cooperative interaction between the amino acid 
residues of the substrate subsites and corresponding subsites surrounding the active site of 
the enzyme. Each of these mutually independent interactions contributes incrementally to 
the optimization of the positioning of the cleavage site with respect to the catalytic groups 
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Studies were also performed using prokaryotic mRNAs in a eukaryotic cell-free system. 
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product by co-migration on polyacrylamide gel with authentic coat protein, and by 
mapping of tryptic digests. A specific mRNA for a structural lipoprotein of E. coli was 
translated in a wheat germ cell-free system [16]. Eukaryotic ribosomes can thus faithfully 
translated prokaryotic initiation signals and initiate translation. The translation of 
prokaryotic mRNAs by eukaryotic ribosomes also means that the initiation signals in 
prokaryotes and eukaryotes are identical or very similar, and that the eukaryotic ribosomes 
translate prokaryotic mRNAs by initiating translation with a prokaryotic-like mechanism, or 
with an evolutionarily conserved prokaryotic mechanism.  
Experiments with heterologous systems that were extremely important in establishing the 
universality of the initiation signals involved the translation of capped prokaryotic mRNAs 
by eukaryotic ribosomes. In the experiments, λ phage 8S cro mRNA and other λ transcripts 
that still retained their prokaryotic ISs, when capped in vitro, were found to be  translated in 
a wheat germ cell-free system as efficiently as — or even more efficiently than—naturally 
capped eukaryotic mRNAs [17,18]. The efficient translation of capped prokaryotic mRNAs 
by a eukaryotic cell-free system means that prokaryotic initiation signals are equivalent to, 
or as effective as, the initiation signals of naturally capped eukaryotic mRNAs. Additionally, 
in light of the cross heterologous translations reviewed above, the preceding can be 
construed as evidence that prokaryotic initiation signals with the underlying prokaryotic 
initiation mechanism are conserved in eukaryotes. Thus, the heterologous experiments 
indicate the conservation of a universal initiation mechanism, or at least, the conservation of 
a common initiation mechanism in the domains of the prokaryotes and the eukaryotes.  
2.4. Ribosomal initiation complex 
The ribosome is the predominant constituent of the complex protein synthesizing apparatus. 
In all domains of life it is composed of two subunits, one small and one large. It was 
assumed for some time that the subunits of the ribosome functioned in protein synthesis 
combined as a 70 S ribosome unit. In 1967, however, it was demonstrated that the 
prokaryotic 70S ribosome operates in a cycle when participating in protein synthesis. The 
70S ribosome dissociates into subunits when initiating synthesis, re-associates into the 70S 
ribosome at the completion of initiation and during polypeptide chain elongation, and again 
dissociates into subunits when synthesis is complete [19]. Phage f2 RNA as well as poly 
AUG (1:1:1) in random sequence was shown to stimulate binding of fMet-tRNA to the 30S 
ribosomal subunits, but not to the 70S ribosome. The presence of the 50S subunit inhibited 
the binding of fMet-tRNA to the 30S subunit with phage f2 RNA and the poly AGU. It was 
proposed that the first step in protein synthesis is the formation of a complex consisting of 
the 30S subunit, mRNA, and fMet-tRNA. Later studies established that the binding reaction 
required the participation of GTP and 3 specific initiation protein factors [20]. 
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Although the 70S ribosome does not bind fMet-tRNA with f2RNA or polyAGU, it does bind 
fMet-tRNA with the triplet AUG. This indicates that the mRNA binding site of the 70S 
ribosome can accommodate a small single triplet and not the larger f2 RNA or polyAGU 
containing an AUG codon. These observations support the view that the 30S subunit, being 
only about a third the size of the 70S ribosome, can access the IS more effectively. Another 
obvious possibility for the lower effectiveness of the 70S ribosome to bind mRNA may be 
due in part to the shielding by the 50S subunit in the 70S ribosome of the mRNA biding site. 
A major reason for the difficulty of ribosome binding the IS may be that RNA interacts intra-
molecularly so extensively that a ribosome binding to a nucleotide sequence of about 47 
nucleotides long, which is the length of the model E. coli mRNA initiation site, is no easy 
feat. A synthetic RNA polymer containing 4 bases in equal proportions in random sequence 
has been found to have about 50% of its bases paired [21]. The effectiveness of the small 
ribosomal subunit to access the IS is probably the primary advantage of the ribosome cycle. 
Besides, the 70S ribosome is effective and essential for polypeptide chain elongation.  
Initiation of eukaryotic protein synthesis follows the same pattern as in prokaryotes with the 
small ribosome subunit, the 40S ribosome, forming an initiation complex with eukaryotic 
initiator Met-tRNA that, however, is not formylated. The initiation of the eukaryotic protein 
synthesizing process requires at least 5 initiation factors and is more complex [22].  
2.5. A Cumulative Specificity (CS) reaction model for proteases from human 
immunodeficiency virus (HIV) Types 1 and 2 
The substrate specificities of the aspartyl proteases from HIV Types 1 and 2 were not readily 
discernible. The scissile bond of the substrate chain is surrounded by at least 3-4 amino acids 
on each side without any specific sequence or even a specific amino acid in any given 
position,. To gather some evidence for the basis of the specificity of these enzymes, the 
frequencies of amino acid distribution at each position surrounding the cleavage site of the 
of HIV 1 protease substrate were statistically analyzed in 40 substrates with known amino 
acid sequences [9]. The analysis revealed that certain amino acid residues had quite higher 
than normal frequencies at three subsites in addition to the positions of the amino acids 
directly involved in the cleavage, but there was no absolute requirement for any given 
specific amino acid in any of these positions. Thus, each subsite appeared to have a marked 
specificity toward some residues, and also a marked negative specificity, since some amino 
acid residues did not occur at all at those subsites. Inferring that the characteristics of the 
frequencies of the particular amino acids in given positions are the result of actual molecular 
interactions between the substrate and the active site of the enzyme, a mechanistic model 
was proposed to account for the broad specificity of the HIV proteases. 
The model postulates that the positioning of the cleavage site with respect to the catalytic 
groups of the enzyme is the result of the cooperative interaction between the amino acid 
residues of the substrate subsites and corresponding subsites surrounding the active site of 
the enzyme. Each of these mutually independent interactions contributes incrementally to 
the optimization of the positioning of the cleavage site with respect to the catalytic groups 
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and for this reason the model is called the cumulative specificity mechanism. According to 
this model, the reaction begins with the collision of the enzyme and the substrate, resulting 
in binding at one of the subsites, presumably the most accessible one and the one with the 
most favorable interactions. Once the substrate peptide chain is immobilized, this initial 
binding is then rapidly followed by the independent and sequential interactions with the 
other substrate subsites. The sequential sub-segment interaction mechanism is most likely, 
since the peptide chain of the substrate is not rigid and the binding of the enzyme and the 
subsites could not occur in a single collision. 
In summary, the mechanistic model postulates that the catalytically productive positioning 
of the scissile bond results from the cumulative effect of independent interactions between 
each substrate side-chain and its respective enzyme subsite. According to this view, none of 
these individual interactions is absolutely essential as long as the peptide is properly 
anchored at a sufficient number of adjacent subsites. These subsites should be independent, 
since; there is no discernible cross-correlation between any pair of amino acids occupying 
any two subsites. Finally, the concept of negative specificity accounts for the fact that the 
presence of unfavorable interactions at certain subsites can actually prevent any peptide 
chain from being a substrate for the enzyme. 
The "cumulative specificity model" provides a rational interpretation of the puzzling 
multiplicity of natural substrates for HIV proteases. The essential features of the model are 
that no subsite has absolute specificity and that a combination of several mediocre 
interactions is at least equivalent to the combination of a few strong interactions, as far as 
the catalytic, as opposed to the binding specificity is concerned. The broad specificity of the 
HIV- 1 protease appears to follow from its ability to bind productively substrates in which 
interactions with only a few of the amino acid residues in the subsites need be optimized, 
that is, the amino acids need to have sufficiently high frequencies. 
The analysis, extended to 22 peptide segments cleaved by the HIV 2 protease, delineated 
marked differences in specificity from that of the HIV 1 enzyme. Since the HIV 1 and 2 
proteases are very similar enzymes, both having extended substrate active sites and 
recognition signals of the sites appear to be preferred amino acids in given positions, it was 
concluded that the cumulative specificity model was also the mechanism for the HIV 2 
protease, as well. 
3. Current hypotheses for initiation mechanisms 
3.1. Shine-dalgarno hypothesis for prokaryotes 
Until recently no controversy existed about the initiation mechanism in prokaryotic protein 
synthesis. Most of the attention has been focused on the Shine-Dalgarno (SD) hypothesis [1]. 
It postulates that the initiation site or signal is selected by the base pairing of a nucleotide 
sequence preceding the initiation codon, currently known as the Shine-Dalgarno (SD) 
sequence, and a complementary nucleotide sequence at the 3’ end of the 30S ribosome’s 16S 
rRNA (the anti-SD sequence). The proposal that a unique nucleotide sequence base pairing 
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was the basis for IS selection was so attractive that the SD mechanism quickly became 
accepted even without rigorous proof, and even in the presence of conflicting evidences [23]. 
The initiation signal of the SD hypothesis, the SD sequence, is composed of about 8 
nucleotides [7]. Thus, a sequence of about 8 nucleotides, which is less than 20% of the 
approximately 47 nucleotides of the E. coli model IS with signal character, raises the 
evolutionary problem of conservation of about 80% of unused information of initiation 
signals. Further studies showed that the nucleotide spacing between the SD sequence and 
the initiator codon can vary as much as 6 to 9 nucleotides [7,24]. All the above raise doubts 
on whether the SD interaction alone can effectively direct the in-reading-frame binding of 
the ribosomes to the mRNA. 
As discussed before, the essentials of a proposed mechanism for a central biological reaction 
should be obligatory. In the case of the SD mechanism, the SD sequence, the anti-SD 
sequence of the 16S rRNA, and the base pairing of the SD sequence with the anti-SD 
sequence of the ribosome (the SD interaction) should all be obligatory for the selection of the 
initiation site. In fact, they turn out to be not absolutely necessary for the initiation reaction: 
there exists non-SD and leaderless mRNAs in the cell that do not contain any SD sequence 
and yet they are translated efficiently. Additionally, the 30S ribosomal subunits, which were 
reconstituted with 16S rRNA from which the anti-SD segment was deleted, functioned 
effectively in initiation [25].  
The participation of the SD sequence in the initiation reaction, however, has been 
convincingly demonstrated. SD sequences were isolated base paired to the anti-SD segments 
of the 30S ribosomes from a reaction mixture in which ribosomes were incubated with 
mRNA and fMet-tRNA [26]. Although the SD interaction does participate in the initiation 
reaction, if present in the IS, it does not appear to be absolutely required, or obligatory. 
Thus, there is a conflict between the hypothesis and reality because the hypothesis 
postulates that the SD interaction is the only pathway for initiation, that is, it is obligatory. A 
resolution can be provided for this problem by the CS mechanism if it is accepted as the 
initiation mechanism for prokaryotes, which will be discussed briefly now and then later, 
more in depth.  
According to the CS initiation mechanism of protein synthesis the binding of the ribosome 
to the IS occurs one or a few subsites (sub-segments) at a time, but, except for the initiator 
codon containing subsite, none of the subsite interactions is absolutely essential as long as 
the IS is anchored to the ribosome by a sufficient number of adjacent subside interactions. 
This would be the case with the SD interaction if it is considered as one of the multiple 
subsite interactions of the CS mechanism, it would not always be essential. In other words, 
initiation of proteins synthesis is not solely dependent on the SD interaction and it is not 
obligatory. 
3.2. Scanning hypothesis for eukaryotes 
Since there were no obvious initiation recognition signals in eukaryotic mRNAs, it was 
proposed that the ribosomes do not outright recognize the IS, but only the 5’ end of the 
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and for this reason the model is called the cumulative specificity mechanism. According to 
this model, the reaction begins with the collision of the enzyme and the substrate, resulting 
in binding at one of the subsites, presumably the most accessible one and the one with the 
most favorable interactions. Once the substrate peptide chain is immobilized, this initial 
binding is then rapidly followed by the independent and sequential interactions with the 
other substrate subsites. The sequential sub-segment interaction mechanism is most likely, 
since the peptide chain of the substrate is not rigid and the binding of the enzyme and the 
subsites could not occur in a single collision. 
In summary, the mechanistic model postulates that the catalytically productive positioning 
of the scissile bond results from the cumulative effect of independent interactions between 
each substrate side-chain and its respective enzyme subsite. According to this view, none of 
these individual interactions is absolutely essential as long as the peptide is properly 
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3. Current hypotheses for initiation mechanisms 
3.1. Shine-dalgarno hypothesis for prokaryotes 
Until recently no controversy existed about the initiation mechanism in prokaryotic protein 
synthesis. Most of the attention has been focused on the Shine-Dalgarno (SD) hypothesis [1]. 
It postulates that the initiation site or signal is selected by the base pairing of a nucleotide 
sequence preceding the initiation codon, currently known as the Shine-Dalgarno (SD) 
sequence, and a complementary nucleotide sequence at the 3’ end of the 30S ribosome’s 16S 
rRNA (the anti-SD sequence). The proposal that a unique nucleotide sequence base pairing 
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was the basis for IS selection was so attractive that the SD mechanism quickly became 
accepted even without rigorous proof, and even in the presence of conflicting evidences [23]. 
The initiation signal of the SD hypothesis, the SD sequence, is composed of about 8 
nucleotides [7]. Thus, a sequence of about 8 nucleotides, which is less than 20% of the 
approximately 47 nucleotides of the E. coli model IS with signal character, raises the 
evolutionary problem of conservation of about 80% of unused information of initiation 
signals. Further studies showed that the nucleotide spacing between the SD sequence and 
the initiator codon can vary as much as 6 to 9 nucleotides [7,24]. All the above raise doubts 
on whether the SD interaction alone can effectively direct the in-reading-frame binding of 
the ribosomes to the mRNA. 
As discussed before, the essentials of a proposed mechanism for a central biological reaction 
should be obligatory. In the case of the SD mechanism, the SD sequence, the anti-SD 
sequence of the 16S rRNA, and the base pairing of the SD sequence with the anti-SD 
sequence of the ribosome (the SD interaction) should all be obligatory for the selection of the 
initiation site. In fact, they turn out to be not absolutely necessary for the initiation reaction: 
there exists non-SD and leaderless mRNAs in the cell that do not contain any SD sequence 
and yet they are translated efficiently. Additionally, the 30S ribosomal subunits, which were 
reconstituted with 16S rRNA from which the anti-SD segment was deleted, functioned 
effectively in initiation [25].  
The participation of the SD sequence in the initiation reaction, however, has been 
convincingly demonstrated. SD sequences were isolated base paired to the anti-SD segments 
of the 30S ribosomes from a reaction mixture in which ribosomes were incubated with 
mRNA and fMet-tRNA [26]. Although the SD interaction does participate in the initiation 
reaction, if present in the IS, it does not appear to be absolutely required, or obligatory. 
Thus, there is a conflict between the hypothesis and reality because the hypothesis 
postulates that the SD interaction is the only pathway for initiation, that is, it is obligatory. A 
resolution can be provided for this problem by the CS mechanism if it is accepted as the 
initiation mechanism for prokaryotes, which will be discussed briefly now and then later, 
more in depth.  
According to the CS initiation mechanism of protein synthesis the binding of the ribosome 
to the IS occurs one or a few subsites (sub-segments) at a time, but, except for the initiator 
codon containing subsite, none of the subsite interactions is absolutely essential as long as 
the IS is anchored to the ribosome by a sufficient number of adjacent subside interactions. 
This would be the case with the SD interaction if it is considered as one of the multiple 
subsite interactions of the CS mechanism, it would not always be essential. In other words, 
initiation of proteins synthesis is not solely dependent on the SD interaction and it is not 
obligatory. 
3.2. Scanning hypothesis for eukaryotes 
Since there were no obvious initiation recognition signals in eukaryotic mRNAs, it was 
proposed that the ribosomes do not outright recognize the IS, but only the 5’ end of the 
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mRNA [2]. According to this proposal, the process begins with the 40S ribosome-Met-tRNA 
complex, which first recognizes and binds to the 5’ end of the mRNA [2], found to consist of 
a 7-methyl guanosine and referred to as cap [27]. The ribosomal complex then scans the 
initiation site for the first AUG codon, which was found subsequently not always to be the 
initiator codon so modifications were made to account for the findings [28]. Later studies 
have shown that initiation factors (eIF-4F) facilitated the binding of the 40S ribosomal 
subunit to the mRNA [29]. When the initiator codon is located, the 60S ribosome joins the 
40S complex to form the 80S ribosome complex, an aminoacyl-tRNA is bound next and the 
first peptide bond is formed. 
Numerous exceptions to the mechanism have been observed where eukaryotic ribosomes 
do bind directly to internal sites of the mRNA and initiate synthesis. The observations were 
construed as evidence for another, separate pathway, referred to as the cap-independent or 
IRES (internal ribosome entry sites) –mediated translation [5]. According to advocates of the 
IRES mechanism, a complex IRES RNA structure of the initiation site somehow promotes 
the correct binding of the 40S ribosomes to internal sites. If as concluded earlier, however, 
that the prokaryotic initiation signals, along with the prokaryotic initiation mechanism, are 
conserved in the eukaryotic ribosomal system is true, then there is a simple and alternative 
explanation for the IRES observations than a separate IRES synthetic pathway. 
Before turning to the alternative explanation for the IRES observations, the weaknesses of 
the proposals of the scanning and the IRES reactions will be addressed. The proposed two 
mechanistically quite different reactions immediately pose a difficult problem: the same 
ribosome cannot perform the two very different functions, even with the aid of auxiliary 
proteins. This, implausibly, would require the evolution of another species of ribosomes. A 
related major weakness is the absence of a gradual evolutionary change in the scanning 
proposal: there would not be a gradual evolutionary change in the case of a prokaryotic 
ribosome that recognizes the IS, binds directly to it, changes to a eukaryotic ribosome that 
recognizes only the end of the mRNA, and then scans the IS for the initiator codon. Such a 
process would involve too great a change in the mechanistic characteristics of the ribosome. 
These shortcomings of the scanning mechanism suggested the proposal of the modified CS 
initiation mechanism for eukaryotes, which will be reviewed below. 
The above complications may be resolved if the modified CS mechanism for the initiation of 
eukaryotic protein synthesis is indeed adopted as the mechanism for eukaryotes. This 
mechanism postulates its evolution from the prokaryotic mechanism [6,10,11]. According to 
this proposal, the initiation of eukaryotic protein synthesis involves two steps. The first step 
now needs to be restated in less specific, but broader terms. Instead of specifying that an 
initiation factor complex (eIF-4F) binds the cap of the mRNA, it is now proposed that 
evolved initiation factors, including eIF-4F, bind to, or interact with the mRNA [30]. Thus, 
the revised version of step 1 is: the evolved initiation factors, including eIF-4F, first bind to, 
or interact with, the mRNA. These bindings or interactions are assumed to make the IS 
eminently accessible, and enhance step 2, which is the initiation of translation by the 
conserved prokaryotic CS mechanism. As mentioned before, in the CS mechanism the 
ribosome binds directly to the IS of the mRNA, without ribosomal scanning of the IS. In 
 
Cumulative Specificity: A Universal Mechanism for the Initiation of Protein Synthesis 
 
101 
summary, this modification of the prokaryotic CS initiation mechanism only adds the 
participation of evolved initiation factors to the function of the basic prokaryotic CS 
mechanism, and thus renders the eukaryotic model compatible with the proposal of a 
universal initiation mechanism, basically identical in all domains of life. 
The alternative explanation for the IRES observations can now be conveniently discussed. 
From the viewpoint of the modified CS initiation mechanism, the existence of the scanning 
mechanism is only theoretical. There is no experimental evidence that proves that this 
mechanism actually operates in eukaryotic protein synthesis. Furthermore, the existence of 
the IRES pathway as a separate protein synthesizing pathway is questioned. The IRES 
pathway is viewed only as the in vitro expression of the activity of step 2 of the modified CS 
initiation mechanism without the expression of step 1. The IRES pathway is, in other words, 
only the in vitro expression of the conserved prokaryotic initiation mechanism in the 
eukaryotic ribosomes. This, then, is the alternative explanation for the IRES observations.  
3.3. Cumulative specificity hypothesis for prokaryotes and eukaryotes 
As mentioned earlier, the CS initiation mechanism of protein synthesis has its origin in a 
1966 proposal that provided an essentially unique accessibility of the IS mechanism for 
prokaryotes [3]. It postulated that the initiator codon is selected by virtue of its unique 
accessibility. All non-initiator internal methionine codons were assumed to be sequestered 
and inaccessible to the ribosomes by secondary structure. This assumption was based on the 
observation that synthetic polynucleotides containing all four bases in equal proportions in 
random sequence, failed to act as mRNA in a cell-free protein synthesizing system, which 
was interpreted as that all AUG codons in the synthetic polynucleotide were inaccessible to 
ribosomes because of secondary structure (unpublished experiment). An experiment much 
later, however, indicated the need for an extension of the proposal. In that study, a non-SD 
model mRNAs was prepared for kinetic measurements [31]. The mRNAs—created to 
minimize secondary\structures —had an accessible AUG but no other obvious recognition 
signal, and yet, they were able to able to direct the initiation of polypeptide synthesis, 
apparently in full agreement with our proposed mechanism. However, a second, still 
unrestrained and thus supposedly accessible AUG, failed to act as an initiator. This seems to 
indicate that that the ribosomes were somehow able to discriminate the IS negatively by 
rejecting certain bases surrounding the initiator codon.  
The unique accessibility proposal was thus modified to postulate that a site containing a 
non-initiator methionine codon can be made functionally inaccessible by sequestration with 
secondary structure or by other unfavorable local interactions, i.e., through steric hindrance, 
hydrophilic/hydrophobic mismatch, or by electrostatic repulsion, which all contribute 
negative specificity. The proposal was renamed as the unique accessibility hypothesis. 
However, when more was learned about the novel features of the CS model reaction for 
HIV proteases [9], the model reaction was incorporated into the unique accessibility 
proposal. The incorporation of CS reaction replaced the discrimination of ISs by the negative 
specificity of the unique accessibility hypothesis with the positive recognition of the IS by 
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mRNA [2]. According to this proposal, the process begins with the 40S ribosome-Met-tRNA 
complex, which first recognizes and binds to the 5’ end of the mRNA [2], found to consist of 
a 7-methyl guanosine and referred to as cap [27]. The ribosomal complex then scans the 
initiation site for the first AUG codon, which was found subsequently not always to be the 
initiator codon so modifications were made to account for the findings [28]. Later studies 
have shown that initiation factors (eIF-4F) facilitated the binding of the 40S ribosomal 
subunit to the mRNA [29]. When the initiator codon is located, the 60S ribosome joins the 
40S complex to form the 80S ribosome complex, an aminoacyl-tRNA is bound next and the 
first peptide bond is formed. 
Numerous exceptions to the mechanism have been observed where eukaryotic ribosomes 
do bind directly to internal sites of the mRNA and initiate synthesis. The observations were 
construed as evidence for another, separate pathway, referred to as the cap-independent or 
IRES (internal ribosome entry sites) –mediated translation [5]. According to advocates of the 
IRES mechanism, a complex IRES RNA structure of the initiation site somehow promotes 
the correct binding of the 40S ribosomes to internal sites. If as concluded earlier, however, 
that the prokaryotic initiation signals, along with the prokaryotic initiation mechanism, are 
conserved in the eukaryotic ribosomal system is true, then there is a simple and alternative 
explanation for the IRES observations than a separate IRES synthetic pathway. 
Before turning to the alternative explanation for the IRES observations, the weaknesses of 
the proposals of the scanning and the IRES reactions will be addressed. The proposed two 
mechanistically quite different reactions immediately pose a difficult problem: the same 
ribosome cannot perform the two very different functions, even with the aid of auxiliary 
proteins. This, implausibly, would require the evolution of another species of ribosomes. A 
related major weakness is the absence of a gradual evolutionary change in the scanning 
proposal: there would not be a gradual evolutionary change in the case of a prokaryotic 
ribosome that recognizes the IS, binds directly to it, changes to a eukaryotic ribosome that 
recognizes only the end of the mRNA, and then scans the IS for the initiator codon. Such a 
process would involve too great a change in the mechanistic characteristics of the ribosome. 
These shortcomings of the scanning mechanism suggested the proposal of the modified CS 
initiation mechanism for eukaryotes, which will be reviewed below. 
The above complications may be resolved if the modified CS mechanism for the initiation of 
eukaryotic protein synthesis is indeed adopted as the mechanism for eukaryotes. This 
mechanism postulates its evolution from the prokaryotic mechanism [6,10,11]. According to 
this proposal, the initiation of eukaryotic protein synthesis involves two steps. The first step 
now needs to be restated in less specific, but broader terms. Instead of specifying that an 
initiation factor complex (eIF-4F) binds the cap of the mRNA, it is now proposed that 
evolved initiation factors, including eIF-4F, bind to, or interact with the mRNA [30]. Thus, 
the revised version of step 1 is: the evolved initiation factors, including eIF-4F, first bind to, 
or interact with, the mRNA. These bindings or interactions are assumed to make the IS 
eminently accessible, and enhance step 2, which is the initiation of translation by the 
conserved prokaryotic CS mechanism. As mentioned before, in the CS mechanism the 
ribosome binds directly to the IS of the mRNA, without ribosomal scanning of the IS. In 
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summary, this modification of the prokaryotic CS initiation mechanism only adds the 
participation of evolved initiation factors to the function of the basic prokaryotic CS 
mechanism, and thus renders the eukaryotic model compatible with the proposal of a 
universal initiation mechanism, basically identical in all domains of life. 
The alternative explanation for the IRES observations can now be conveniently discussed. 
From the viewpoint of the modified CS initiation mechanism, the existence of the scanning 
mechanism is only theoretical. There is no experimental evidence that proves that this 
mechanism actually operates in eukaryotic protein synthesis. Furthermore, the existence of 
the IRES pathway as a separate protein synthesizing pathway is questioned. The IRES 
pathway is viewed only as the in vitro expression of the activity of step 2 of the modified CS 
initiation mechanism without the expression of step 1. The IRES pathway is, in other words, 
only the in vitro expression of the conserved prokaryotic initiation mechanism in the 
eukaryotic ribosomes. This, then, is the alternative explanation for the IRES observations.  
3.3. Cumulative specificity hypothesis for prokaryotes and eukaryotes 
As mentioned earlier, the CS initiation mechanism of protein synthesis has its origin in a 
1966 proposal that provided an essentially unique accessibility of the IS mechanism for 
prokaryotes [3]. It postulated that the initiator codon is selected by virtue of its unique 
accessibility. All non-initiator internal methionine codons were assumed to be sequestered 
and inaccessible to the ribosomes by secondary structure. This assumption was based on the 
observation that synthetic polynucleotides containing all four bases in equal proportions in 
random sequence, failed to act as mRNA in a cell-free protein synthesizing system, which 
was interpreted as that all AUG codons in the synthetic polynucleotide were inaccessible to 
ribosomes because of secondary structure (unpublished experiment). An experiment much 
later, however, indicated the need for an extension of the proposal. In that study, a non-SD 
model mRNAs was prepared for kinetic measurements [31]. The mRNAs—created to 
minimize secondary\structures —had an accessible AUG but no other obvious recognition 
signal, and yet, they were able to able to direct the initiation of polypeptide synthesis, 
apparently in full agreement with our proposed mechanism. However, a second, still 
unrestrained and thus supposedly accessible AUG, failed to act as an initiator. This seems to 
indicate that that the ribosomes were somehow able to discriminate the IS negatively by 
rejecting certain bases surrounding the initiator codon.  
The unique accessibility proposal was thus modified to postulate that a site containing a 
non-initiator methionine codon can be made functionally inaccessible by sequestration with 
secondary structure or by other unfavorable local interactions, i.e., through steric hindrance, 
hydrophilic/hydrophobic mismatch, or by electrostatic repulsion, which all contribute 
negative specificity. The proposal was renamed as the unique accessibility hypothesis. 
However, when more was learned about the novel features of the CS model reaction for 
HIV proteases [9], the model reaction was incorporated into the unique accessibility 
proposal. The incorporation of CS reaction replaced the discrimination of ISs by the negative 
specificity of the unique accessibility hypothesis with the positive recognition of the IS by 
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cumulative specificity. The modified reaction was renamed as the CS hypothesis for the 
initiation of protein synthesis [4].  
The CS initiation mechanism of protein synthesis incorporates the key features of the CS 
model reaction of HIV proteases and postulates that recognition of the initiation signal is the 
result of interactions of one or a few subsites (sub-segments), at a time, between the 
ribosome and the IS of the mRNA. Thus, the selection of the IS occurs through cooperativity 
and cumulative specificity of subsite interactions that allow a reaction to occur even if not all 
subsites are occupied [4,32]. This enables many subsites of the IS that share only some of the 
structural elements to be accepted as ligands by the ribosomal subsites, and hence, the broad 
substrate specificity of the protein synthesizing system follows.  
According to the CS model for the HIV protease reaction, none of the individual subsite 
interactions of the substrate active site with the respective subsite of the enzyme is 
absolutely essential as long as the peptide is properly anchored at a sufficient number of 
adjacent subsites. The same rule applies to the CS initiation of protein synthesis that none of 
the subsite interactions is absolutely essential except that the interaction of the initiator 
codon subsite of the IS and the ribosomal subsite with the accessible Met-tRNA anti-AUG 
codon is absolutely required. In the case of the initiation of protein synthesis, there must 
also be a sufficient number of adjacent subsite interactions to anchor the IS properly to the 
ribosome. 
Another important feature of CS initiation mechanism is the role played by the secondary 
structure of the mRNA. It keeps the ISs accessible to the ribosomes and it also reduces the 
accessibility of non-initiator methionine codons by sequestering them and thus favoring the 
recognition of the initiator codon. The multiple roles played by the secondary structure were 
demonstrated in a study in which the secondary structure of bacteriophage f2 RNA was 
disrupted by treatment with formaldehyde. The treated RNA was shown to yield three new, 
non-viral polypeptides when the RNA was translated in an E. coli cell-free protein 
synthesizing system [33]. Three new non-initiator methionine codons were evidently 
selected as initiators because filtering by secondary structure was eliminated, which showed 
that the specificity of the ribosome alone was not sufficient to eliminate all of the non-
initiator methionine codons. 
Cumulative specificity in-reading-frame binding of ribosomes to mRNA  
The proposed CS initiation mechanism [6,10, 11] for the in-reading-frame binding of the 
mRNA by the ribosomes will now be reviewed, critically evaluated as were the SD and 
scanning hypotheses, and then revised with an admission of mea culpa by one of the 
authors (T.N.). This revision of the in-reading-frame binding aspect of the basic CS initiation 
mechanism must not be confused with the previously described modified CS initiation 
mechanism, which only added the participation of evolved initiation factors to the function 
of the basic prokaryotic CS mechanism for the initiation of eukaryotic protein synthesis. 
The initiation reaction was postulated to begin with a relatively strong interaction of the 
small ribosomal subunit initiation complex with an accessible subsite of the IS that contains 
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the initiator AUG codon. The base pairing of the initiator AUG codon and the anti-AUG 
codon of the ribosome bound initiator Met-96tRNA, along with the strong binding of the 
entire sub-segment, secures the mRNA onto the ribosomal complex in reading frame. This 
first interaction is stabilized by subsite interactions that reach out in both directions of the 
AUG subsite in zipper-like fashion, until the ribosomal complex is firmly bound to the 
mRNA. Initiation can then occur when the first designated aminoacyl-tRNA is bound. 
According to the above proposal, the ribosome binds to the mRNA in reading frame at the 
initiator codon containing subsite in a first interaction with the mRNA. This remarkable feat 
is possible only because of a probably invalid assumption of the proposal, namely that the 
initiator codon of the IS of about 50 nucleotides is always accessible for binding to the 
ribosomal initiation complex. As mentioned earlier, for the 30S ribosomal subunit, as an 
example, to bind, meshed perfectly, to a nucleotide sequence of about 47 nucleotides long, 
which is the length of the model E. coli IS, is no easy feat. This is because RNA interacts 
intra-molecularly so extensively by base pairing. A synthetic RNA polymer containing 4 
bases in equal proportions in random sequence has been found to have about 50% of its 
bases paired [21]. Therefore, the mRNA would not likely to have its initiator codon located 
in the middle of the IS of 47 nucleotides   more accessible to the ribosome than any other IS 
subsites, even in natural mRNAs. Prokaryotic viral mRNAs have been shown to have 60-
70% of their nucleotides involved in base pairing [34]. However, one cannot rule out the 
possibility that secondary structure increased with a precise arrangement could enhance the 
accessibility of the initiator codon subsite. So the possibility of an intrinsically accessible 
initiator codon subsite does exist. 
The major problem in binding of the mRNA IS by the ribosome is that the IS, which is about 
50 nucleotides long, must minimize not only its base interactions within the IS, but also its 
intra-molecular interactions with nearby adjoining regions, and even with distant regions of 
the mRNA. Local interactions may be minimized by appropriate evolutionary base 
selections, that is, by controlling the primary sequence of the IS. There are studies indicating 
that regions around and at initiation sites are low in secondary structure.  One group of 
researchers determined the secondary structure of the region by computer analysis of the 
nucleotide sequence of the intracistronic initiation sites of infB mRNA for various bacterial 
species [35]. They found that the mRNA has an open structure around the initiation site. A 
second group computationally folded human and mouse mRNA sequences on sets of 
transcripts, and found that the initiation site is characterized by a relaxed secondary 
structure [36].  
In any case, a significant portion of the IS, nonetheless, must be accessible to the ribosome, 
for otherwise, one would not have a functioning mRNA. The problem, then is surmised to 
be, that despite the accessibility of the IS to the ribosome, the IS may not be fully extended 
with the initiator codon subsite readily accessible. Therefore, some mechanism is needed to 
stretch or to extend the IS on the ribosome so that the initiator codon subsite is accessible. As 
will be suggested by the revised basic CS initiation mechanism below, this can be done by 
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cumulative specificity. The modified reaction was renamed as the CS hypothesis for the 
initiation of protein synthesis [4].  
The CS initiation mechanism of protein synthesis incorporates the key features of the CS 
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mRNA by the ribosomes will now be reviewed, critically evaluated as were the SD and 
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mechanism must not be confused with the previously described modified CS initiation 
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the initiator AUG codon. The base pairing of the initiator AUG codon and the anti-AUG 
codon of the ribosome bound initiator Met-96tRNA, along with the strong binding of the 
entire sub-segment, secures the mRNA onto the ribosomal complex in reading frame. This 
first interaction is stabilized by subsite interactions that reach out in both directions of the 
AUG subsite in zipper-like fashion, until the ribosomal complex is firmly bound to the 
mRNA. Initiation can then occur when the first designated aminoacyl-tRNA is bound. 
According to the above proposal, the ribosome binds to the mRNA in reading frame at the 
initiator codon containing subsite in a first interaction with the mRNA. This remarkable feat 
is possible only because of a probably invalid assumption of the proposal, namely that the 
initiator codon of the IS of about 50 nucleotides is always accessible for binding to the 
ribosomal initiation complex. As mentioned earlier, for the 30S ribosomal subunit, as an 
example, to bind, meshed perfectly, to a nucleotide sequence of about 47 nucleotides long, 
which is the length of the model E. coli IS, is no easy feat. This is because RNA interacts 
intra-molecularly so extensively by base pairing. A synthetic RNA polymer containing 4 
bases in equal proportions in random sequence has been found to have about 50% of its 
bases paired [21]. Therefore, the mRNA would not likely to have its initiator codon located 
in the middle of the IS of 47 nucleotides   more accessible to the ribosome than any other IS 
subsites, even in natural mRNAs. Prokaryotic viral mRNAs have been shown to have 60-
70% of their nucleotides involved in base pairing [34]. However, one cannot rule out the 
possibility that secondary structure increased with a precise arrangement could enhance the 
accessibility of the initiator codon subsite. So the possibility of an intrinsically accessible 
initiator codon subsite does exist. 
The major problem in binding of the mRNA IS by the ribosome is that the IS, which is about 
50 nucleotides long, must minimize not only its base interactions within the IS, but also its 
intra-molecular interactions with nearby adjoining regions, and even with distant regions of 
the mRNA. Local interactions may be minimized by appropriate evolutionary base 
selections, that is, by controlling the primary sequence of the IS. There are studies indicating 
that regions around and at initiation sites are low in secondary structure.  One group of 
researchers determined the secondary structure of the region by computer analysis of the 
nucleotide sequence of the intracistronic initiation sites of infB mRNA for various bacterial 
species [35]. They found that the mRNA has an open structure around the initiation site. A 
second group computationally folded human and mouse mRNA sequences on sets of 
transcripts, and found that the initiation site is characterized by a relaxed secondary 
structure [36].  
In any case, a significant portion of the IS, nonetheless, must be accessible to the ribosome, 
for otherwise, one would not have a functioning mRNA. The problem, then is surmised to 
be, that despite the accessibility of the IS to the ribosome, the IS may not be fully extended 
with the initiator codon subsite readily accessible. Therefore, some mechanism is needed to 
stretch or to extend the IS on the ribosome so that the initiator codon subsite is accessible. As 
will be suggested by the revised basic CS initiation mechanism below, this can be done by 
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anchoring the IS onto the ribosome at a sufficient number of adjacent subsite interactions. 
Such a mechanism essentially stretches the IS to make the initiator codon subsite accessible 
to the appropriate ribosomal binding subsite. 
The original proposal, that is, the prokaryotic CS initiation mechanism, will now be revised 
and recapitulated. The revised proposal, which assumes that all subsites of the IS, are more 
or less, equally accessible, postulates that the first subsite interaction will occur, more or less 
randomly, between one or more of all of the various subsites of the ribosome and its or their 
respective IS subsites. If the first interaction happens to be between the ribosomal subsite 
with the anti-AUG codon of the initiator Met-tRNA and the initiator AUG codon containing 
IS subsite, then the remaining subsites will interact in  zipper-like fashion to stabilize the 
first interaction. In this manner an in-reading-frame binding of the mRNA by the ribosome 
will be completed. In all other first subsite interactions, the critical interaction which 
involves the anti-AUG codon of the initiator Met-tRNA and the initiator codon IS subsite 
will occur only after the IS is anchored onto the ribosome by a sufficient number of adjacent 
IS subsites and the initiator codon subsite is made accessible. In other words, the critical 
subsite interaction of the ribosomal subsite with the anti-AUG codon of the initiator Met-
tRNA and the initiator codon IS subsite, occurs towards the end of the subsite interactions 
for all first non-initiator codon subsite interactions.  
If, however, the IS initiator codon subsite is somehow intrinsically accessible because of the 
organized secondary structures of the mRNA, then all pathways will be a single pathway as 
originally proposed, i.e., al first ribosomal subsite bindings will be of the initiator codon IS 
subsite, and the remaining subsites will interact in  zipper-like fashion to stabilize the first 
interaction. The in-reading-frame binding of the mRNA by the ribosome will all be 
completed in this manner. Another way in which the preceding single pathway may 
predominate under conditions in which the initiator codon subsite is not intrinsically 
accessible and the ribosome interacts with it only randomly, is the favorability or strength of 
the first interaction as described below. 
Evidence for the strength of the critical subsite interaction where the initiator codon containing 
IS subsite is bound to the ribosomal subsite with the anti-AUG codon of the initiator Met-
tRNA is the strength of the specific base pairing of the initiator AUG codon  and the anti-AUG 
codon of the initiator Met-tRNA. Further evidence for the strength of this interaction was 
provided by studies in which nucleotides around the AUG initiation codon were replaced. 
Protein synthesis was decreased by as much as 95% upon replacement of three nucleotides 
adjoining the initiator AUG codon on the 5’ side [37]. Similarly, the replacement of three 
nucleotides just next to the AUG codon on the 3’ side decreased translation by more than 65% 
[38]. These observations underscore the importance of the AUG segment in initiation, and 
suggest a strong interaction of the ribosome with this particular IS subsite. 
The process of the binding of ribosomes to leaderless mRNA is as described above for 
canonical mRNAs, except that the binding of eIF4F may not occur and subsite interactions 
are only between the ribosomal binding subsites and the initiator codon subsite and the 
amino acid coding region subsites of the IS . The final step in the initiation of translation of 
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canonical and leaderless mRNAs is the binding of the aminoacyl-tRNA directed by the 
codon following the initiator codon, and the formation of the first peptide bond. 
Base pairing is probably not the only means of molecular recognition of the nucleotides of 
the IS by the ribosome in the interactions, since the ribosomal binding site is composed of 
RNA and proteins. In the interaction of the ribosomal subsites containing the anti-SD 
sequence, base pairing is the predominant means of nucleotide recognition when the SD 
sequence is present in the mRNA. The Shine-Dalgarno base-pairing interaction may be 
considered as just one of the multiple independent interactions of the CS initiation 
mechanism. Recognition in other ribosomal binding sub-sites may also involve steric fit, 
steric hindrance, hydrophilic or hydrophobic match or mismatch, and electrostatic attraction 
or repulsion. In other words, the recognition is also the product of both positive and 
negative specificities. 
The revised CS hypothesis for the initiation of protein synthesis assumes that the productive 
positioning of the initiator codon of the IS on the ribosome results from the cumulative 
effect of independent interactions between each base and its respective subsite on the 
ribosome. According to this view, except for the subsite containing the initiator codon, none 
of these individual interactions is absolutely essential as long as the IS is properly anchored 
at a sufficient number of adjacent subsites. It is assumed that, to make the initiator codon 
region accessible, enough adjacent subsite interactions are needed to anchor the IS to the 
ribosome, which extends or stretches out the IS. The extension or stretching of the IS exposes 
the initiator codon region, making the initiator codon accessible. This allows the in-reading-
frame binding of the ribosome to the mRNA to be completed by the interaction of the 
ribosomal subsite with the accessible anti-codon of the initiator Met-tRNA and the IS subsite 
containing the initiator codon AUG. In this manner the base-pairing of the AUG and the 
anti-AUG codon of the ribosome bound initiator Met-tRNA can occur.  
Thus, it follows that recognition of the IS does occur by recognition of a number of individual 
subsites. As mentioned several times, it is most unlikely that collision of the ribosome binding 
site with the IS of the mRNA would be a single step in which the ribosome binding site and 
the IS would already be perfectly oriented to achieve an optimal fitting of all subsites. Rather, 
the initial collision probably results in the binding at just one or a few of the subsites, each 
contributing incrementally to anchoring the IS to the ribosome. Then if these interactions are 
favorable, the rest of the subsites will be filled in cooperatively, in a zipper-like fashion. The 
ultimate result is, however, the binding of the whole IS as a block, and the exact positioning on 
the ribosome of the subsite containing the initiator codon. In that ultimate ribosome-mRNA 
complex the global strength of binding and the precise positioning of the initiator codon 
subsite of the IS at the reaction site still depends on the sum of the contributions of the 
individual subsites, i.e., the cooperativity of the subsites. 
4. Conclusion 
It is important to understand that this evaluation of current hypotheses have the advantage 
of hindsight provided by knowledge of the initiation of protein synthesis, not available 
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when the SD and the scanning hypotheses were proposed. Critical evaluations are thus 
made while appreciating the great value of the two older hypotheses in stimulating 
research. 
Returning to the conclusion of this review, we have essentially taken the view that there are 
three keys to unlocking the secrets of the initiation of protein synthesis. The first two keys 
provide insights into the nature of the initiation mechanism, and the third key is the 
initiation mechanism that is compatible with those insights.  
The first key consists of the implications of the characteristics of the IS. The E. coli model IS 
consists of a nucleotide sequence of about 47 bases, with preferred bases in given positions, 
but no particular base in any given position, except for the initiator codon located in a 
specific position in every IS of the mRNA. An important feature of the model IS is that all, or 
nearly all of its nucleotides presumably have signal character, which includes the leader and 
amino acid coding regions. This means that the initiation signal of a comprehensive 
mechanism must include the leader, as well as, the amino acid coding regions. The length of 
the model IS indicates that the IS is extensive, nonrigid, and complex, and that the ribosome 
is unlikely to bind the IS of the mRNA, meshed perfectly, in a single collision with the 
mRNA. The unlikelihood of the binding of the mRNA by the ribosome in a single collision 
predicts that the ribosome would bind the IS of the mRNA via a sub-segment or a few sub-
segments, at a time. The ribosomal binding of the IS of the mRNA thus must happen 
between the ribosomal subsites and the respective IS subsites, one or a few at a time. The 
initiation mechanism must also account for the recognition of initiation signals consisting of 
about 47 nucleotides, at least in E coli, with preferred bases in given positions. 
The second key consists of the implications of evolutionary evidence and logic that point to 
a universal initiation mechanism in all domains of life. This implies that a common or 
universal initiation mechanism should be constantly favored, even when one is faced with 
an appealing mechanism for a particular phylum, and when one examines any data, always 
being alert for indications of conservation of initiation signals or mechanisms. As reviewed 
earlier in this chapter, when such diligence was maintained in reviewing the studies of 
heterologous systems in which ribosomes or mRNAs of different phyla were interchanged, 
the conclusion was reached that prokaryotic initiation signals as well as the underlying 
prokaryotic initiation mechanism are conserved in eukaryotes. The conservation of the 
initiation signals and the initiation mechanism has been interpreted as evidence of the 
existence of a universal initiation mechanism. 
The third key consists of the initiation mechanism for protein synthesis that is most 
compatible with the insights provided for a mechanism by keys 1 and 2. Unfortunately 
the SD and scanning hypotheses were proposed before publication of the study 
revealing the IS characteristics of E. coli, although many base sequences of IS were 
known. That evolutionary evidence and logic supported a universal initiation 
mechanism was not unknown, but the proposal of an initiation mechanism for 
eukaryotes vastly different for that of prokaryotes indicated a lack of conviction in a 
universal mechanism, or at least, in the evidence for it. Thus, key 1 was not in existence 
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at the time of proposal of the two hypotheses, and there was not much faith in key 2. 
For these reasons, each of the SD and the scanning hypotheses has only considered its 
own particular facet of the mechanism and ignored most of the insights provided by 
keys 1 and 2.  
For example, despite the observation that the signal character of the IS is divided about half 
in the leader region and the other half in the amino acid coding region, the SD hypothesis 
postulates an initiation signal located exclusively in the leader region, less than 20% of the 
nucleotides with signal character, while the scanning hypothesis postulates a single 
nucleotide at the 5’ end of the mRNA as a recognition signal, not even included in the IS. For 
this reason, the two hypotheses cannot account for the initiation of translation of leaderless 
mRNAs. Furthermore, the two hypotheses also do not acknowledge the problem of the need 
of ribosomes to bind to an extensive, nonrigid and complex IS, sub-segment by sub-
segment, nor do they address the possibility of a universal initiation mechanism. The SD 
and the scanning hypotheses, in other words, essentially ignored most of the insights 
provided by keys 1 and 2. 
Recapitulating, in the view described above, the SD as well as the scanning hypotheses 
hardly account for the insights of keys 1 and 2, i.e., the implications of the characteristics of 
the IS of the mRNA and of the dictum of universality of the initiation mechanism. The CS 
hypothesis, on the other hand, is more compatible with the insights provided by keys 1 and 
2. The CS mechanism for initiation of prokaryotic synthesis is essentially the mechanism 
formulated for the HIV proteases with minor changes to adapt it to the initiation of protein 
synthesis. This mechanism postulates a cooperative and cumulative, sub-segment by sub-
segment recognition binding of the IS. As initiation signals, the CS mechanism recognizes 
nucleotide sequences with preferred bases in given positions, that is, the entire IS with 
signal character. 
Finally, the CS initiation mechanism for prokaryotes modified for eukaryotic protein synthesis 
appears to be in accord with all experimental observations. The proposal postulates an 
evolutionary link of the initiation mechanism of eukaryotic protein synthesis to that of the 
prokaryotes. It assumes that evolved eukaryotic initiation factors interact with the mRNA and 
make the IS eminently accessible. This dramatically enhances the ribosomal binding to the IS 
and greatly increases the rate of initiation of protein synthesis by the conserved CS mechanism 
in the eukaryotic ribosomes. This modification keeps the eukaryotic initiation mechanism 
basically identical to the prokaryotic mechanism, and therefore, one may conclude that the two 
mechanisms are essentially identical as well as universal. The modified CS mechanism is 
compatible with the conclusion that the prokaryotic initiation signals and the prokaryotic 
initiation mechanism are conserved in eukaryotes. 
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1. Introduction 
Accuracy of protein synthesis is critical for life since a high degree of fidelity of the 
translation of the genetic information is required to accomplish the needs of the cellular 
functions as well as to preserve the variability developed by evolution. More than one 
hundred macromolecules are involved in this process even in the simplest organisms, 
including ribosomal proteins, translation factors, aminoacyl-tRNA synthetases as well as 
ribosomal and transfer RNAs (being rRNAs near 80% of total cellular RNAs in bacteria). 
Accuracy of translation of the genetic information is accomplished at different levels, being 
one of the most relevant the specific interaction of the aminoacyl-tRNA synthetases with 
their substrates, tRNA and amino acids. Either specific molecular interactions that avoid the 
miss-incorporation of amino acids or the hydrolysis of wrong aminoacyl-tRNAs represent 
strategies utilized by the aminoacyl-tRNA synthetases to reduce the formation of miss-
acilated tRNAs. Additionally, the discrimination by the elongation factor Tu (EF-Tu) against 
miss-acylated aminoacyl-tRNAs over correctly acylated increases the accuracy of 
incorporation of the proper aminoacyl-tRNAs to the ribosome. The accurate decodification of 
the mRNA by the incorporation of the aminoacyl-tRNA with the correct anticodon ensures 
the fidelity of translation of the genetic information. The consequence of these discriminatory 
events led to an accuracy of translation of the genetic information to as low as 10-4 errors per 
amino acid incorporated. However, certain level of inaccuracy might be tolerated, even 
might be beneficial to the cells under certain physiological and environmental conditions.  
How does the cellular translational machinery respond against stress conditions? Is protein 
synthesis as accurate as in normal conditions when cells are stressed? These are topics that 
are not well understood. Different kinds of stressing conditions might have different 
responses in the components of the protein synthesis system. In this chapter, we will briefly 
describe how bacteria respond to two stress conditions, oxidative stress and amino acid 
starvation, that microorganisms are commonly exposed to including in environmental 
conditions.  
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2. Oxidation of the translation machinery during oxidative stress 
Oxidative stress is defined as the condition where oxidative species production is faster than 
the ability of the cell to eliminate them and reduce or degrade oxidized products, leading to 
damage [1–3]. This condition can be met when production of or exposure to oxidative 
species is increased, such as when bacterial cells are attacked by the immune system of a 
host [4–7] or when oxygen reactive species (ROS) are generated in cyanobacteria as a 
byproduct of photosystem II irradiation with strong light [8]. Also, “normal” ROS levels can 
cause oxidative stress when there is a lower level of protective enzymes as when bacteria 
pass from an anaerobic environment to another with oxygen [9]. As a consequence of the 
increase in oxidative species concentration several macromolecules can be modified, 
including proteins, RNA, DNA and lipids [10–12]. In this chapter we are mainly interested 
in the oxidation of the first two, proteins and RNA, as they are directly involved in the 
translation process. Several amino acids and cofactors of proteins can be target of oxidation 
in vivo. Within these, the most sensitive to oxidation are Fe/S clusters, methionines and 
cysteines [11,12]. Some of the oxidation states of cysteine (sulfenic acid and disulfide bond) 
can be reduced so this amino acid is frequently involved in regulatory processes [13–15]. 
The rest of the amino acids are usually considered to be more stable to oxidation, although 
many of them are carbonylated during oxidative stress, especially when they are located 
near to cations that can catalyze the oxidation reaction [11,12,16,17]. RNA oxidation is less 
well studied, although we know that ribonucleotide bases can be oxidized to 5-
hydroxyuridine, 5-hydroxycytidine, 8-hydroxyadenosine and 8-hydroxyguanosine [18]. In 
addition to these oxidative modifications, nucleotides can also completely loss their bases 
during oxidative stress [19]. 
When cells enter in oxidative stress several targets are oxidized decreasing the activity of 
many metabolic pathways including translation in both bacteria [4,20–23] and eukaryotes 
[24–27]. Part of this inhibition might be due to the oxidative inactivation of several enzymes 
involved in the metabolism of energy and amino acid synthesis [7,11,12,28,29] both of which 
are essential for protein synthesis. Also, several macromolecules that participate in 
translation have been found to be a target of oxidation in in vivo or in vitro experiments 
indicating that translation is directly targeted by oxidative species. In bacteria, these target 
macromolecules include elongation factors Tu [30–34], Ts (EF-Ts) [32] and G (EF-G) 
[8,9,22,32,35], several ribosomal proteins [31,36,37], tRNA [38–42] and aminoacyl-tRNA 
synthetases (aaRS) [31,34,36,37,43,44] (Table 1). rRNA and mRNA has also been shown to be 
oxidized in vivo in eukaryotes [19,25,26], but in bacteria this has not been tested. 
Although many macromolecules involved in translation have been found to be target of 
oxidation, there is little information on the effects of this oxidation on translation and the 
bacterial physiology (Figure 1). The effects of oxidation of any of the ribosomal proteins or 
of elongation factors Tu and Ts have not been studied, although we know that the deletion 
of yajL (that encodes for a chaperon/oxido-reductase that protects this and other proteins 
during oxidative stress) increases the error rates of translation when Escherichia coli is 
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incubated with a moderate concentration of H2O2 (~100 µM)[34,45]. Conversely, the effect of 
oxidation of EF-G has been characterized in a much greater detail. In E. coli cells, EF-G has 
been shown to be carbonylated in several stress conditions including incubation with H2O2, 
menadione or paraquat, transference from anaerobic to aerobic conditions in high iron 
concentrations [9] and growth arrest conditions in strains deleted for superoxide dismutase 
[35]. EF-G has also been shown to be carbonylated in Bacillus subtilis cells growing 
exponentially or exposed to H2O2 [32]. Finally, in the cyanobacteria Synechocystis sp., 
oxidation of three isoforms of EF-G during oxidative stress caused by excessive light 
exposure has been shown to inhibit translation [8,20,21] 
 
Target Type Reference 
Ribosomal proteins  
Ribosomal proteins L5, L14, L7/L12, 
L27, L31, S2, S4, S17 and S21 
Cysteine oxidation [31,36,37] 
Ribosomal proteins S1, S2, S3, S4, S8, 
S10, S11, S12, S19, L2, L5, L6, L10, 
L11, L12, L13, L14, L27, L28 
Covalent binding to chaperon/oxido-
reductase protein through cysteine 
bond 
[34] 
Ribosomal proteins S2, S4, S7, S11, 
S13, S18, L16, L17 
Disulfide bond formation [37] 
Elongator factors  
EF-Tu Cysteine oxidation [30,31] 
EF-Tu Covalent binding to chaperon/oxido-
reductase protein through cysteine 
bond 
[34] 
EF-Tu Carbonylation [32,33] 
EF-Ts Carbonylation [32] 
EF-G Cysteine oxidation [8,20,21,46] 
EF-G Carbonylation [9,32,35] 
Aminoacyl-tRNA synthetases  
Alanyl, Phenylalanyl, Glutamyl, 
Glycyl, Aspartyl, Leucyl, Isoleucyl, 
Seryl and Threonyl-tRNA synthetase 
Cysteine oxidation [31,36,37,43
,44] 
Alanyl, Isoleucyl, Leucyl, Threonyl 
and Phenylalanyl tRNA synthetases 
Covalent binding to chaperon/oxido-




tRNA 4-thiouridine oxidation [41,47] 
tRNA Cross-linking of 4-thiouridine in 
position 8 with C8. 
[42,48,49] 
Table 1. Some macromolecules involved in translation that have been shown to be oxidized in bacteria. 
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Figure 1. Effect on protein synthesis of the oxidation of translation related macromolecules. Oxidation 
of proteins may produce loss of function and structure which further produce protein aggregates that are 
toxic to the cell. Control of the translation machinery may sometimes protect the cell by decreasing the 
protein synthesis rate or enhancing the translation of specific proteins that protect the cell such as 
chaperons and proteases. Nevertheless, oxidation of the translation machinery may also increase its error 
rates which would produce proteins that are less stable increasing the toxicity of the oxidative stress. 
2.1. EF-G oxidation in Synechocystis sp. during exposure to high intensity light 
In Synechocystis sp., as well as in all photosynthetic organisms, light provides the energy that 
drives photosynthesis. Nevertheless, using photosynthesis is risky because photosynthetic 
transport of electrons or transfer of excitation energy to oxygen can produce ROS and 
subsequent oxidative stress [50]. Absorption of excessive light can also decrease the 
photosynthetic capacity of an organism in a process referred to as photodamage. The main 
target of photodamage is protein D1 which is part of photosystem II where the 
photochemical reaction and subsequent transport of electrons from water to plastoquinone 
occurs [51]. Loss of activity depends on the balance between both the speed of damage and 
repair of protein D1. The limiting step of repair is the de novo translation of the protein, thus 
the use of protein synthesis inhibitors like chloramphenicol has allowed to study damage 
separated from repair. These experiments have shown that, although oxidative stress 
increases the sensitivity of photosystem II to photodamage, its role is mainly to inhibit the 
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translation of protein D1 while damage is caused directly by light [8,20,21]. [35S]-Methionine 
incorporation experiments confirmed that D1 protein translation is inhibited under 
oxidative stress and also showed that this is a rather general effect where translation of all 
thylakoid membrane proteins is inhibited [20,21]. 
Most of D1 protein translation elongation is performed in membrane bound polysomes. 
During oxidative stress the fraction of mRNA associated to those polysomes decrease 
suggesting that the inhibition of translation happens at the elongation step [8,20,21]. Further 
in vitro experiments showed that the main target of oxidation is EF-G. Synechocystis sp 
genome encodes for 3 EF-G proteins, all of which can enhance protein translation in cell 
extracts that have been oxidized in vitro with H2O2 [22]. Mutation analysis of one of this EF-
G variant, encoded by gene slr1463 of Synechocystis sp. PCC6803, showed that Cys105, which 
is near to the GTP-binding site, is the primary target of oxidation. Mutations on this cysteine 
or Cys242 (with which Cys105 form a disulfide bond) bears an EF-G protein that is resistant 
to H2O2 oxidation in vitro as measured by its ability to stimulate translation in oxidized cell 
extracts [8,46]. It has not been possible to substitute the slr1463 gene by a Cys105Ser mutant. 
Instead the mutant protein has been expressed in a strain of Synechocystis sp. that maintains 
its copy of the wild type gene. In this system, expression of slr1463 Cys105Ser decreased the 
loss of photosystem II activity and increased the rate of D1 translation confirming the 
relevance of this cysteine during oxidative stress inhibition of translation [52]. 
EF-G is substrate of reduction by thioredoxin in Synechocystis [46,53]. Based on this 
observation, it has been proposed that the translation activity could be rapidly recovered 
after oxidative stress through the reduction of cysteines 105 and 242 by thioredoxin. This last 
protein in turn would be reduced by NADPH-thioredoxin reductase and ferredoxin-
thioredoxin reductase with reducing power from photosystem I [8,46].  
2.2. Oxidation of tRNA 
Together with the oxidation of ribosomal proteins and translation factors, other 
macromolecules involved in translation can be oxidized during oxidative stress. In this 
context, oxidation of RNA has been found in eukaryotes during oxidative stress, senescence 
or some age related diseases [19,25,26]. This reaction would depend on the ability of RNA to 
bind Fe+2 which catalyzes its oxidation. As mRNA and especially the more abundant rRNA 
bind Fe+2 better than tRNAs, these molecules would be more prone to oxidize [26]. The effect 
of oxidation over some specific mRNAs was shown to decrease translation of those genes 
through either increasing ribosome stalling or decreasing translational speed [25]. Oxidation 
of eukaryotic ribosomes also decreases translation efficiency, although in this case it is not 
clear whether oxidation of rRNA or ribosomal proteins is responsible of the effect [26].  
In bacteria oxidation of rRNA and mRNA has not been studied, but on the other hand tRNA 
is known to be subject of oxidation in vitro [38,47] and in vivo [41,42]. Many of the tRNA 
bases are modified after its transcription [54] and apparently those modifications are very 
relevant for the role that tRNA plays during oxidative stress. In E. coli some of these 
modifications have a protective effect. For example, methylation of A37 in tRNA1Val 
increases survival after an incubation of 2 hrs in 5 mM H2O2 [55]. The authors of this study 
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chaperons and proteases. Nevertheless, oxidation of the translation machinery may also increase its error 
rates which would produce proteins that are less stable increasing the toxicity of the oxidative stress. 
2.1. EF-G oxidation in Synechocystis sp. during exposure to high intensity light 
In Synechocystis sp., as well as in all photosynthetic organisms, light provides the energy that 
drives photosynthesis. Nevertheless, using photosynthesis is risky because photosynthetic 
transport of electrons or transfer of excitation energy to oxygen can produce ROS and 
subsequent oxidative stress [50]. Absorption of excessive light can also decrease the 
photosynthetic capacity of an organism in a process referred to as photodamage. The main 
target of photodamage is protein D1 which is part of photosystem II where the 
photochemical reaction and subsequent transport of electrons from water to plastoquinone 
occurs [51]. Loss of activity depends on the balance between both the speed of damage and 
repair of protein D1. The limiting step of repair is the de novo translation of the protein, thus 
the use of protein synthesis inhibitors like chloramphenicol has allowed to study damage 
separated from repair. These experiments have shown that, although oxidative stress 
increases the sensitivity of photosystem II to photodamage, its role is mainly to inhibit the 
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translation of protein D1 while damage is caused directly by light [8,20,21]. [35S]-Methionine 
incorporation experiments confirmed that D1 protein translation is inhibited under 
oxidative stress and also showed that this is a rather general effect where translation of all 
thylakoid membrane proteins is inhibited [20,21]. 
Most of D1 protein translation elongation is performed in membrane bound polysomes. 
During oxidative stress the fraction of mRNA associated to those polysomes decrease 
suggesting that the inhibition of translation happens at the elongation step [8,20,21]. Further 
in vitro experiments showed that the main target of oxidation is EF-G. Synechocystis sp 
genome encodes for 3 EF-G proteins, all of which can enhance protein translation in cell 
extracts that have been oxidized in vitro with H2O2 [22]. Mutation analysis of one of this EF-
G variant, encoded by gene slr1463 of Synechocystis sp. PCC6803, showed that Cys105, which 
is near to the GTP-binding site, is the primary target of oxidation. Mutations on this cysteine 
or Cys242 (with which Cys105 form a disulfide bond) bears an EF-G protein that is resistant 
to H2O2 oxidation in vitro as measured by its ability to stimulate translation in oxidized cell 
extracts [8,46]. It has not been possible to substitute the slr1463 gene by a Cys105Ser mutant. 
Instead the mutant protein has been expressed in a strain of Synechocystis sp. that maintains 
its copy of the wild type gene. In this system, expression of slr1463 Cys105Ser decreased the 
loss of photosystem II activity and increased the rate of D1 translation confirming the 
relevance of this cysteine during oxidative stress inhibition of translation [52]. 
EF-G is substrate of reduction by thioredoxin in Synechocystis [46,53]. Based on this 
observation, it has been proposed that the translation activity could be rapidly recovered 
after oxidative stress through the reduction of cysteines 105 and 242 by thioredoxin. This last 
protein in turn would be reduced by NADPH-thioredoxin reductase and ferredoxin-
thioredoxin reductase with reducing power from photosystem I [8,46].  
2.2. Oxidation of tRNA 
Together with the oxidation of ribosomal proteins and translation factors, other 
macromolecules involved in translation can be oxidized during oxidative stress. In this 
context, oxidation of RNA has been found in eukaryotes during oxidative stress, senescence 
or some age related diseases [19,25,26]. This reaction would depend on the ability of RNA to 
bind Fe+2 which catalyzes its oxidation. As mRNA and especially the more abundant rRNA 
bind Fe+2 better than tRNAs, these molecules would be more prone to oxidize [26]. The effect 
of oxidation over some specific mRNAs was shown to decrease translation of those genes 
through either increasing ribosome stalling or decreasing translational speed [25]. Oxidation 
of eukaryotic ribosomes also decreases translation efficiency, although in this case it is not 
clear whether oxidation of rRNA or ribosomal proteins is responsible of the effect [26].  
In bacteria oxidation of rRNA and mRNA has not been studied, but on the other hand tRNA 
is known to be subject of oxidation in vitro [38,47] and in vivo [41,42]. Many of the tRNA 
bases are modified after its transcription [54] and apparently those modifications are very 
relevant for the role that tRNA plays during oxidative stress. In E. coli some of these 
modifications have a protective effect. For example, methylation of A37 in tRNA1Val 
increases survival after an incubation of 2 hrs in 5 mM H2O2 [55]. The authors of this study 
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cite unpublished data that indicates that several other tRNA modifications would improve 
the fitness of E. coli in such oxidative conditions. It has also been shown that deletion of 
several tRNA modification enzymes affect survival of E. coli in a milder oxidative stress 
condition (0.5 mM H2O2) [56]. Despite these reports, it is not clear how tRNA modifications 
improve survival to oxidative stress. It has been suggested that tRNA modifications increase 
the efficiency of translation in this condition, which would be necessary to cope with the 
degradation of proteins due to loss of function and/or structure [55]. There are some reports 
in the literature that show that an increase in error rates during protein synthesis enhances 
protein oxidation. In theory, this would be due to an increased exposure of oxidation targets 
that are normally hidden in the interior of proteins [3,57]. Thus, it is also possible that the 
requirement of tRNA modification during oxidative stress is related with the need of 
decreasing error rates to hide possible oxidation targets. 
Nevertheless, in the only well studied example, tRNA modification is required because it 
directly participates in initiating the response to oxidative stress. An important source of 
oxidative stress for bacteria in environments exposed to sun light is near UV irradiation (300-
400 nm), which corresponds to the sun irradiation with highest energy that can cross the 
atmosphere [58]. Near UV irradiation of bacteria like E. coli, Salmonella Thyphimurium or 
Enterobacter cloacae produces growth arrest which depends mainly in the photochemical 
oxidation of the tRNA modified base 4-thiouridine (s4U) present in position 8 of all tRNAs [39–
42]. In some tRNAs that also have a C in position 13 (50% of bulk tRNA) an internal cross-
linking reaction happens that produces 5-(4´-pyrimidin 2´-one) [39,40,59]. Some cross-linked 
tRNAs have been shown to be poor substrates for aminoacylation [40,60,61] and in some cases 
also for translation [60]. The accumulation of such deacylated tRNAs can trigger the stringent 
response (see below). Thus, a combination of the trigger of stringent response plus the 
decrease in tRNA aminoacylation inhibits protein synthesis after UV exposure [40,62,63]. 
In E. cloacae, a short period of exposure to UV light protects the cells from the growth arrest 
produced by a second exposition of 60 minutes. This effect coincides with a decrease in the 
content of s4U modification in tRNA [48], which could be interpreted as the presence of a 
protective effect mediated by the loss of this tRNA modification. Concordantly, mutation of 
the genes involved in s4U modification of tRNAs (nuv mutant) also protect S. thyphimurium 
cells from the lag in the growth curves produced by short exposures (15 min) to near UV 
light. Nevertheless, the lag in growth seems to have a protective effect in long term 
exposure. After 4 to 5 hours of exposure to near UV, the mutant cells died at a faster rate 
than wild type (over 10 fold difference of survival after 8 hrs.). Part of this increased 
sensitivity to UV exposure is due to the lack of stringent response, but s4U modification is 
somehow also relevant in the induction of several heat shock and oxidative stress response 
proteins such as alkyl hydroperoxide reductase [41]. Thus, it seems that the loss of s4U 
modification after exposure to UV could be associated with a lag in the tRNA turnover 
process and not with a long term protection process, although similar long term exposures 
have not been performed with E. cloacae. In accordance, tRNA sulfuretransferase activity, 
which is necessary for the synthesis of s4U tRNA modification, is inhibited in E. coli extracts 
from cells exposed to UV irradiation [49]. 
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2.3. 5´-adenylyl dinucleotides and oxidative stress 
Beside its direct effect on stringent response and the induction of several oxidative stress 
response enzymes, cross-linking of s4U also induce the synthesis of 5´-adenylyl 
dinucleotides of the general structure AppppN (adenosine-5´, 5´´-ribonucleotide 
tetraphosphate) and ApppN (adenosine-5´, 5´´-ribonucleotide triphosphate) [41]. These 
dinucleotides are synthesized by aminoacyl-tRNA synthetases during stressful conditions 
such as oxidative stress and heat shock [41,64–67]. During the synthesis of aminoacyl-tRNA, 
aaRS produce aminoacyl-adenylate (aa-aMP) as an intermediate of the reaction (reaction 1). 
In this intermediate molecule the amino acid (aa) is activated for its transference to tRNA 
(reaction 2) [68], but the adenylate is also activated and can be transferred to either ATP, 
ADP, ppGpp or other nucleotides in a side reaction that forms dinucleotides of the general 
structure AppppN, ApppN or ApppNpp [69–71] (reaction 3). This reaction can be catalyzed 
by several aaRS, but the most active are Phenylalanyl-tRNA synthetase (PheRS) and 
specially Lysyl-tRNA synthetase (LysRS) [64,69].  
 ATP + aa → aa-AMP + PPi  (1) 
 aa-AMP + tRNA → aa-tRNA + AMP  (2) 
 aa-AMP + NDP/NTP → Appp(p)N +Pi  (3) 
During UV irradiation cross-linking of s4U somehow stimulates the production of AppppA 
and ApppA [41], but these dinucleotides are also synthesized by bacteria under other 
oxidative stress conditions and during heat shock, where s4U state has not been evaluated 
[65–67,72]. Probably, an important source of the increase of these molecules concentration 
during heat shock is that the rate of dinucleotides synthesis by LysRS increases with 
temperature, while the rate of Lys-tRNALys synthesis decreases [64]. Also, the induction at 
higher temperatures of a specific LysRS isoenzyme (encoded by lysU gene) that is more 
stable and active for dinucleotides synthesis may explain the increase in AppppN during 
heat shock [64]. A possible explanation for the increase of these dinucleotides during 
oxidative stress could be the inactivation of their degradation enzyme, P1,P4-bis(5'-
adenosyl) tetraphosphate pyrophosphohydrolase (ApaH), which in vitro is sensitive to 
cysteine oxidation [73]. An alternative is that oxidation of tRNA modified bases by itself 
activate the synthesis of the dinucleotides [65], similar to the case of UV irradiation where it 
has been shown that mutants that lack the s4U modification cannot trigger the synthesis of 
AppppN [41]. 
Originally it was thought that these dinucleotides would function as “alarmones”, that is, 
small molecules that are synthesized during a stress condition (in this case oxidative stress 
and heat shock) and trigger a fast response to it, similar to the role of (p)ppGpp during 
amino acid stringency (see below) [41,65–67,74]. Nevertheless, time course experiments 
showed that AppppA increase in concentration lags behind the synthesis of heat shock 
proteins during stress conditions, suggesting that it is not an alarmon in this case [72]. Also, 
over expression of apaH, the gene coding for AppppN hydrolase that eliminates these 
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cite unpublished data that indicates that several other tRNA modifications would improve 
the fitness of E. coli in such oxidative conditions. It has also been shown that deletion of 
several tRNA modification enzymes affect survival of E. coli in a milder oxidative stress 
condition (0.5 mM H2O2) [56]. Despite these reports, it is not clear how tRNA modifications 
improve survival to oxidative stress. It has been suggested that tRNA modifications increase 
the efficiency of translation in this condition, which would be necessary to cope with the 
degradation of proteins due to loss of function and/or structure [55]. There are some reports 
in the literature that show that an increase in error rates during protein synthesis enhances 
protein oxidation. In theory, this would be due to an increased exposure of oxidation targets 
that are normally hidden in the interior of proteins [3,57]. Thus, it is also possible that the 
requirement of tRNA modification during oxidative stress is related with the need of 
decreasing error rates to hide possible oxidation targets. 
Nevertheless, in the only well studied example, tRNA modification is required because it 
directly participates in initiating the response to oxidative stress. An important source of 
oxidative stress for bacteria in environments exposed to sun light is near UV irradiation (300-
400 nm), which corresponds to the sun irradiation with highest energy that can cross the 
atmosphere [58]. Near UV irradiation of bacteria like E. coli, Salmonella Thyphimurium or 
Enterobacter cloacae produces growth arrest which depends mainly in the photochemical 
oxidation of the tRNA modified base 4-thiouridine (s4U) present in position 8 of all tRNAs [39–
42]. In some tRNAs that also have a C in position 13 (50% of bulk tRNA) an internal cross-
linking reaction happens that produces 5-(4´-pyrimidin 2´-one) [39,40,59]. Some cross-linked 
tRNAs have been shown to be poor substrates for aminoacylation [40,60,61] and in some cases 
also for translation [60]. The accumulation of such deacylated tRNAs can trigger the stringent 
response (see below). Thus, a combination of the trigger of stringent response plus the 
decrease in tRNA aminoacylation inhibits protein synthesis after UV exposure [40,62,63]. 
In E. cloacae, a short period of exposure to UV light protects the cells from the growth arrest 
produced by a second exposition of 60 minutes. This effect coincides with a decrease in the 
content of s4U modification in tRNA [48], which could be interpreted as the presence of a 
protective effect mediated by the loss of this tRNA modification. Concordantly, mutation of 
the genes involved in s4U modification of tRNAs (nuv mutant) also protect S. thyphimurium 
cells from the lag in the growth curves produced by short exposures (15 min) to near UV 
light. Nevertheless, the lag in growth seems to have a protective effect in long term 
exposure. After 4 to 5 hours of exposure to near UV, the mutant cells died at a faster rate 
than wild type (over 10 fold difference of survival after 8 hrs.). Part of this increased 
sensitivity to UV exposure is due to the lack of stringent response, but s4U modification is 
somehow also relevant in the induction of several heat shock and oxidative stress response 
proteins such as alkyl hydroperoxide reductase [41]. Thus, it seems that the loss of s4U 
modification after exposure to UV could be associated with a lag in the tRNA turnover 
process and not with a long term protection process, although similar long term exposures 
have not been performed with E. cloacae. In accordance, tRNA sulfuretransferase activity, 
which is necessary for the synthesis of s4U tRNA modification, is inhibited in E. coli extracts 
from cells exposed to UV irradiation [49]. 
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2.3. 5´-adenylyl dinucleotides and oxidative stress 
Beside its direct effect on stringent response and the induction of several oxidative stress 
response enzymes, cross-linking of s4U also induce the synthesis of 5´-adenylyl 
dinucleotides of the general structure AppppN (adenosine-5´, 5´´-ribonucleotide 
tetraphosphate) and ApppN (adenosine-5´, 5´´-ribonucleotide triphosphate) [41]. These 
dinucleotides are synthesized by aminoacyl-tRNA synthetases during stressful conditions 
such as oxidative stress and heat shock [41,64–67]. During the synthesis of aminoacyl-tRNA, 
aaRS produce aminoacyl-adenylate (aa-aMP) as an intermediate of the reaction (reaction 1). 
In this intermediate molecule the amino acid (aa) is activated for its transference to tRNA 
(reaction 2) [68], but the adenylate is also activated and can be transferred to either ATP, 
ADP, ppGpp or other nucleotides in a side reaction that forms dinucleotides of the general 
structure AppppN, ApppN or ApppNpp [69–71] (reaction 3). This reaction can be catalyzed 
by several aaRS, but the most active are Phenylalanyl-tRNA synthetase (PheRS) and 
specially Lysyl-tRNA synthetase (LysRS) [64,69].  
 ATP + aa → aa-AMP + PPi  (1) 
 aa-AMP + tRNA → aa-tRNA + AMP  (2) 
 aa-AMP + NDP/NTP → Appp(p)N +Pi  (3) 
During UV irradiation cross-linking of s4U somehow stimulates the production of AppppA 
and ApppA [41], but these dinucleotides are also synthesized by bacteria under other 
oxidative stress conditions and during heat shock, where s4U state has not been evaluated 
[65–67,72]. Probably, an important source of the increase of these molecules concentration 
during heat shock is that the rate of dinucleotides synthesis by LysRS increases with 
temperature, while the rate of Lys-tRNALys synthesis decreases [64]. Also, the induction at 
higher temperatures of a specific LysRS isoenzyme (encoded by lysU gene) that is more 
stable and active for dinucleotides synthesis may explain the increase in AppppN during 
heat shock [64]. A possible explanation for the increase of these dinucleotides during 
oxidative stress could be the inactivation of their degradation enzyme, P1,P4-bis(5'-
adenosyl) tetraphosphate pyrophosphohydrolase (ApaH), which in vitro is sensitive to 
cysteine oxidation [73]. An alternative is that oxidation of tRNA modified bases by itself 
activate the synthesis of the dinucleotides [65], similar to the case of UV irradiation where it 
has been shown that mutants that lack the s4U modification cannot trigger the synthesis of 
AppppN [41]. 
Originally it was thought that these dinucleotides would function as “alarmones”, that is, 
small molecules that are synthesized during a stress condition (in this case oxidative stress 
and heat shock) and trigger a fast response to it, similar to the role of (p)ppGpp during 
amino acid stringency (see below) [41,65–67,74]. Nevertheless, time course experiments 
showed that AppppA increase in concentration lags behind the synthesis of heat shock 
proteins during stress conditions, suggesting that it is not an alarmon in this case [72]. Also, 
over expression of apaH, the gene coding for AppppN hydrolase that eliminates these 
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dinucleotides in vivo [73], decreased significantly the levels of AppppA, but did not affected 
protein expression or cell survival under heat shock or H2O2 incubation [75]. Conversely, 
deletion of apaH, that increases the cellular level of AppppA, does affect cell survival and 
protein expression on several stress conditions including heat shock [76,77], UV irradiation 
[76], incubation with N-ethylmaleimide [76] as well during starvation [78]. It was shown 
that deletion of apaH somehow decreases expression of CAP-cAMP controlled genes which 
would decrease oxidative phosphorylation and limit further production of oxygen radicals. 
apaH mutant cells also showed prolonged synthesis of heat shock protein DnaK after heat 
shocked cells were returned to 30°C suggesting that the role of dinucleotides would be to 
modulate the long term response to stress conditions and not to trigger it [76]. The idea that 
the dinucleotides modulate the stress response is also supported by the fact that these 
molecules specifically bind several heat shock proteins including DnaK, GroEL[77] and 
ClpB [78]. Binding to DnaK inhibit its 5'-nucleotidase activity [79], but it is not known if it 
affects its ability to bind denatured proteins. Effects of AppppA binding to the other heat 
shock proteins has not been investigated, although it has been shown that increases in 
cellular level of Appp(p)N enhance the degradation of abnormal proteins synthesized 
during incubation with puromycin [78]. 
2.4. Role of aminoacyl-tRNA synthetases during oxidative stress 
As discussed previously, LysRS and PheRS participate in the modulation of oxidative stress 
response through the synthesis of 5'-adenylyl dinucleotides. Many other aaRS that are 
oxidized during diverse oxidative stress conditions (Table 1) could also have relevant roles. 
Unfortunately, the effect of oxidation on most of these enzymes has not been characterized, 
although from some studied examples we know that oxidation can inactivate the enzyme 
[44] or increase its error rates [43]. In the case of human histidyl-tRNA synthetase (HisRS) 
apparently oxidation can even activate the enzyme [80], although we lack a thorough 
biochemical characterization of this oxidized enzyme. 
In E. coli, cysteines from glutamyl-tRNA synthetase (GluRS) have been shown to be oxidized 
in vivo in cells lacking a periplasmic disulfuro isomerase (DsbA) [36]. The specific oxidized 
cysteines as well as the effect of their oxidation have not been characterized. Nevertheless, 
there are reports of the effect of in vitro oxidation on GluRS1 from Acidithiobacillus 
ferrooxidans. This enzyme has 4 cysteines one of which is near the active site, while the others 
form part of a Zn+2 binding domain. Oxidation of the Zn+2 binding cysteines inactivate the 
enzyme and release part of the Zn+2 [44]. Inactivation of the enzyme has been observed in 
vivo during excessive synthesis of tetrapyrroles like heme and it is supposed to regulate the 
synthesis of these molecules through modulation of the intracellular levels of its precursor, 
Glu-tRNAGlu [81]. Nevertheless, it is not known if the in vivo inactivation is due to oxidation 
and thus, if oxidative reactions are involved in this regulatory process.  
The best characterized example of oxidation of a bacterial aaRS is the case of Threonyl-tRNA 
synthetase (ThrRS) which increases its error rates after in vivo or in vitro oxidation. ThrRS 
active site normally charges a small fraction of the tRNAThr with serine (Ser). This Ser-
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tRNAThr could be potentially toxic to cells due to miss-incorporation of Ser in position of 
threonine (Thr) during protein translation. To prevent this mis-incorporation, ThrRS has an 
editing site that deacylate the mis-aminoacylated tRNAThr [82]. Incubation of the enzyme 
with H2O2 inactivates its editing site, but does not affect the aminoacylation site. Thus, in 
these conditions the enzyme mis-acylation rate increases. Incubation of E. coli cells with 
H2O2 enhances the miss-incorporation of Ser in Thr positions confirming that oxidative 
stress do increase the error rates of the enzyme in vivo [43]. A similar example has been 
observed in eukaryotic cells where oxidative stress also increases the error rates of 
Methionyl-tRNA synthetase (MetRS), although instead of using the incorrect amino acid, the 
enzyme utilize non-cognate tRNAs [83]. Apparently, these mis-incorporation also happens 
in bacteria, where E. coli methionyl-tRNA synthetase (MetRS) is able to aminoacylate non-
cognate tRNAs with Met, mainly tRNAArgCCU and tRNAThrCGU [84]. Unfortunately, there is no 
data with respect to the effect of oxidation on the mis-incorporation of Met in bacteria. It is 
expected that the mis-incorporation of Met could protect proteins from oxidative damage by 
oxidizing them before relevant targets [83]. This is in striking difference with the case of 
ThrRS, where it has been shown that mis-incorporation of Ser produces a lag in cell growth 
curves and a higher susceptibility to deletion of proteases [43]. 
2.5. Final remarks on the effects of oxidative stress on protein translation  
While the increase of error rate by MetRS apparently protects the cell from further damage, 
a similar behavior by ThrRS decrease the fitness of cells to this stressful environment [43,83]. 
These contradictory effects of very similar phenomena are representative of what happens 
with all the components of the translation machinery and sometimes makes it difficult to 
determine whether an oxidized molecule is part of the control of protective mechanism or is 
itself a target of oxidation with deleterious consequences. At the same time, some of these 
effects can be deleterious or advantageous depending on the extent of the oxidative insult. 
An example of this is the role of s4U modification on tRNA. The absence of this modification 
prevents the lag on replication after a short near UV irradiation and thus increases the cell 
fitness on these conditions. Nevertheless, when exposed for longer times to near UV, 
bacteria survive better when are able to produce the modification.  
Cells cannot avoid using reactive molecules that are necessary for catalysis, but at the same 
time are easy targets of oxidative species. In many cases oxidation inactivates proteins that 
use this molecules and also destabilize their structure enhancing the formation of protein 
aggregates that are toxic to the cell. Thus, bacteria also need to have systems that protect 
them from further damage. An important step in cell protection is to prevent the synthesis of 
new proteins that could be targets of oxidation by inactivating several macromolecules 
involved in translation (Figure 1). At the same time, cells need to activate the translation of 
proteins that participate in the synthesis and usage of antioxidant molecules, as well as 
proteases and chaperons that prevent the formation of aggregates that are toxic to bacteria. 
After the stressful condition has passed, translation has to be re-initiated and proteases have 
to be inactivated in order to prevent the degradation of newly synthesized proteins that are 
folded correctly. The data presented in this chapter shows that the translation system has a 
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dinucleotides in vivo [73], decreased significantly the levels of AppppA, but did not affected 
protein expression or cell survival under heat shock or H2O2 incubation [75]. Conversely, 
deletion of apaH, that increases the cellular level of AppppA, does affect cell survival and 
protein expression on several stress conditions including heat shock [76,77], UV irradiation 
[76], incubation with N-ethylmaleimide [76] as well during starvation [78]. It was shown 
that deletion of apaH somehow decreases expression of CAP-cAMP controlled genes which 
would decrease oxidative phosphorylation and limit further production of oxygen radicals. 
apaH mutant cells also showed prolonged synthesis of heat shock protein DnaK after heat 
shocked cells were returned to 30°C suggesting that the role of dinucleotides would be to 
modulate the long term response to stress conditions and not to trigger it [76]. The idea that 
the dinucleotides modulate the stress response is also supported by the fact that these 
molecules specifically bind several heat shock proteins including DnaK, GroEL[77] and 
ClpB [78]. Binding to DnaK inhibit its 5'-nucleotidase activity [79], but it is not known if it 
affects its ability to bind denatured proteins. Effects of AppppA binding to the other heat 
shock proteins has not been investigated, although it has been shown that increases in 
cellular level of Appp(p)N enhance the degradation of abnormal proteins synthesized 
during incubation with puromycin [78]. 
2.4. Role of aminoacyl-tRNA synthetases during oxidative stress 
As discussed previously, LysRS and PheRS participate in the modulation of oxidative stress 
response through the synthesis of 5'-adenylyl dinucleotides. Many other aaRS that are 
oxidized during diverse oxidative stress conditions (Table 1) could also have relevant roles. 
Unfortunately, the effect of oxidation on most of these enzymes has not been characterized, 
although from some studied examples we know that oxidation can inactivate the enzyme 
[44] or increase its error rates [43]. In the case of human histidyl-tRNA synthetase (HisRS) 
apparently oxidation can even activate the enzyme [80], although we lack a thorough 
biochemical characterization of this oxidized enzyme. 
In E. coli, cysteines from glutamyl-tRNA synthetase (GluRS) have been shown to be oxidized 
in vivo in cells lacking a periplasmic disulfuro isomerase (DsbA) [36]. The specific oxidized 
cysteines as well as the effect of their oxidation have not been characterized. Nevertheless, 
there are reports of the effect of in vitro oxidation on GluRS1 from Acidithiobacillus 
ferrooxidans. This enzyme has 4 cysteines one of which is near the active site, while the others 
form part of a Zn+2 binding domain. Oxidation of the Zn+2 binding cysteines inactivate the 
enzyme and release part of the Zn+2 [44]. Inactivation of the enzyme has been observed in 
vivo during excessive synthesis of tetrapyrroles like heme and it is supposed to regulate the 
synthesis of these molecules through modulation of the intracellular levels of its precursor, 
Glu-tRNAGlu [81]. Nevertheless, it is not known if the in vivo inactivation is due to oxidation 
and thus, if oxidative reactions are involved in this regulatory process.  
The best characterized example of oxidation of a bacterial aaRS is the case of Threonyl-tRNA 
synthetase (ThrRS) which increases its error rates after in vivo or in vitro oxidation. ThrRS 
active site normally charges a small fraction of the tRNAThr with serine (Ser). This Ser-
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tRNAThr could be potentially toxic to cells due to miss-incorporation of Ser in position of 
threonine (Thr) during protein translation. To prevent this mis-incorporation, ThrRS has an 
editing site that deacylate the mis-aminoacylated tRNAThr [82]. Incubation of the enzyme 
with H2O2 inactivates its editing site, but does not affect the aminoacylation site. Thus, in 
these conditions the enzyme mis-acylation rate increases. Incubation of E. coli cells with 
H2O2 enhances the miss-incorporation of Ser in Thr positions confirming that oxidative 
stress do increase the error rates of the enzyme in vivo [43]. A similar example has been 
observed in eukaryotic cells where oxidative stress also increases the error rates of 
Methionyl-tRNA synthetase (MetRS), although instead of using the incorrect amino acid, the 
enzyme utilize non-cognate tRNAs [83]. Apparently, these mis-incorporation also happens 
in bacteria, where E. coli methionyl-tRNA synthetase (MetRS) is able to aminoacylate non-
cognate tRNAs with Met, mainly tRNAArgCCU and tRNAThrCGU [84]. Unfortunately, there is no 
data with respect to the effect of oxidation on the mis-incorporation of Met in bacteria. It is 
expected that the mis-incorporation of Met could protect proteins from oxidative damage by 
oxidizing them before relevant targets [83]. This is in striking difference with the case of 
ThrRS, where it has been shown that mis-incorporation of Ser produces a lag in cell growth 
curves and a higher susceptibility to deletion of proteases [43]. 
2.5. Final remarks on the effects of oxidative stress on protein translation  
While the increase of error rate by MetRS apparently protects the cell from further damage, 
a similar behavior by ThrRS decrease the fitness of cells to this stressful environment [43,83]. 
These contradictory effects of very similar phenomena are representative of what happens 
with all the components of the translation machinery and sometimes makes it difficult to 
determine whether an oxidized molecule is part of the control of protective mechanism or is 
itself a target of oxidation with deleterious consequences. At the same time, some of these 
effects can be deleterious or advantageous depending on the extent of the oxidative insult. 
An example of this is the role of s4U modification on tRNA. The absence of this modification 
prevents the lag on replication after a short near UV irradiation and thus increases the cell 
fitness on these conditions. Nevertheless, when exposed for longer times to near UV, 
bacteria survive better when are able to produce the modification.  
Cells cannot avoid using reactive molecules that are necessary for catalysis, but at the same 
time are easy targets of oxidative species. In many cases oxidation inactivates proteins that 
use this molecules and also destabilize their structure enhancing the formation of protein 
aggregates that are toxic to the cell. Thus, bacteria also need to have systems that protect 
them from further damage. An important step in cell protection is to prevent the synthesis of 
new proteins that could be targets of oxidation by inactivating several macromolecules 
involved in translation (Figure 1). At the same time, cells need to activate the translation of 
proteins that participate in the synthesis and usage of antioxidant molecules, as well as 
proteases and chaperons that prevent the formation of aggregates that are toxic to bacteria. 
After the stressful condition has passed, translation has to be re-initiated and proteases have 
to be inactivated in order to prevent the degradation of newly synthesized proteins that are 
folded correctly. The data presented in this chapter shows that the translation system has a 
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central role in all this process. At one side is by itself a very important target of oxidation, 
which affects the rate of translation and its fidelity. This has profound effects on the cellular 
physiology some of which are protective and others deleterious. Also, as a target of oxidation, 
it appears that the translation system participate in the modulation of the response to stress. 
We still lack enough information in order to fully understand what is the specific effect of 
oxidation on each of the components of the system. At the same time, although we do have 
some hints, we do not understand how all these components interact between them during 
oxidative stress or how they coordinate with other oxidative stress response components. 
3. Bacterial response to amino acid starvation 
During evolution, living organisms have acquired various systems to survive under adverse 
environmental conditions. Upon nutrient starvation, bacteria slow down all processes related 
to cell growth and increase the functionality of processes that overcome nutrient deficit. This 
generalized process is known as the stringent response and occurs in cells designated as rel+. 
The stringent response is triggered by the increase in the cellular levels of (p)ppGpp, also 
known as the “alarmone” or “magic spot” [85]. The level of these G nucleotide derivatives is 
regulated in E. coli by the activities of RelA and SpoT, two distinct but homologous enzymes. 
Under conditions of amino acid starvation, RelA senses uncharged tRNA stalled in the 
ribosome and synthesizes (p)ppGpp by pyrophosphorylation of GDP (or GTP) using ATP as 
the donor of pyrophosphate [86]. SpoT is a bifunctional enzyme that either synthesizes or 
degrades ppGpp [87] and its function is regulated in response to carbon, fatty acids or iron 
limitation. Catalytic activities in both enzymes are oriented to the amino termini regions that 
show conservation of the amino acid sequence. Conversely, carboxy termini are idiosyncratic 
since they are specific for each enzyme and their function is related to the signaling activities. 
Carboxy terminal domain (CTD) from RelA interacts with the ribosome probably sensing the 
uncharged tRNA [88]. SpoT contains in the CTD a region that interacts with the acyl carrier 
protein in the activation process [89]. RelA/SpoT related proteins have been found in all 
bacteria including the recently discovered “small alarmone synthetases” (SAS). These 
proteins seem to have complementary roles to RelA/SpoT. They are never alone but always in 
addition to RelA/SpoT in different combinations. RelA/SpoT homologous proteins have also 
been found in chloroplast probably with functions similar as in bacteria. Another ppGpp 
synthetase was found in chloroplasts of land plants that is sensitive to Ca++ [90]. Also in 
metazoan, another SpoT related protein, Mesh1, was recently identified [91]. The gene 
encoding Mesh1 compensates SpoT deficiencies in bacteria and Drosophila deficient in this 
protein show several impairments related to starvation. These findings widen the horizons of 
the functions of RelA/SpoT proteins to all kingdoms and also provide new relationships on 
signaling networks to control response to starvation.  
3.1. Biosynthesis of (p)ppGpp in the ribosome 
Aminoacyl-transfer RNAs (aa-tRNAs) are essential to cell physiology since they provide the 
amino acids to the ribosome for the translation of the genetic information encoded in the 
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mRNA. Aa-tRNAs are synthetized by the aminacyl-tRNA synthetases and are delivered to 
the ribosome by the elongation factor EF-Tu (in bacteria) in the ternary complex aa-
tRNA/EF-Tu/GTP. The ternary complex is positioned in the A site of the ribosome and as 
long as a correct pairing of the anticodon of tRNA with the codon in the mRNA is achieved, 
EF-Tu is released from the complex after hydrolysis of GTP. Upon formation of the peptide 
bond, the deacylated tRNA is released from the ribosome and is rapidly aminoacylated 
again by the corresponding aminoacyl-tRNA synthetase. Thus under normal growth 
conditions, the majority of tRNAs are aminoacylated and actively participating in protein 
synthesis. In contrast, under amino acid starvation, an important accumulation of 
deacylated tRNA takes place since the aminoacylation reaction is reduced. Under these 
conditions, an increasing number of A sites in the ribosome become empty or loaded with 
deacylated-tRNA and pausing of translation at these sites takes place [92-94]. Binding of 
deacylated-tRNA in the A site of the ribosome induce the formation of the RelA Activating 
Complex (RAC). RelA binds to RAC and catalyzes the transference of the β-γ 
pyrophosphate from ATP to either GTP or GDP for the formation of pppGpp or ppGpp 
respectively [93] (pppGpp is rapidly transformed to ppGpp, thus we will refer as ppGpp). 
Once ppGpp is formed, RelA is released from the ribosome but the deacylated tRNA might 
remain bound being released passively and independent from RelA. While deacylated-
tRNA is still bound to the ribosome, it is unable to accommodate an incoming aa-tRNA/EF-
Tu/GTP complex, thus it is stalled for protein synthesis. As long as RAC is active, new RelA 
molecules can bind and catalyze the formation of ppGpp [86]. As deacylated tRNA 
passively dissociates from the ribosome the stability of the interaction with the ribosome is a 
critical factor that influences the formation of ppGpp and thus the stringent response [95]. 
Recent data on the activation of RelA has shown that stalled ribosomes loaded with weakly 
bound deacylated-tRNAs require higher concentrations of enzyme than those loaded with 
tightly bound deacylated-tRNAs [96], suggesting that the recovery of cells from stringent 
response might be dependent on the type of starved amino acid. 
3.2. Role of ppGpp in the transcription of stable RNAs and amino acids 
biosynthesis genes 
The most well known effect of an increase in the concentration of ppGpp is the down 
regulation of the rRNA and tRNA transcription and thus of ribosomes and protein 
biosynthesis upon amino acid starvation. This is primarily an effect at the transcription level 
(reviewed in [97, 95]) and requires a direct interaction of the “alarmone” with the β and β´ 
subunits of the RNA polymerase affecting several activities, but mainly reducing 
transcription of rRNA genes. Biochemical, genetic and structural data indicate that ppGpp 
binds near the active site of RNA polymerase suggesting that the vicinity of this interaction 
might be involved in some of the observed effects [99-101]. There seems to be a reduced 
stability in the interaction between RNA polymerase and DNA in the open complex upon 
binding of ppGpp to the β and β´ subunits. Open complex at rRNA promoters is 
particularly unstable, thus this might be a requirement for the observed effect [102, 103]. 
However some stable open complexes are also affected by ppGpp suggesting that other 
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central role in all this process. At one side is by itself a very important target of oxidation, 
which affects the rate of translation and its fidelity. This has profound effects on the cellular 
physiology some of which are protective and others deleterious. Also, as a target of oxidation, 
it appears that the translation system participate in the modulation of the response to stress. 
We still lack enough information in order to fully understand what is the specific effect of 
oxidation on each of the components of the system. At the same time, although we do have 
some hints, we do not understand how all these components interact between them during 
oxidative stress or how they coordinate with other oxidative stress response components. 
3. Bacterial response to amino acid starvation 
During evolution, living organisms have acquired various systems to survive under adverse 
environmental conditions. Upon nutrient starvation, bacteria slow down all processes related 
to cell growth and increase the functionality of processes that overcome nutrient deficit. This 
generalized process is known as the stringent response and occurs in cells designated as rel+. 
The stringent response is triggered by the increase in the cellular levels of (p)ppGpp, also 
known as the “alarmone” or “magic spot” [85]. The level of these G nucleotide derivatives is 
regulated in E. coli by the activities of RelA and SpoT, two distinct but homologous enzymes. 
Under conditions of amino acid starvation, RelA senses uncharged tRNA stalled in the 
ribosome and synthesizes (p)ppGpp by pyrophosphorylation of GDP (or GTP) using ATP as 
the donor of pyrophosphate [86]. SpoT is a bifunctional enzyme that either synthesizes or 
degrades ppGpp [87] and its function is regulated in response to carbon, fatty acids or iron 
limitation. Catalytic activities in both enzymes are oriented to the amino termini regions that 
show conservation of the amino acid sequence. Conversely, carboxy termini are idiosyncratic 
since they are specific for each enzyme and their function is related to the signaling activities. 
Carboxy terminal domain (CTD) from RelA interacts with the ribosome probably sensing the 
uncharged tRNA [88]. SpoT contains in the CTD a region that interacts with the acyl carrier 
protein in the activation process [89]. RelA/SpoT related proteins have been found in all 
bacteria including the recently discovered “small alarmone synthetases” (SAS). These 
proteins seem to have complementary roles to RelA/SpoT. They are never alone but always in 
addition to RelA/SpoT in different combinations. RelA/SpoT homologous proteins have also 
been found in chloroplast probably with functions similar as in bacteria. Another ppGpp 
synthetase was found in chloroplasts of land plants that is sensitive to Ca++ [90]. Also in 
metazoan, another SpoT related protein, Mesh1, was recently identified [91]. The gene 
encoding Mesh1 compensates SpoT deficiencies in bacteria and Drosophila deficient in this 
protein show several impairments related to starvation. These findings widen the horizons of 
the functions of RelA/SpoT proteins to all kingdoms and also provide new relationships on 
signaling networks to control response to starvation.  
3.1. Biosynthesis of (p)ppGpp in the ribosome 
Aminoacyl-transfer RNAs (aa-tRNAs) are essential to cell physiology since they provide the 
amino acids to the ribosome for the translation of the genetic information encoded in the 
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mRNA. Aa-tRNAs are synthetized by the aminacyl-tRNA synthetases and are delivered to 
the ribosome by the elongation factor EF-Tu (in bacteria) in the ternary complex aa-
tRNA/EF-Tu/GTP. The ternary complex is positioned in the A site of the ribosome and as 
long as a correct pairing of the anticodon of tRNA with the codon in the mRNA is achieved, 
EF-Tu is released from the complex after hydrolysis of GTP. Upon formation of the peptide 
bond, the deacylated tRNA is released from the ribosome and is rapidly aminoacylated 
again by the corresponding aminoacyl-tRNA synthetase. Thus under normal growth 
conditions, the majority of tRNAs are aminoacylated and actively participating in protein 
synthesis. In contrast, under amino acid starvation, an important accumulation of 
deacylated tRNA takes place since the aminoacylation reaction is reduced. Under these 
conditions, an increasing number of A sites in the ribosome become empty or loaded with 
deacylated-tRNA and pausing of translation at these sites takes place [92-94]. Binding of 
deacylated-tRNA in the A site of the ribosome induce the formation of the RelA Activating 
Complex (RAC). RelA binds to RAC and catalyzes the transference of the β-γ 
pyrophosphate from ATP to either GTP or GDP for the formation of pppGpp or ppGpp 
respectively [93] (pppGpp is rapidly transformed to ppGpp, thus we will refer as ppGpp). 
Once ppGpp is formed, RelA is released from the ribosome but the deacylated tRNA might 
remain bound being released passively and independent from RelA. While deacylated-
tRNA is still bound to the ribosome, it is unable to accommodate an incoming aa-tRNA/EF-
Tu/GTP complex, thus it is stalled for protein synthesis. As long as RAC is active, new RelA 
molecules can bind and catalyze the formation of ppGpp [86]. As deacylated tRNA 
passively dissociates from the ribosome the stability of the interaction with the ribosome is a 
critical factor that influences the formation of ppGpp and thus the stringent response [95]. 
Recent data on the activation of RelA has shown that stalled ribosomes loaded with weakly 
bound deacylated-tRNAs require higher concentrations of enzyme than those loaded with 
tightly bound deacylated-tRNAs [96], suggesting that the recovery of cells from stringent 
response might be dependent on the type of starved amino acid. 
3.2. Role of ppGpp in the transcription of stable RNAs and amino acids 
biosynthesis genes 
The most well known effect of an increase in the concentration of ppGpp is the down 
regulation of the rRNA and tRNA transcription and thus of ribosomes and protein 
biosynthesis upon amino acid starvation. This is primarily an effect at the transcription level 
(reviewed in [97, 95]) and requires a direct interaction of the “alarmone” with the β and β´ 
subunits of the RNA polymerase affecting several activities, but mainly reducing 
transcription of rRNA genes. Biochemical, genetic and structural data indicate that ppGpp 
binds near the active site of RNA polymerase suggesting that the vicinity of this interaction 
might be involved in some of the observed effects [99-101]. There seems to be a reduced 
stability in the interaction between RNA polymerase and DNA in the open complex upon 
binding of ppGpp to the β and β´ subunits. Open complex at rRNA promoters is 
particularly unstable, thus this might be a requirement for the observed effect [102, 103]. 
However some stable open complexes are also affected by ppGpp suggesting that other 
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mechanisms contribute to the effect of ppGpp in the activity of RNA polymerase at this level 
[104]. Other steps might be affected upon binding of ppGpp to RNA polymerase such as 
promoter clearance, open complex formation, pausing of transcription elongation and 
competition between ppGpp and other nucleotide substrates. These effects are not mutually 
exclusive and might take place at the same time.  
Although the effect on stable RNAs is the major and the most well known effect on gene 
expression, a number of other functions related to cell growth are also affected upon ppGpp 
increase in the cell. Ribosomal proteins and elongation factors gene expression are negatively 
affected as well as fatty acids and cell wall biosynthesis. DNA biosynthesis is particularly 
sensitive to ppGpp and thus to amino acid starvation since in E. coli its progression stops 
soon after induction of ppGpp accumulation [105, 106]. ppGpp binds directly to DNA 
primase inhibiting initiation of DNA replication at both lagging and leading strands [107]. 
3.3. Role of DksA in the regulation by ppGpp 
DksA is a protein that was discovered as a suppressor, when overexpressed, of the thermo 
sensitivity of dnaK mutants [108]. In addition it has many other functions, among these 
being the need of this protein and ppGpp to stimulate the accumulation of RpoS (the 
stationary phase and stress response σ factor) at the translational level [109]. A direct 
involvement of DksA potentiating the effect of ppGpp on the stringent response was 
discovered as one of its major functions [110, 111]. DskA is a structural homolog of the 
transcription elongator factors GreA and GreB [112]. These proteins bind directly to RNA 
polymerase particularly to the secondary channel of the enzyme inducing the cleavage of 
RNA in arrested enzymes rescuing them and restoring the polymerization activity. DskA 
seems to bind to RNA polymerase in a similar way, but without the induction of cleavage of 
RNA. Binding of DskA is believed to stabilize the interaction of RNA polymerase with 
ppGpp [112]. DksA can compensate the effect of a ppGpp0 mutation (complete absence of 
ppGpp) reinforcing the notion that these two factors are synergistic both in positive and 
negative regulation. But DksA has also some other roles that are opposite to ppGpp, for 
instance in cellular adhesion, indicating that although compensatory, these two factors 
might have their own role in the stringent response [114]. 
 Along with the pronounced inhibition of stable RNA transcription, positive effects on gene 
expression have also been observed upon increase of ppGpp levels. Two major ways to 
activate transcription have been proposed, direct and indirect activation. Direct activation 
implies the interaction of RNA polymerase with an efector such as ppGpp, DksA or both to 
activate transcription from a promoter. Transcription of several operons for the biosynthesis 
of amino acids, responding to the housekeeping σ70 factor, is activated by a direct 
mechanism. Promoters for the hisG, thrABC and argI are activated in vitro by a combination 
of ppGpp and DksA [112]. It is proposed that a step in the isomerization during the 
formation of the open complex is favored in the direct activation of these promoters.  
Indirect activation of a specific promoter might be the result of the inhibition of other 
promoter, usually a strong one, that increases the availability of RNA polymerase to activate 
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the target promoter [115, 116]. Evaluation of indirect activation of certain promoters comes 
mainly from in vivo studies. Activation of several σ factors other than σ70 also requires 
ppGpp. A competition mechanism that implies a reduced affinity of the core RNA 
polymerase for σ70 upon binding of ppGpp and/or DksA has been proposed, allowing to 
other σ subunits to bind to the core enzyme [117, 118]. It is speculated that RNA polymerase 
bound to strong promoters is released upon binding of ppGpp/DksA thus increasing the 
availability of the enzyme and also lowering the affinity to σ70 making the core enzyme 
available to the alternative σ factors.  
In general speaking, ppGpp inhibits σ70 promoters of genes involved in cell proliferation 
and growth and activates promoters of genes involved in stress response and maintenance.  
3.4. Targets for control of translation 
The major effect of ppGpp in protein synthesis is certainly the biosynthesis of stable RNAs 
being inhibition of the transcription of rRNA and tRNA the targets for this effect. A marked 
reduction of the general translation of mRNAs as a result of the reduction of ribosomes as 
well as tRNAs is the major response against starvation of amino acids as well as other 
nutrients. In addition to this generalized response, other components of the translation 
machinery are also affected by the stringent response. Particularly translation factors that 
use guanine nucleotides are also target of ppGpp. As G proteins, these are the factors that 
have been the subject of analysis on the effect of (p)ppGpp at the translation level. G 
proteins are generally small proteins that bind GTP. The hydrolysis of this nucleotide, 
generally assisted by a G activating protein (GAP), to form GDP that remains bound to the 
protein, is required for the function to take place. The removal of GDP and its exchange for 
GTP is generally catalyzed by additional exchange proteins (GEP) that form part of the G 
proteins cycle [119].  
Three proteins play important roles in the initiation step of translation, IF1, IF2 and IF3, 
being IF2 a G protein. IF3 binds to the ribosomal 30S subunit in the 70S ribosome releasing it 
from the 50S subunit to initiate a new cycle of elongation for the translation of an mRNA. 
IF1 assists IF3 in the releasing of the 30S subunit and also allows to the fMet-tRNAfMet to be 
positioned in the correct P site to initiate translation. IF2 is a small G protein that in complex 
with GTP (IF2-GTP) binds the initiator fMet-tRNAfMet. This ternary complex docks the fMet-
tRNAfMet in the small ribosome subunit. As the mRNA binds, IF3 helps to correctly position 
the complex such that the fMet-tRNAfMet interacts by base pairing with the initiation codon 
in the mRNA. The mRNA is correctly positioned, assisted by the interaction of the Shine-
Dalgarno sequence with the 16S rRNA, in the small 30S subunit. As the large 50S ribosomal 
subunit binds to the initiation complex, it participates as a GAP, thus GTP bound to the IF2 
is hydrolyzed and released from the complex as IF2-GDP. 
Elongation step of translation also requires in part the participation of the G-proteins EF-Tu 
and EF-G to take place. EF-Tu-GTP binds all aminoacyl-tRNAs with approximately the 
same affinity and delivers them to the A site of the ribosome in the elongation step of 
protein synthesis. Once a correct codon-anticodon interaction is detected by the ribosome, a 
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mechanisms contribute to the effect of ppGpp in the activity of RNA polymerase at this level 
[104]. Other steps might be affected upon binding of ppGpp to RNA polymerase such as 
promoter clearance, open complex formation, pausing of transcription elongation and 
competition between ppGpp and other nucleotide substrates. These effects are not mutually 
exclusive and might take place at the same time.  
Although the effect on stable RNAs is the major and the most well known effect on gene 
expression, a number of other functions related to cell growth are also affected upon ppGpp 
increase in the cell. Ribosomal proteins and elongation factors gene expression are negatively 
affected as well as fatty acids and cell wall biosynthesis. DNA biosynthesis is particularly 
sensitive to ppGpp and thus to amino acid starvation since in E. coli its progression stops 
soon after induction of ppGpp accumulation [105, 106]. ppGpp binds directly to DNA 
primase inhibiting initiation of DNA replication at both lagging and leading strands [107]. 
3.3. Role of DksA in the regulation by ppGpp 
DksA is a protein that was discovered as a suppressor, when overexpressed, of the thermo 
sensitivity of dnaK mutants [108]. In addition it has many other functions, among these 
being the need of this protein and ppGpp to stimulate the accumulation of RpoS (the 
stationary phase and stress response σ factor) at the translational level [109]. A direct 
involvement of DksA potentiating the effect of ppGpp on the stringent response was 
discovered as one of its major functions [110, 111]. DskA is a structural homolog of the 
transcription elongator factors GreA and GreB [112]. These proteins bind directly to RNA 
polymerase particularly to the secondary channel of the enzyme inducing the cleavage of 
RNA in arrested enzymes rescuing them and restoring the polymerization activity. DskA 
seems to bind to RNA polymerase in a similar way, but without the induction of cleavage of 
RNA. Binding of DskA is believed to stabilize the interaction of RNA polymerase with 
ppGpp [112]. DksA can compensate the effect of a ppGpp0 mutation (complete absence of 
ppGpp) reinforcing the notion that these two factors are synergistic both in positive and 
negative regulation. But DksA has also some other roles that are opposite to ppGpp, for 
instance in cellular adhesion, indicating that although compensatory, these two factors 
might have their own role in the stringent response [114]. 
 Along with the pronounced inhibition of stable RNA transcription, positive effects on gene 
expression have also been observed upon increase of ppGpp levels. Two major ways to 
activate transcription have been proposed, direct and indirect activation. Direct activation 
implies the interaction of RNA polymerase with an efector such as ppGpp, DksA or both to 
activate transcription from a promoter. Transcription of several operons for the biosynthesis 
of amino acids, responding to the housekeeping σ70 factor, is activated by a direct 
mechanism. Promoters for the hisG, thrABC and argI are activated in vitro by a combination 
of ppGpp and DksA [112]. It is proposed that a step in the isomerization during the 
formation of the open complex is favored in the direct activation of these promoters.  
Indirect activation of a specific promoter might be the result of the inhibition of other 
promoter, usually a strong one, that increases the availability of RNA polymerase to activate 
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the target promoter [115, 116]. Evaluation of indirect activation of certain promoters comes 
mainly from in vivo studies. Activation of several σ factors other than σ70 also requires 
ppGpp. A competition mechanism that implies a reduced affinity of the core RNA 
polymerase for σ70 upon binding of ppGpp and/or DksA has been proposed, allowing to 
other σ subunits to bind to the core enzyme [117, 118]. It is speculated that RNA polymerase 
bound to strong promoters is released upon binding of ppGpp/DksA thus increasing the 
availability of the enzyme and also lowering the affinity to σ70 making the core enzyme 
available to the alternative σ factors.  
In general speaking, ppGpp inhibits σ70 promoters of genes involved in cell proliferation 
and growth and activates promoters of genes involved in stress response and maintenance.  
3.4. Targets for control of translation 
The major effect of ppGpp in protein synthesis is certainly the biosynthesis of stable RNAs 
being inhibition of the transcription of rRNA and tRNA the targets for this effect. A marked 
reduction of the general translation of mRNAs as a result of the reduction of ribosomes as 
well as tRNAs is the major response against starvation of amino acids as well as other 
nutrients. In addition to this generalized response, other components of the translation 
machinery are also affected by the stringent response. Particularly translation factors that 
use guanine nucleotides are also target of ppGpp. As G proteins, these are the factors that 
have been the subject of analysis on the effect of (p)ppGpp at the translation level. G 
proteins are generally small proteins that bind GTP. The hydrolysis of this nucleotide, 
generally assisted by a G activating protein (GAP), to form GDP that remains bound to the 
protein, is required for the function to take place. The removal of GDP and its exchange for 
GTP is generally catalyzed by additional exchange proteins (GEP) that form part of the G 
proteins cycle [119].  
Three proteins play important roles in the initiation step of translation, IF1, IF2 and IF3, 
being IF2 a G protein. IF3 binds to the ribosomal 30S subunit in the 70S ribosome releasing it 
from the 50S subunit to initiate a new cycle of elongation for the translation of an mRNA. 
IF1 assists IF3 in the releasing of the 30S subunit and also allows to the fMet-tRNAfMet to be 
positioned in the correct P site to initiate translation. IF2 is a small G protein that in complex 
with GTP (IF2-GTP) binds the initiator fMet-tRNAfMet. This ternary complex docks the fMet-
tRNAfMet in the small ribosome subunit. As the mRNA binds, IF3 helps to correctly position 
the complex such that the fMet-tRNAfMet interacts by base pairing with the initiation codon 
in the mRNA. The mRNA is correctly positioned, assisted by the interaction of the Shine-
Dalgarno sequence with the 16S rRNA, in the small 30S subunit. As the large 50S ribosomal 
subunit binds to the initiation complex, it participates as a GAP, thus GTP bound to the IF2 
is hydrolyzed and released from the complex as IF2-GDP. 
Elongation step of translation also requires in part the participation of the G-proteins EF-Tu 
and EF-G to take place. EF-Tu-GTP binds all aminoacyl-tRNAs with approximately the 
same affinity and delivers them to the A site of the ribosome in the elongation step of 
protein synthesis. Once a correct codon-anticodon interaction is detected by the ribosome, a 
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conformational change in the ribosome takes place that induces the release of the EF-Tu 
factor along with the hydrolysis of GTP, thus the ribosome in this conformation acts as the 
GAP for the EF-Tu-GTP complex. EF-Ts is the GEP that assists EF-Tu-GDP to exchange GDP 
for GTP to initiate another elongation cycle. 
EF-G is a G protein factor that complexed with GTP participates in the translocation of the 
nascent peptidyl-tRNA in the ribosome. Peptidyl transferase activity of the 23S RNA in the 
50S subunit forms the peptide bond between the newly incorporated aminoacyl-tRNA in the 
A site delivered by EF-Tu and the existing peptidyl-tRNA already positioned in the P site 
from previous elongation cycles. The new peptidyl-tRNA with one extra amino acid is 
translocated from the A to the P site by EF-G-GTP. This process also implies the movement 
of the free tRNA positioned in the P site to the E site in the ribosome. EF-G itself seems to 
carry its own GEP. 
RF3 releasing factor is also a G protein that participates in the termination of translation. Its 
function will not be discussed in this article.  
As it is expected, these G proteins have been the subject of attention as potential targets for 
the action of ppGpp in the control of translation under the stringent response. GTP is at very 
high concentrations in the cell reaching more than 1 mM under normal growth conditions 
whereas GDP reaches very low concentrations. Upon amino acid starvation ppGpp can 
accumulate at the expenses of GTP that lowers its concentrations to nearly 50% [120-122]. 
Both nucleotides reach similar concentrations, thus depending on their affinities for the 
binding sites in proteins, they might compete. It is expected that G proteins can be severely 
affected under starvation since the levels of GTP are lowered, but also because ppGpp might 
interfere with its function. These proteins have been target of analysis since the early periods 
after discovery of the alarmone as the factor that influenced the stringent response. Initial 
studies indicated that pppGpp was able to substitute GTP in the reactions of EF2 and EF-Tu, 
but not in the function of EF-G [123]. Later studies revealed that EF-Tu as well as EF-G are 
inhibited by ppGpp, but this inhibition is dependent on the conditions of the reaction. EF-Tu 
is inhibited only if EF-Ts is not present. The inhibition can be fully reversed by the presence 
of aminoacyl-tRNA and EF-Ts [124].  
As was mentioned before, IF2 is a G protein involved in the initiation of translation. This 
factor interacts in the initiation process with different ligands, ribosomal subunits, fMet-
tRNAfMet, GTP, GDP as well as ppGpp [125]. This protein participates in the entire initiation 
process and it has been shown by several methodologies that different conformational 
changes are necessary to each step. Because of the similar affinities of IF2 with GTP and 
GDP (dissociation constants between 10-100 µM), it is expected that under normal growth 
conditions (GTP 1 mM), IF2 binds the 30S subunit mostly with GTP bound. Hydrolysis of 
GTP, upon binding of the 50S subunit triggers the release of IF2-GDP from the initiation 
complex. Because this hydrolysis has not been proven as essential for this process, it led 
Milon et al. (2006) [126] to question the real role of this activity and asked about the reason 
for the evolutionary conservation of this process. The binding site of GTP and GDP in IF2, as 
well as in other G proteins involved in translation, is also the binding site for ppGpp. NMR 
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data illustrates that ppGpp binds basically in the same site as GDP, although some 
differences might account for the different structure and function. To test the role of ppGpp 
on the IF2 function the authors measured the effect on different steps of the initiation 
process, i.e. binding of the fMet-tRNAfMet, dipeptide formation, and the translation from the 
initiation codons on mRNAs containing AUG or AUU as initiator codon (the later being 
more dependent on IF2). All these steps in initiation of translation are severely affected 
upon ppGpp binding. From these studies the authors concluded that binding of ppGpp to 
IF2 might represent the signal to inhibit translation under conditions of metabolic shortage 
[126]. Thermodynamic analysis revealed that ppGpp binds to IF2 with higher affinity than 
to EF-G. Binding of fMet-tRNAfMet to IF2 occurs with little variation in the presence of 
ppGpp compared to GTP while it is very sensitive to the nucleotides when complexed with 
the 30S subunit [127]. These results support the notion that initiation of translation is 
preferentially regulated by ppGpp under conditions of nutrient starvation. 
3.5. Translation accuracy in the stringent response 
Translational accuracy has been a topic of debate since the discovery of the stringent 
response. It is known that under amino acid starvation, rel+ cells translation is at least 10 fold 
more accurate than in rel- although the rate of protein synthesis is the same in either type of 
cell. Different interpretations for this accuracy have been proposed, i.e. increased ribosome 
proof reading by ppGpp upon binding of either initiation or elongation factors, alterations 
of A site in the ribosome by binding of uncharged tRNA and different ribosome states 
controlled by the binding of ppGpp. It has also been proposed that there is no need for a 
special mechanism to maintain accuracy of translation since under amino acid starvation 
concentration of charged tRNA is not reduced as much as uncharged tRNA is increased 
[128]. At the same time, uncharged tRNA might bind to the A site in the ribosome 
competing for non-cognate tRNA thus reducing the chance to enter in the A site with the 
incorrect codon. Reduction in the activity of EF-Tu at the A site upon binding of ppGpp 
might reduce the chance to an error in translation. Measurements of aminoacylation levels 
for several tRNA revealed that rel- strains have at least five fold less aminoacyl-tRNAs than 
rel+ strains suggesting that increased inaccuracy in these strains might be explained only by 
the charging level of tRNAs rather than other particular mechanisms [129]. These results 
imply that accuracy of translation is not affected under stringent response because there are 
either particular mechanisms that account for it or because there is a combination of effects 
(based on the real concentration of aminoacyl-tRNA, deacylated-tRNA bound to the A site 
of ribosome and the reduction in the translation rate by inhibition of IF2 and EF-Tu 
functions) that minimize the possibility that non-cognate aminoacyl-tRNAs enter the A site 
of the ribosome.  
3.6. Overview of the effects of stringent response on translation 
Upon amino acid starvation a generalized response, the stringent response, is achieved in 
bacterial cells. The major effector of this response is the marked increase of the cellular 
concentration of the nucleotide ppGpp, also known as the “magic spot” or the “alarmone”. 
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conformational change in the ribosome takes place that induces the release of the EF-Tu 
factor along with the hydrolysis of GTP, thus the ribosome in this conformation acts as the 
GAP for the EF-Tu-GTP complex. EF-Ts is the GEP that assists EF-Tu-GDP to exchange GDP 
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data illustrates that ppGpp binds basically in the same site as GDP, although some 
differences might account for the different structure and function. To test the role of ppGpp 
on the IF2 function the authors measured the effect on different steps of the initiation 
process, i.e. binding of the fMet-tRNAfMet, dipeptide formation, and the translation from the 
initiation codons on mRNAs containing AUG or AUU as initiator codon (the later being 
more dependent on IF2). All these steps in initiation of translation are severely affected 
upon ppGpp binding. From these studies the authors concluded that binding of ppGpp to 
IF2 might represent the signal to inhibit translation under conditions of metabolic shortage 
[126]. Thermodynamic analysis revealed that ppGpp binds to IF2 with higher affinity than 
to EF-G. Binding of fMet-tRNAfMet to IF2 occurs with little variation in the presence of 
ppGpp compared to GTP while it is very sensitive to the nucleotides when complexed with 
the 30S subunit [127]. These results support the notion that initiation of translation is 
preferentially regulated by ppGpp under conditions of nutrient starvation. 
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proof reading by ppGpp upon binding of either initiation or elongation factors, alterations 
of A site in the ribosome by binding of uncharged tRNA and different ribosome states 
controlled by the binding of ppGpp. It has also been proposed that there is no need for a 
special mechanism to maintain accuracy of translation since under amino acid starvation 
concentration of charged tRNA is not reduced as much as uncharged tRNA is increased 
[128]. At the same time, uncharged tRNA might bind to the A site in the ribosome 
competing for non-cognate tRNA thus reducing the chance to enter in the A site with the 
incorrect codon. Reduction in the activity of EF-Tu at the A site upon binding of ppGpp 
might reduce the chance to an error in translation. Measurements of aminoacylation levels 
for several tRNA revealed that rel- strains have at least five fold less aminoacyl-tRNAs than 
rel+ strains suggesting that increased inaccuracy in these strains might be explained only by 
the charging level of tRNAs rather than other particular mechanisms [129]. These results 
imply that accuracy of translation is not affected under stringent response because there are 
either particular mechanisms that account for it or because there is a combination of effects 
(based on the real concentration of aminoacyl-tRNA, deacylated-tRNA bound to the A site 
of ribosome and the reduction in the translation rate by inhibition of IF2 and EF-Tu 
functions) that minimize the possibility that non-cognate aminoacyl-tRNAs enter the A site 
of the ribosome.  
3.6. Overview of the effects of stringent response on translation 
Upon amino acid starvation a generalized response, the stringent response, is achieved in 
bacterial cells. The major effector of this response is the marked increase of the cellular 
concentration of the nucleotide ppGpp, also known as the “magic spot” or the “alarmone”. 
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This nucleotide is synthetized in the ribosome by the RelA protein upon activation by the 
presence in the A site of the ribosome of deacylated-tRNA. Two major effects on translation 
of the genetic information are observed. First, the dramatic reduction on the transcription of 
stable RNAs, i.e. rRNAs and tRNAs. The binding of ppGpp to the β and β´ of RNA 
polymerase triggers this effect by the destabilization of the open complex between RNA 
polymerase and strong promoters of stable RNAs. As consequence a marked reduction in 
the concentration of ribosomes and tRNAs slows down the translation of mRNAs. The 
second effect of the increase in the concentration of ppGpp on translation is an inhibition of 
translation itself by the effect on initiation and elongation steps. IF2, EF-Tu as well as EF-G 
are affected by the binding of ppGpp, but it seems likely that the initiation of translation 
through the inhibition of the IF2 function is the preferred target for the action of ppGpp to 
modulate the translation process. Accordingly, it has been proposed that IF2 might be a 
sensor to modulate translation depending on the nutritional status of the cell. 
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